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Abstract
Far from being a passive demarcation between the cell and the environment, the cellular membrane is a
vibrant and dynamic ecosystem. Membrane proteins constitute an integral piece of this ecosystem, allowing
for communication between the cell and its environment that is necessary for adaptation and robustness of
the cell. Often, membrane proteins are expressed in a default inactive state requiring a signal from either the
extracellular milieu or from the cell itself to be activated, undergoing a significant structural shift in order
to perform its function. Due to the transient nature of these activated states, however, it has been difficult
to characterize the structural transitions needed to activate peripheral and integral membrane proteins. The
work presented herein leverages molecular dynamics (MD) simulations as a method to explore and charac-
terize the dynamics of both peripheral and integral membrane proteins in the context of the membrane.
While MD simulations have unrivaled spatiotemporal resolution, the timescales accessible to MD simula-
tions often prevents characterization of spontaneous membrane insertion of peripheral proteins. Many biasing
protocols have been developed to observe the binding of peripheral membrane proteins on the timescales
routinely accessible in MD simulations. These protocols, however, inherently bias the final structure derived
from the study. A novel membrane mimetic model, termed the highly mobile membrane mimetic (HMMM), is
presented which shows expedited lipid dynamics and decreased time to insertion for peripheral proteins. The
physicochemical properties of the model are fully characterized and compared to conventional membranes,
showing good agreement with key elastic, electric, and energetic properties of the membrane. Moreover, the
HMMM model is utilized to simulate the unbiased binding of a peripheral protein, the talin F2F3 subdo-
main. In addition to characterizing the membrane-bound form of this protein, which has remained elusive
to multiple crystallization studies, the simulations describe a large, interdomain conformational change that
reconciles previous discrepancies between biochemical and structural studies.
In addition to the studies on peripheral proteins, MD simulations were utilized to probe the dynamics
of a ligand-gated ion channel (LGIC) in response to anesthetics, which antagonize channel function. There
is significant debate over the proper anesthetic binding site in LGICs, with extracellular, transmembrane,
and ion conduction pore mechanisms proposed. A variety of molecular dynamics techniques, starting from
parameterization of the anesthetics to free energy calculations, have been utilized and show that anesthetics
bind to a transmembrane site identified in crystal structures. An additional and previously undescribed
binding site was discovered in the simulations that stabilizes the anesthetic in the previously unidentified
site as shown by free energy and mutation studies. Moreover, conformational changes in the transmembrane
accompanied anesthetic binding that immensely increase the energy barrier to sodium conduction.
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Chapter 1
Introduction: The Membrane as a Vibrant Ecosystem
“If you want to have good ideas, you must have many ideas. Most of them will be wrong, and what you have
to learn is which ones to throw away.” –Linus Pauling
Once thought of as a passive barrier to the diffusion of molecules such as nutrients and waste products,
it is now known that the cellular membrane is a vibrant and dynamic ecosystem. In the simplest terms,
the cellular membrane is composed of a double layer of amphiphilic molecules, called lipids, which forms
an outer hydrophilic layer that interacts with aqueous environments and an inner hydrophobic layer that
effectively insulates the cell from its environment. This description, however, ignores the contribution that
lipids make to the dynamics and functionality of the cellular membrane. The composition of lipids in the
cellular membrane determines a wide array of membrane properties, including electrical [1, 2] and elastic [3–
5] properties, phase behavior [3, 6], and protein binding affinity and function [7–9]. In addition to affecting
physical membrane properties, several lipid species acts as a potent chemical signal. For example, bacterial
lipopolysaccharides (endotoxin) act as a potent inflammatory signal, steroid hormones regulate functions
ranging from water homeostasis to development of secondary sex characteristics, and phosphatidylserine
(PS) activates coagulation [10] as well as apoptotic [11] pathways. Therefore, the lipid composition of the
membrane is very tightly controlled and regulated by the cell, with about 5% of the genome dedicated to
lipid metabolism [9].
While there is a high level of heterogeneity, the cellular membrane is comprised mostly of glycerophos-
pholipids. Each glycerophospholipid (referred to as lipid(s) herein) is composed of four chemical building
blocks (Fig. 1.1): two extended hydrocarbon “tails” that form the hydrophobic interior of the membrane,
an interfacial glycerol backbone, and a phosphate-linked “headgroup” that forms the water soluble exterior
of the membrane. From these basic building blocks, it has been estimated that there are over 1000 types of
naturally occurring lipids [12], which provides considerable complexity and diversity to cellular membranes.
Despite the multitude of lipid species, phosphatidylcholine (PC) lipids comprise well over 50% of the lipids
in the eukaryotic cellular membrane [9, 13], most likely due to their net neutral charge and cylindrical shape
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Figure 1.1: Chemical Components and Structures of Common Phospholipids. Each glycerophospholipid is com-
posed of four chemical building blocks: two hydrocarbon tails (yellow background) which form the hydrophobic interior of the
membrane, a glycerol backbone (green background), and a phosphate-linked headgroup, which forms the water soluble exterior
of the lipid bilayer. Headgroups are generally classified as either zwitterionic (blue background), meaning the headgroup has a
net neutral charge, or anionic (red background), meaning the headgroup has a net negative charge. Shown are two examples
of common biological phospholipids: POPC (bottom left) and DOPS (bottom right). Each of the atoms in these molecules are
colored based on component they belong to (e.g., gold for lipid tail, green for glycerol and red/blue for headgroup.
that provides much of the force for bilayer formation [14]. Other common biological phospholipid head-
groups, such as PS and phosphatidylethanolamine (PE), are found in smaller concentrations and almost
always in the cytosolic leaflet, as their conical shape induces stress curvature that contributes to the overall
shape of the cell. Additionally, sequestration of these lipids to the cyotsolic leaflet induces a transbilayer
asymmetry that serves as the basis for the chemical signaling detailed above.
While phospholipids are essential for separating the cell from the extracellular milieu, the cellular mem-
brane is not a vast, unending ocean of phospholipids. In fact, membrane proteins occupy anywhere from
20–75% of the cellular membrane surface area, depending on the cell type [15], and are estimated to account
for 30% of human genes [16–18]. Membrane proteins are abundant because they are essential for maintaining
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communication between the cell and its environment across the cellular membrane. These proteins serve
essential functions such as glucose [19] and amino acid [20] transport, steroid reception [21], action potential
propogation [22], and even maintenance of the transbilayer asymmetry discussed earlier [23]. Underscoring
their importance, mutations that alter membrane protein function lead to grave cellular irregularities that
can manifest as cystic fibrosis, cancer, diabetes, and stroke. Thus, roughly half of the drugs available and
prescribed today target membrane proteins [24].
Membrane proteins belong to one of two major classes (Fig. 1.2): peripheral membrane proteins or
integral membrane proteins [25]. The division of membrane proteins into two classes is based on how inti-
mate the contact between protein and membrane is. For peripheral membrane proteins, association with the
cellular membrane is superficial. In general, a reversible membrane anchor determines whether or not the
protein is stabilized by the membrane. When exposed, the protein binds to the membrane. Conformational
changes, however, that lead to the concealment of the membrane anchor tend to solubilize the protein. Thus,
peripheral proteins can reversibly bind the membrane. In contrast, integral membrane proteins contain one
or more transmembrane helices. These proteins are very initmately assocaited with the membrane, due to
expansive hyrophobic belts, which are large sections of hydrophobic residues in the center of these helices.
Figure 1.2: Classification of Membrane Proteins. An example of a peripheral membrane protein (green) and an integral
membrane protein (blue) are depicted. The peripheral membrane protein has a reversible membrane anchor (tan) that allows
the protein to be stabilized on the membrane surface when exposed and allows the protein to be solublizied when concealed.
The integral membrane protein has a large section of each transmembrane helix that is completely hydrophobic which keeps
the protein embedded in the membrane.
3
The hydrophobic belts ensure that the protein remains completely embedded within the membrane. Integral
membrane proteins are often involved in transport and signaling. Although they interact with the membrane
differently, peripheral and integral membrane proteins will often work together to propogate signals that lead
to communication between the intra- and extracellular environments as is seen in the talin/integrin system
discussed below.
1.1 Barriers to Studying Membrane Proteins with Molecular Dynamics
Figure 1.3: Simple Molecular Dynamics System with
Potential Functions. Cartoon representation of a simple
molecular dynamics simulation system. Here, each teal bead
represents one atom and the colored lines represent bonds be-
tween atoms. Each of the five fundamental potential functions
are shown (Ubond, red; Uangle, green; Udihedral, blue; Uelec, or-
ange; UvdW , purple) along with an accompanying illustration of
how they act on the molecular structure, either through bonds
(red, green, and blue “bonded” terms) or through space (orange
and purple “non-bonded” terms).
Molecular dynamics (MD) simulations is an unpar-
alleled tool for studying the functional dynamics
of membrane proteins in atomic detail. Unlike ex-
perimental techniques, MD simulations have simul-
taneous sub-A˚ngstro¨m/femstosecond spatiotempo-
ral resolution, allow for direct visualization of the
dynamics of the molecule, and are not limited to
exploring physical states. Often, MD simulations
can make use of artificial potentials and alternative
chemical structures not accessible by experimental
techniques to creatively answer structural questions
raised by experimental results [26]. Yet, as with any
other scientific method, there are disadvantages to
MD simulations. Currently, most researchers can
sample the dynamics of biological systems up to the
sub-microsecond (µs) timescale, with a select few
researchers recently being able to simulate into millisecond (ms) times [27–29] through the use of specialized
hardware or access to large amounts of time on supercomputers. Most biological phenomena happen on
timescales that are ms or greater, however. This makes direct comparison between experimental observa-
tions and simulation reults difficult and indirect. Moreover, MD simulations require membrane proteins with
solved crystal structures as a starting point, which necessarily limits the scope of work able to be conducted.
Most commonly, MD simulations utilize classical mechanics to describe the dynamics of a molecular
system by solving a stochastic derivation of Newton’s equations of motion, called the Langevin equation, for
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all N atoms in the system [30, 31]:
Fi − γmir˙i + η(t) = mir¨i i = 1, 2, ..., N (1.1)
where Fi is the applied force on the i
th atom, γ is the Langevin damping coefficient, mi is the mass, r˙i is the
velocity, η(t) is a random noise term, and r¨i is the acceleration. The force felt by each atom is dependent
on a number of factors, each of which is accounted for in the potential function, U(r):
Fi = −∇U(ri), U(ri) = Ubond + Uangle + Udihedral + Uelec + UvdW (1.2)
where Ubond is the potential function for the bond length between two connected atoms, Uangle is the potential
function for the angle between three connected atoms, Udihedral describes the potential function for the
torsional angle between four connected atoms, Uelec is the Coulomb energy between two atoms, and UvdW
describes the van der Waals interaction between two atoms (Fig. 1.3). These potential functions are generally
grouped into “bonded” terms (Ubond, Uangle, Udihedral), which exert their forces through bonded atoms, and
“non-bonded” terms (Uelec, UvdW ), which exert their effects through space. The potential functions of these
two groups are quite different. Bonded potentials generally take the form of a simple harmonic (see Fig. 1.3
for exact form of bonded potentials):
U = k (ζ − ζ0)2 (1.3)
where k is the harmonic constant of the potential, ζ is the current value of the parameter (i.e., bond length,
bond angle, dihedral) and ζ0 describes the equilibrium value of the parameter. Each of the non-bonded
potentials have a unique expression, Uelec being the Coulomb potential and UvdW being the Lennard-Jones
potential:
Uelec =
qiqj
4piε0rij
, UvdW = 
(Reqij
rij
)12
− 2
(
Reqij
rij
)6 (1.4)
where qi is the charge of the i
th atom, rij is the distance between the two atoms, ε0 is the permittivity of
free space,  is the potential well (strength of interaction), and Reqij is the equilibrium distance between the
two atoms. The values for all of these parameters are collected into “force fields”, the accuracy of which are
crucial to reliable MD simulations.
While the formalism is quite simple to develop, solution of these equations is hindered by the sheer size of
the systems studied. Systems containing membrane proteins routinely range from N = 100, 000−1, 000, 000
atoms in size, meaning that for each step forward taken in time, N potential functions need to be calculated,
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followed by N gradient calculations, and, lastly, N applications of force. Because our timestep is limited
to 2 fs, based on the vibration frequency of chemical bonds, it becomes clear why simulations are restricted
to the sub-µs range. Since non-bonded terms (i.e., van der Waals and electrostatic forces) consume most
of the time required for calculation, focus has naturally shifted towards reducing the computational cost of
these terms. Introduction of cut-off distances has reduced the number of van der Waals calculations and
the particle mesh Ewald sums method has decreased the time required to calculate long-range electrostatic
terms [32]; moreover, adaptation of MD code to graphics processing units has increased the number of
computations per unit time [33, 34]. The problem of timescales remains, however.
This problem is exacerbated when wanting to study membrane phenomena. The lateral diffusion of lipids
is extremely slow, 10−8 cm2s−1 [35, 36], due to the disordered and entangled nature of the lipids’ extended
hydrocarbon tails, meaning that in a typical 100 ns simulation, any given lipid might only diffuse 10 A˚ from
its initial position. While this environment is restrictive to integral proteins, accomodation of the membrane
to insertion of peripheral proteins is essentially prohibited at these timescales. Methods such as implicit
membranes [37, 38], coarse-grained models [39, 40], and non-equilibrium simulations [41] have been utilized
to generate membrane-bound forms of peripheral proteins. Each of these methods, however, suffer from
drawbacks such as a lack of atomic detail and inherent biases in the final model. The focus of the first two
chapters of this work represents a novel approach aimed at generating membrane-bound forms of peripheral
proteins unbiasedly:
Chapter 2 – The slow dynamics of lipids on the timescales accessible by MD simulations has
necessitated the development of protocols that expedite protein insertion, either by decreasing
atomic detail or artificially forcing proteins into the membrane. Here, we detail a novel method
that decreases the time needed to observe spontaneous insertion of peripheral proteins. Utilizing
the idea that the membrane can be divided into a polar and non-polar region, we approximate
the membrane interface as a biphasic solvent system. This biphasic solvent system provides a
much more fluid hydrophobic volume, as measured by diffusion constants of the organic phase,
expediting the dynamics of protein insertion. We utilize the human Protein C (hPrC) GLA
domain as a test case for this new system, as the membrane-bound structure has been previously
simulated, demonstrating efficient identification of the bound form.
Chapter 3 – The headgroup character and composition of the membrane can have drastic effects
on the both the kinetics and thermodynamics of protein binding. Therefore, in order to fully
understand the role of lipids in forming protein-lipid interactions, atomic-detail lipid headgroups
are necessary; however, this aspect is omitted in the biphasic solvent system model. In this
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chapter, we detail the addition of short-tailed lipids to the interface of the biphasic system from
Chapter 2, which function as a highly mobile headgroup representation, in a novel model we have
termed the highly mobile membrane mimetic (HMMM) model. We show that the short-tailed
lipids expedite headgroup dynamics compared to conventional membranes, allowing for faster
insertion of the GLA domain test case. In addition, we calculate membrane physical constants
and energetics of insertion for comparison with conventional, full-tailed membranes.
1.2 Talin-Dependent Integrin Activation: A Conformational “Switch” to
Platelet Adhesion
Integrin is a ubiquitous protein essential to physiological functions such as embryonic development, basement
membrane attachment, leukocyte recruitment, tumor metastasis, and platelet coagulation [42–45]. Integrins
are heterodimers composed of one α and one β subunit (Fig. 1.4a), with the mammalian genome encoding
for 18 unique α subunits and 8 unique β subunits that can be assembled into 24 distinct heterodimers [42].
Each subunit is composed of a short cytoplasmic domain, a single pass transmembrane helix called the “tail”,
and a large extracellular domain [46, 47] that binds extracellular matrix proteins (i.e., fibrinogen, collagen,
laminin, etc.) [48]. Most integrins, however, are expressed in a low ligand affinity or “off” state in which the
α- and β-tails are stably interacting (Fig. 1.4b) and the extracellular domain cannot bind ligand [42, 43, 47].
Figure 1.4: Talin-Mediated Integrin Activation. (a) This diagram demonstrates the two main conformational states
of the integrin αβ heterocomplex: resting and activated. In the resting state, the integrin αβ complex is bent such that the
ligand-binding domain is angled toward the membrane and unable to bind the extracellular matrix. Upon talin binding to
integrin, the transmembrane domains (“tails”) are separated, leading to conformational changes in the extracellular domain
and binding of the extracellular matrix.
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The inactive state is maintained by two separate interactions in the transmembrane domain termed the inner
membrane clasp (IMC), which is a GX3G motif, and the outer membrane clasp (OMC), which is composed
of a conserved, intermolecular salt bridge [49]. In response to certain signals, the α- and β-tails of integrin
are separated in a process termed “integrin activation” [50], causing a large conformational change that
takes the extracellular domain from bent extended (Fig. 1.4a), and also leads to a high ligand affinity or
“on” state in which integrin binds its substrate [51].
The most potent integrin activating signal is the cytoskeletal-assocaited peripheral protein, talin [51–
53]. Talin is a large protein (270 kDa) composed of a large C-terminal rod domain (talin rod domain;
TRD) that interacts mainly with cytoskeletal elements and a smaller N-terminal head domain (talin head
domain; THD) [54, 55], which interacts with the membrane and contains the integrin binding site [53, 56–
58]. It is known that talin requires acidic phospholipids to both bind the membrane [59–61] and to activate
integrin [62], demonstrating the importance of the membrane in adhesion signaling. Mutational data suggests
that basic residues in the F2 subdomain of the THD contact the membrane [60, 63, 64] while basic residues in
the F3 subdomain interact with integrin at the membrane surface [61]. The crystal structures for talin solved
in aqueous solution (i.e., in the absence of any membrane structure) [60, 63], however, appear to prohibit
simultaneous binding of both the F2 and F3 subdomains. Additionally, no study to date has identified a
hydrophobic membrane anchor, which is essential to stabilizing peripheral proteins on the membrane surface.
These results suggest that the membrane induces conformational changes in the THD that leads to an active
state capable of separating the integrin tails. Therefore, understanding how talin binds to and interacts
with the membrane is essential to understanding the integrin activation process. The focus of Chapter 4 is
on understanding the membrane-binding process and membrane-bound structure of talin as well as gaining
insight into how integrin is activated in the membrane utilzing the HMMM model developed in Chapter 3:
Chapter 4 – While it is known that talin only activates integrin at the membrane surface, very
little is known about the membrane-bound form of talin and how the protein interacts with
membrane lipids. Here, we detail a series of studies aimed at characterizing and understanding
the membrane-binding of talin. Using the HMMM model detailed in Chapter 3, the membrane-
binding of talin F2F3 to the membrane surface was simulated several times and spontaneous
binding was observed across all simulations. Multiple molecular mechanisms important for the
complete membrane binding of the protein were elucidated, including description of a previously
unidentified membrane anchor as well as a large-scale conformational change that helps explain
integrin activation. Further, simulations of mutant isoforms show that the newly elucidated
membrane anchor is essential for proper membrane-binding of talin.
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1.3 Anesthetic Modulation of Ion Channel Dynamics
Widespread use of general anesthetics as a medical and surgical tool began in the 1850s with relatively simple
chemicals such as chloroform and ether [65]. Since that time, the number of clinically-used anesthetics
has grown significantly, but our understanding of the molecular mechanism behind general anesthesia is
still incomplete. Early theories focused on a non-specific membrane disruption mechanism [66], called the
Meyer-Overton hypothesis. In the past few decades, however, several lines of evidence has pointed to several
groups of ion channels as the primary targets of general anesthetics, including the Cys-loop superfamily of
receptors, voltage-gated cation (Na+ and K+) channels, and K+ leak channels. Most studies, including the
work presented herein, have focused on the Cys-loop receptors.
The Cys-loop receptors are a family of post-synaptic, ionotropic channels that are an essential component
of neurotransmission, responding to a variety of neurotransmitters [67, 68]. Members of this family, such as
nicotinic acetylcholine receptor (nAChR) and type A GABA receptor (GABAAR), are the major targets of
anesthetics such as alcohols, barbituates, benzodiazepines, and volatile anesthetics, with cation-permeable
channels being inhibited by anesthetics and anion-permeable channels potentiated by anesthetics [69, 70].
The Cys-loop receptors are pentameric structures with a five-fold symmetry axis located coaxial with the ion
conduction pore (Fig. 1.5). Each subunit is composed a an extracellular domain (ECD) where agonist binds,
a transmembrane domain (TMD) where anesthetics are thought to bind, and an intracellular domain [67, 69–
71]. Understanding of how anesthetics bind these channels, however, has been hindered by the difficulty
associated with structural characterization of eukaryotic membrane proteins (i.e., difficulties in protein
production, necessity of cholesterol for function, etc.). Several low resolution (>4 A˚) structures of nAChR
exist [72–76], however, this resolution is not sensitive enough to determine the position of any anesthetics
bound to the channel, nor is the resolution high enough to unambiguously assign sidechain conformations
and any changes that might occur upon anesthetic binding.
Recently, bioinformatics studies discovered a group of prokaryotic homologues of the Cys-loop receptor
superfamily [77] and several structures of these channels, including GLIC (Gloeobacter violaceus ligand-
gated ion channel) [78–83] and ELIC (Erwinia chrisanthemi ligand-gated ion channel) [84, 85], have been
solved to date. These prokaryotic homologues show the same pentameric structure as their eukaryotic
counterparts, with the exception of the intracellular domain, which has been shortened to a small loop in
the prokaryotic channels. [71] Moreover, these channels have been shown to be sensitive to clinical, and in
some cases sub-clinical, concentrations of commonly used anesthetics [86, 87]. Multiple techniques, including
photolabeling [88–90], mutagenesis [91, 92], NMR [93], crystallography [80, 82], and simulation [94–96], have
been utilized to characterize binding of anesthetics to these channels, often with conflicting results. The
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Figure 1.5: Schematic of Cys-Loop Receptor Ligand-Bound States. Depicted in these cartoons are the structural
transitions thought to occur in the TMD of Cys-loop receptors with ligand bound (resting state, left), with agonist bound (open
state, middle), and with both agonist and anesthetic bound (anesthetized state, right). Shown in the inset of each panel is a
cross-sectional view of the channel through the transmembrane domain approximately located at the black dashed line. The
white pentamer demonstrates the five-fold symmetry axis of the channel.
solution of a GLIC structure with anesthetics bound, however, has created the opportunity for detailed
molecular study of anesthetic binding by MD simulations, which forms the focus of Chapters 5–6.
Chapter 5 – With the solution of multiple structures of pLGICs in multiple proposed states,
MD simulations are poised to make a significant contribution to understanding the effects of
general anesthetics on ion channels. There is a distinct lack of thoroughly tested parameters for
the most commonly used general anesthetics, however, which has hindered progress in this field.
In this chapter, we utilized the novel Force Field Toolkit machinery to parameterize four ubiq-
uitous general anesthetics: desflurane, isoflurane, sevoflurane, and propofol. These models were
validated against several experimentally determined physicochemical properties to ensure their
accuracy, including dipole moment, density, heat of vaporization and free energy of solvation.
Moreover, we utilized these novel models to determine if clinical concentrations of general anes-
thetics have any effect on the structure of the membrane. Through structural measurements such
as membrane width, area per lipid, order parameters, hydration dynamics, and stress profiles,
we observed that clinical concentrations of anesthetics do not greatly alter membrane structure.
Chapter 6 – Despite multiple methods and studies, a consensus binding site for general anesthet-
ics has yet to be described. Whereas experimental approaches determine binding sites indirectly
via mutation/function studies, MD simulations can be used to directly visualize binding. Here,
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we describe a set of studies aimed at describing and characterizing the anesthetic binding site
in GLIC. Utilizing the parameters developed in Chapter 6, we performed simulations on a fully
desflurane-bound structure that showed the anesthetic was unstable in the binding site identified
in the crystal structure. Independent flooding simulations identified two putative binding sites,
one of which was novel and adjacent to the crystal structure site. Free energy calculations as
well as mutant simulations demonstrate that the novel binding site increases anesthetic affinity
for the binding site first identified in the crystal structure.
1.4 General Simulation Protocols
While techniques unique to each chapter will be discussed within that chapter, there is significant overlap in
simulation protocols acorss all chapters that an introduction to general simulation conditions are warranted.
All simulations were performed with NAMD2 [97] utilizing the CHARMM36 set of force field parameters
for lipids [98] and the CHARMM27 set of force field parameters [99] with the CMAP correction terms [100].
The TIP3P water model was used throughout all simulations [101]. Unless otherwise noted, simulations
were performed at a temperature of 310 K and a pressure of 1.0 atm. Constant temperature was maintained
by Langevin dynamics, utilizing a damping coefficient of 1 ps−1, and constant pressure was maintained
with the Nose´-Hoover Langevin piston method [102, 103]. Long-range interactions were cut-off after 13.5 A˚
with a smoothing function applied between 10.0-13.5 A˚. Full electrostatics were calculated utilizing the
particle mesh Ewald (PME) sums method [32] with a grid density greater than 1 A˚−3. A timestep of 2 fs was
utilized across all simulations, with bonded contributions calculated every 2 fs and non-bonded contributions
calculated every 4 fs.
11
Chapter 2
Using a Biphasic Solvent System to Determine the
Membrane-Bound Form of Peripheral Proteins
“The measure of greatness in a scientific idea is the extent to which it stimulates thought and opens up new
lines of research.” –Paul A.M. Dirac
The plasma membrane is a highly dynamic ecosystem that serves as a platform for the binding of periph-
eral membrane proteins and their complexes, which are involved in a wide range of essential physiological
processes such as intercellular signaling, cell adhesion, membrane trafficking, and coagulation [10, 53, 104].
The association of peripheral proteins is necessarily transient and these proteins have evolved specialized do-
mains, termed “membrane anchoring domains”, which impart the protein with the ability to reversibly bind
the membrane. Each membrane anchoring domain takes advantage of various specific protein-lipid interac-
tions to achieve a membrane affinity tuned to the function of the protein, although the overall protein-lipid
interaction can be viewed as a combination of electrostatic interactions with the (often anionic) lipid head-
group and hydrophobic interactions with the apolar membrane core [10, 53, 104]. In many cases, membrane
binding constitutes a crucial step in the activation of peripheral proteins, a process which is chiefly controlled
through modulating the expression and/or concentration of specific lipid types [61, 105–109]. Therefore, un-
derstanding how specific protein-lipid interactions affect the membrane-bound form of peripheral proteins on
a molecular level is essential to understanding the function and the design of rational inhibitors of peripheral
proteins.
Despite the importance of understanding the protein-lipid interactions that underlie peripheral protein
membrane binding, there have been relatively few studies that have achieved atomic-level detail of the
membrane-bound forms of peripheral proteins due to the technical challenges involved in capturing high res-
olution information on these transient states [25, 110, 111]. In this vein, different experimental approaches
often arrive at different membrane-bound models for the same protein. For example, a variety of techniques
including EPR [112–115], NMR [116], and fluorescent labeling [114] have been utilized to characterize the
membrane-bound form of the C2 domain, a motif essential to membrane binding of protein kinase C and
This chapter is based, in part, on work previously published, and reprinted with permission, as M.J. Arcario, Y.Z. Ohkubo,
and E. Tajkhorshid. 2011. Capturing spontaneous insertion of peripheral proteins using a biphasic membrane-mimetic model.
J. Phys. Chem. B 115:7029–7037. Copyright 2011 American Chemical Society.
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synaptotagmin. These studies have resulted in a wide range of models that show the protein inserted any-
where from 5.2–10 A˚ [112–114] and making an angle with the membrane normal between 52–77◦ [117, 118].
Moreover, the relative role of three Ca2+-binding loops in the C2 domain membrane-bound form are still dis-
puted despite extensive study [119]. Similar discrepancies are found in studies on other membrane-binding
domains such as the GLA domain of vitamin K-dependent coagulation factors [120–124] and the FERM
domain [60, 63].
Figure 2.1: Structure of human Protein C (hPrC). (a) Cartoon
schematic of the overall domain structure of human Protein C (hPrC), de-
picting the GLA domain, the two EGF domains, and the serine protease
(SP) catalytic domain. The GLA domain is shown in gray to highlight its
role in membrane binding. (b) Molecular image of the GLA domain showing
pertinent features including the backbone structure (gray), the membrane-
penetrating keel residues (red), the γ-carboxyglutamate residues (cyan), the
seven bound Ca2+ ions (yellow) and their numbering scheme based on the
crystal structure of human factor VII (hfVII) [125]. The arrow shows the
vector connecting Ca2+-4 to the Cα of F40, which was used to represent the
hPrC GLA domain in subsequent calculations of the domain angle relative
to the aqueous-organic interface.
Computational studies of membrane-
binding have been equally as difficult. In
stark contrast to integral membrane pro-
teins whose membrane-embedded forms
are fairly well understood and for which
semiautomated protocols exist for mem-
brane insertion [126, 127], there are no
robust methods to determine how deep a
peripheral protein will insert and what
the protein’s orientation on the mem-
brane surface is. Often, the membrane-
binding residues, which constitute the
“membrane anchor”, are generally not
known a priori and can be composed of
only a few amino acids. Making the prob-
lem even more difficult is that peripheral
proteins generally undergo conformational changes upon interacting with the membrane, which can be quite
large and lead to exposure of the membrane anchor [128] or can be quite small and lead to stabilization
of the protein on the membrane [119], but are nevertheless hampered by the extremely slow diffusion of
lipids. Due to the challenges inherent in these systems, only a handful of membrane-binding domains have
been studied computationally, namely the BAR [129–132], C2 [133, 134], GLA [41], FERM [64, 135], and
PX [136, 137] domains. Most of these studies have either initially embedded the protein within the mem-
brane or utilized artificial biasing terms in order to observe stabilization of the protein on the membrane
surface [41, 133, 134, 136, 137]. While these studies have provided important information on protein-lipid
interactions, these models do not describe the dynamic process of protein insertion and are inherently biased
based on the initial orientation of the protein and/or the artificial potentials used to forcibly insert the
13
protein. Implicit [138] and coarse-grained [64, 129, 131, 135] membranes have also been utilized to decrease
the time needed to observe spontaneous insertion of peripheral proteins. These methods, however, lack
the atomic-level detail that is important for establishing how the protein interacts with specific lipids in
the membrane, which is central to understanding the role of lipid specificity in peripheral protein binding.
Moreover, these methods often require 100s of nanoseconds of simulation to obtain a membrane-embedded
form, which is prohibitively expensive and does not allow multiple simulations to gather statistics and build
a robust model of how the protein interacts with the membrane.
In this study, the human protein C (hPrC) GLA domain (Fig. 2.1) was used as a test case to test the effec-
tiveness and efficiency of a simple biphasic, membrane-mimetic model in characterizing the bound orientation
of the membrane anchor and in describing the dynamic process of insertion. This membrane-binding domain
was chosen due to the abundance of experimental observations on the membrane-bound form [120–124] in
addition to the complete membrane-binding of this domain to a conventional, full-tailed membrane having
been previously simulated [41]. A vitamin K-dependent protein, hPrC is an anti-coagulant that enzymat-
ically cleaves residues in the prothrombinase complex, greatly reducing the amount of thrombin generated
and halting formation of a clot [139, 140]. hPrC, like other vitamin K-dependent coagulation proteins, has
four main domains: the membrane-binding GLA domain, two epidermal growth factor (EGF)-like domains,
and a serine protease domain, which cleaves the substrate (factor Va and factor VIIIa, in this case) [141].
The structure of the hPrC GLA domain is very similar to other GLA domains, such as those of factor
VII and prothrombin [142], containing seven Ca2+ ions coordinated by nine post-translationally modified γ-
carboxyglutamate (three letter code: Gla; one letter code: γ) residues (Fig. 2.1b). The presence of Ca2+ ions
is essential to membrane-binding, as incorporation of Ca2+ into the vitamin K-dependent proteins cause a
conformational change that leads to formation of the ω-loop and an active tertiary structure [143, 144]. The
ω-loop is the membrane-penetrating moiety whose formation also leads to the exposure of three hydrophobic
residues, termed the “keel”, which forms the main hydrophobic body of the membrane-anchor [121, 122].
The keel, together with residues on the ω-loop act to stabilize hPrC on the membrane surface.
In this chapter, a conceptually simple, yet extremely efficient MD-based method is introduced and devel-
oped, which can not only obtain the relative insertion depth and orientation of bound peripheral membrane
proteins, but also generate preliminary models of membrane-bound anchoring domains. After constructing a
water/1,1-dichloroethane (DCLE) biphasic system, multiple simulations were performed in order to calculate
physical properties of the system and ensure agreement with experimental measurements. When fidelity of
the biphasic system was established, the GLA domain of hPrC was placed in six different initial orientations
across six independent simulations, with all simulations converging to a single inserted state within a few
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(<10) nanoseconds. It appears that DCLE provides an optimal organic phase due to its slight polarity,
which can accommodate both hydrophobic sidechains and hydrophilic backbone atoms by creating suitable
microenvironments. To my knowledge, this study represents the first attempt to utilize biphasic systems to
probe the atomic details of membrane insertion of peripheral protein anchoring domains.
2.1 Designing the Optimal Biphasic System
As detailed above, there is interest in understanding the tentative and reversible nature of membrane asso-
ciation in peripheral proteins. Significant hurdles exist, however, in studying the membrane-binding form
of peripheral proteins using all-atom MD simulations. Namely, lipid molecules exhibit slow lateral diffusion
and respond very slowly to the inserting of protein into the membrane, leading to insufficient relaxation of
the protein and insufficient protein-lipid sampling on the timescales accessible to MD simulations. One of
the main factors behind the slow diffusion of lipids is the extended hydrocarbon tails that often form highly
disordered and entangled structures making relative movement of lipids difficult. Because the lipid tails are
one of the contributing factors to slow lateral diffusion and, thus, slow peripheral protein insertion, replacing
the hydrophobic membrane core with a more diffusive representation should decrease the time needed to ob-
serve peripheral protein insertion. In general, organic solvent molecules are smaller than lipids tails, diffuse
much faster (Dorg ∼ 10−5 cm2s−1 vs. Dlip ∼ 10−8 cm2s−1) [145–147], and would accommodate the insertion
of proteins better than full-tailed lipids on MD timescales. Therefore, creating a biphasic simulation system
Figure 2.2: Self-Diffusion of Small Molecule Candidates. (Left) Diffusion coefficients of DCLE (green), DMS (orange),
EPE (purple), and heptane (red) plotted as a function of time difference (∆t). ∆t represents the length of the time window
used to calculate the diffusion coefficient according to Eq. 3.1. (Right) Molecular image of DCLE (green box), DMS (orange
box), EPE (purple box), and heptane (red box).
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would allow much faster identification of the membrane anchor and approximate bound state of the protein.
Four criteria were enumerated and used to select the small organic molecule that would represent the
membrane core, namely (1) the small molecule acting as the membrane core should be much shorter than a
fatty acid tail to prevent the disordered and entangled structures often encountered in the membrane that
hamper membrane insertion, (2) the molecule needs to have a low aqueous solubility in order to maintain
a hydrophilic/hydrophobic partitioned environment, (3) the molecule must remain at liquid at physiological
(i.e., simulation) temperatures in order to expedite the dynamics of the membrane core which is often solid-
like, and (4) the molecule should have readily available parameters for use in MD simulations to make the
model much easier to implement for a wide audience. With the release of “generalized” force fields meant
to be used for piecemeal construction of parameters for drug-like molecules [148, 149], multiple choices are
available for the choice of a membrane core; however, a majority of the parameterized molecules in the
CHARMM General Force Field (CGenFF) we either too large, voltaile at 310 K (the temperature of most
biological simulations), or too polar to act as a hydrophobic environment. Only four molecules available in
the CGenFF satisfied the criteria set forth: 1,1-dichloroethane (DCLE), dimethylsulfide (DMS), ethyl propyl
ether (EPE) and heptane. Heptane was chosen for obvious similarity to the lipid tails of the membrane core
as well as being the smallest alkane that is liquid at simulation temperature. The choices of DCLE, DMS,
and EPE were made due to their small size (8-16 atoms) and their relatively non-polar nature (permanent
dipole moment of less than 1.83 D) [150].
The fluidity and mobility of the organic phase is absolutely critical to the success of this model.
Figure 2.3: Structure of hPrC GLA Domain Inserted into a Biphasic System. (a) Side view of the inserted hPrC
GLA structure showing the height of the keel Cα above the DCLE/water interface. (b) Front view of the inserted hPrC-GLA
showing the angle the GLA domain makes with the interface normal as well as the vector which was used to calculate the angle.
(c) Front view of hfVII GLA bound to a full membrane [41]. The GLA domain is shown in gray, with keel residues shown in
red, γ-carboxyglutamate residues shown in cyan, and Ca2+ ions in yellow. Water is omitted for clarity. In (a) and (b) the
DCLE layer is shown in green. In (c) the lipid tails, which are replaced by DCLE in the biphasic system, are shown in green
and the lipid headgroups are shown in pink.
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Figure 2.4: Local Structure of DCLE around the Inserted Keel. Radial distribution functions (g(r)) are shown for the
methyl (black) and dichloromethyl (purple) groups of DCLE with respect to the sidechains (top row) and backbone carbonyl
(bottom row) of F4 (left column), L5 (middle column), and L8 (right column). Depicted by the arrows is the peak of greatest
probability within the 15 A˚ radius sampled; the black arrow depicts the most probable distance for a methyl group and the
purple arrow denotes the most probable distance for a dichloromethyl group.
Therefore, we measured the three-dimensional diffusion coefficient of each molecule (Fig. 2.2) from two sep-
arate 30 ns MD trajectories. The larger molecules of heptane and EPE clearly showed a slower diffusion
(0.73×10−5 cm2s−1 and 0.81×10−5 cm2s−1, respectively) than the smaller molecules of DCLE and DMS
(1.35×10−5 cm2s−1 and 1.24×10−5 cm2s−1, respectively). While EPE and heptane were judged less desir-
able for use as the membrane core, DMS and DCLE showed expedited diffusion dynamics and were deemed
suitable replacements for the membrane core. Therefore, as a final test as to which small molecule to uti-
lize in the biphasic system, the partitioning of the hPrC GLA domain into each biphasic, aqueous-organic
system was simulated. The GLA domain, a membrane-binding domain common in coagulation proteins,
was chosen because of its small size (∼44 amino acids), the fact that the membrane-binding residues are
largely known, and that its membrane-bound form had been previously characterized computationally [41]
allowing us to asses how well each small molecule can substitute for the membrane core. For EPE and
heptane, insertion into the organic phase was not observed within the 30 ns needed for DCLE insertion.
This is possibly due to the large size of these molecules, that, when randomly oriented in three dimensions,
cause the formation of net-like structures that prohibit insertion rapidly. These choices were therefore ex-
cluded. In the case of DMS, partial insertion of the GLA domain is observed, but it does not penetrate
the organic phase as deep as in the full membrane simulation [41]. In contrast, the hPrC GLA domain
was able to fully insert its keel only into the DCLE phase, resulting in a structure similar to that ob-
served in full membranes (Fig. 2.3) [41]. The more efficient insertion into DCLE can be attributed to the
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chemical environment provided by DCLE and the larger dipole moment, as well as its small size. DCLE
has a methyl group on one end of the molecule and a dichloromethyl group on the opposing end allowing
for both hydrophobic and dipole-dipole interactions, which is necessary in a simple model such as this.
This can be seen in the radial distribution functions of the DCLE chemical groups with respect to ei-
ther the sidechains or backbone of the inserted hPrC GLA domain keel residues (Fig. 2.4). The DCLE
molecules around the keel residue sidechains (Phe and Leu) orient themselves such that the methyl group
is surrounding the sidechain, forming a microscopic hydrphobic environment (Fig. 2.4, top). In the case of
the keel residues’ backbone, the dichloromethyl groups are oriented such that they establish dipole-dipole
interactions that stabilize the inserted form of the protein (Fig. 2.4, bottom). The other solvents, such
as heptane and EPE, only provide hydrophobic interactions, which are unaccommodating to the protein
backbone and may have ultimately contributed to the difficulty in insertion of the hPrC GLA domain.
Figure 2.5: Density Profile of the Biphasic System. Plot-
ted is the density for DCLE (solid) and water (dashed) in the
biphasic system averaged over the last 1 ns of a 2 ns trajectory.
The vertical dashed line at x = 0 denotes the location of the
aqueous organic interface.
Finally, to ensure the validity of the DCLE
model used in the biphasic solvent system, the
density and aqueous solubility was calculated
(Table 2.1). The density was measured as
1.14± 0.05 g/mL, which compares favorably with
the experimental value of 1.2 g/mL [150]. Moreover,
the density of water was observed to be ∼1 g/mL,
which serves as a control to ensure the density of
DCLE was correctly measured. The low aqueous
solubility of DCLE (8.6×10−3 g/mL H2O) is neces-
sary because it maintains the integrity of the bipha-
sic nature of the system. Therefore, it is important
that the aqueous solubility of DCLE be accurately modeled by the parameters given in the CGenFF. Indeed,
the aqueous solubility of DCLE was measured as (9.89± 2.90)×10−3 g/mL H2O, which is within error of
the experimental value. Moreover, the maintenance of the interface is evident from Fig. 2.5, depicting the
density of DCLE and water as a function of the z-coordinate. The steep gradients on either side of the
interface demonstrate that the interface is sharply defined and there is little mixing between the phases.
Table 2.1: Physical Properties of DCLE. The instantaneous density and aqueous solubility was measured every 2 ps over
a 2 ns trajectory. Shown in the table is the average measured over the last 1 ns of the trajecory ±s.d.
Property Simulation Experiment
Density (g/mL) 1.14± 0.05 1.2
Aqueous Solubility (10−3 g/mL H2O) 9.89± 2.90 8.6
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2.2 Utilizing a Biphasic System to Probe Multiple Binding Events
Due to the fact that simulating the insertion of peripheral proteins using a conventional, full-tailed lipid model
requires either hundreds of nanoseconds or the use of artificial biasing forces [41], a common concern has
been whether or not the final model suffers from a bias due to the initial orientation of the protein. Moreover,
due to limited computational resources, this process can usually only be simulated once, prohibiting any
statistical comparison of the model to experimental results. The problem of the structural convergence of
membrane-bound model is not only encountered in MD simulations either. Looking at the GLA domain of
clotting factors, it becomes obvious that multiple experimental models have been proposed based on findings
from a variety of techniques [120–124]. This demonstrates that the residues interacting with the membrane
are not always clearly defined and this exacerbates the concern over bias in the final MD model. Thus, to
ensure that the results of the protein insertion simulation were not biased by the initial orientation and,
in fact, robust to multiple initial orientations, the simulation of the hPrC GLA domain in a DCLE/water
biphasic system was repeated a total of six times from different initial heights and initial angles with respect
to the interface (Fig. 2.6).
The time course of the heights and angles for the different initial configurations is shown in Fig. 2.6.
The hPrC GLA keel residues insert into the DCLE layer in less than 10 ns (compared to well over 200 ns
in previous full membrane simulations [41]), irrespective of the initial configuration, representing at least an
order of magnitude decrease in the time needed to simulate insertion of peripheral proteins. This speed-up
makes MD simulations of peripheral proteins more accessible as well as allows for several simulations to be
performed in order to gather sufficient statistics to create a robust model of the inserted protein. Notably,
the 60◦ and 90◦ trials took the longest to insert as should be expected. Due to their more extreme deviation
from the equilibrium structure, these trials needed the longest to explore the solution to determine the
optimal orientation with respect to the aqueous-organic interface. As can be seen from the plots in Fig. 2.6,
Table 2.2: Equilibrium Height and Angle of hPrC GLA in a Biphasic System. The instantaneous height was taken
as a difference between the center-of-mass of the keel residue Cα and the interface. The instantaneous angle was measured
between the interface normal (defined as z-axis) and the GLA domain vector (defined as the vector from Ca2+-4 to the Cα of
F40). The instantaneous averages were then averaged over the last 10 ns of each trajectory. The overall average was taken as
an average over all trajectories.
Configuration Height above Interface (A˚) Angle to Interface Normal (deg)
Inserted 1.42± 0.96 22.25± 10.36
Interface 2.79± 1.09 20.33± 12.41
0◦ 2.60± 2.21 23.82± 17.03
45◦ 2.13± 0.17 22.86± 11.87
60◦ 2.13± 0.82 23.61± 12.99
90◦ 2.13± 1.01 27.39± 10.23
Average 2.20± 1.04 23.37± 12.48
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Figure 2.6: Repeated Insertion of the hPrC GLA Domain. The snapshots show the six initial conditions used to test
the robustness of the biphasic model in capturing the inserted form of hPrC-GLA. Different heights (inserted, interface, 0◦)
and different angles (45◦, 60◦, 90◦) were tested. The DCLE layer is shown as the green liquid, with the hPrC GLA shown in
gray, bound calcium ions as yellow spheres, and keel residues in red. Water is omitted for clarity. The color of each curve in
the plots corresponds to the particular orientation framed in the same color (e.g., the black curves correspond to the trajectory
where the hPrC GLA starts from an inserted position). Plots of the keel residue Cα above the interface (top) and angle of the
hPrC GLA with respect to the interface normal (bottom) are shown. The height was calculated by taking the center of mass
of the keel residue Cα and subtracting the z-coordinate of the DCLE/water interface. The vector used to calculate the angles
was determined to be between the center Ca2+ ion and the Cα of F40 in the hPrC GLA as described previously [41].
20
a convergent equilibrium structure was reached across all six cases in which the keel residues are inserted
2.20± 1.04 A˚ into the hydrophobic DCLE phase and the GLA domain makes an angle of 23.37± 12.48◦
with the interface normal, averaged over all six trajectories (Table 2.2). Most importantly, the biphasic
DCLE/water system gives the same inserted structure as obtained using the much more computationally
expensive full membrane simulations (Fig. 2.3), as measured both by insertion depth and angle of the domain
relative to the interface normal.
Across the six simulations, the height of the keel residues fluctuates ∼5 A˚ around the equilibrium average,
similar to that observed in the full-tailed simulations of hfVII [41]. The angle of the hPrC GLA domain
relative to the interface normal shows greater fluctuations, however, some trajectories fluctuating ∼40◦
around the equilibrium average. This is most likely due to the lack of headgroups in the biphasic model. It
is well known that headgroups form tight interactions with the Ca2+ ions and some residues in the ω-loop
of the GLA domain [41, 109]. The inserted for of the hPrC GLA domain is less stable than it would be with
headgroups present and, therefore, explores more space than it would in a conventional, full-tailed model.
These protein-headgroup interactions are very important for all peripheral proteins in the normal course of
binding [60, 109, 151], and while the model is expeditious at determining the hydrophobic anchor, it is not
able to describe the specific protein-headgroup interactions that are critical to binding.
2.3 Computational Methods
2.3.1 Construction of the Biphasic System
Here, we will use DCLE as an example of how to create a biphasic solvent system. The same procedure was
used to generate biphasic systems of DMS, EPE, and hexane. The initial coordinates for the DCLE molecule
were created by taking an ethane molecule and exchanging two hydrogen atoms for two chlorine atoms. The
resulting structure was then relaxed in vacuo (i.e., with DCLE as the only molecule in the simulation system)
for 100 ps with the parameters being taken from the CGenFF [148]. This gave enough time for the small
molecule to adjust to its equilibrium structure. A 60×60×60 A˚3 box of DCLE was then generated using
the Packmol program [152], which takes the equilibrated structure, replicates it, and generates a volume
of arbitrary shape and predetermined density utilizing a packing algorithm. A cube of DCLE measuring
60×60×60 A˚3 with a density of 1.2 g/mL [150] required 1,578 DCLE molecules. An identically-sized cube
of water molecules was placed in opposition to the DCLE cube (+z-direction in this case) utilizing the
Solvate plugin of VMD [153]. The energy of the system was minimized over 5000 steps and the system
equilibrated for 2 ns using an NPT ensemble (P =1.0 atm, T =310 K). The equilibrated system was then
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used for both calculation of physical properties (density, aqueous solubility, diffusion constant) as well as
insertion simulations.
2.3.2 Modeling the hPrC GLA Domain
Although a structure of the complete GLA domain of hPrC now exists [154], no such structure was solved
at the time of this study. Therefore, a model of the hPrC GLA domain had to be constructed. A partial
structure of the hPrC GLA (PDB ID: 1LQV) [155], containing residues 1-33 and the seven bound Ca2+ ions,
was taken from the RCSB protein databank and used as a template for the complete hPrC GLA structure.
The structure of the missing eleven residues, comprising the C-terminal helix of hPrC, was modeled based on
the the C-terminal helix of bovine factor X (bfX) GLA domain (PDB ID: 1IOD) [122]. The partial hPrC GLA
structure was superimposed on the complete bfX GLA domain, a copy of the C-terminal helix was attached
to the last residue of the hPrC GLA domain, and the following mutations were made to the newly attached
helix to properly model the C-terminal helix of hPrC: A43V, γ35D, Q36D, D38L, γ39A, and Y44H (where
γ stands for Gla). Because the hPrC GLA domain was partially created by homology, the protein needed
to be equilibrated with its new molecular environment prior to use in insertion simulations. Therefore, the
complete hPrC GLA domain structure was solvated in 10,263 water molecules and 3 Na+ ions were added
to the system using the Solvate and Autoionize plugins of VMD, bringing the system dimensions to
56×48×45 A˚3 and containing approximately 11,000 atoms. The energy of the system was then minimized
over 5000 steps and simulated under an NPT ensemble (P = 1.0 atm, T = 310 K) for 50 ps, during which, all
Cα atoms were restrained to their original position by a spherical harmonic potential (k = 5.0 kcal/mol·A˚2),
allowing sidechains a short time to interact. The system was then equilibrated for 0.5 ns without restraints
in order to let the entire structure relax. The structure resulting from this equilibration process was then
used as a starting configuration for all insertion simulations.
2.3.3 Generation of the Initial Configurations for Insertion Simulations
To demonstrate the robustness of the biphasic model in capturing an inserted state, multiple initial orien-
tations were simulated to remove any initial orientational bias in the final inserted model. The equilibrated
hPrC model was placed at one of six predetermined positions shown in Fig. 2.6 (molecular images). The
initial configurations were chosen to represent a variety of heights and orientations with respect to the
aqueous-organic interface, spanning from overly inserted in the correct orientation (“Inserted”) to distant
from the interface and with an orientation perpendicular to the interface (“90◦”). Once placed, any over-
lapping solvent molecules were removed from the system and the system was ionized to 150 mM NaCl using
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the Autoionize plugin of VMD. The resulting systems were simulated using the general protocols outlined
in Chapter 1.
2.3.4 Analysis of Trajectories
In order to calculate the aqueous solubility, any DCLE that was within 2.5 A˚ of a water molecule, but not
within 2.5 A˚ of another DCLE molecule was considered “solvated”. The number of solvated DCLE molecules
was calculated for every frame and averaged over the entire trajectory to obtain the aqueous solubility of
DCLE. Before calculating the penetration depth, the aqueous-organic interface needed to be defined. Any
DCLE molecule that was within 2.5 A˚ of a water molecule and also within 2.5 A˚ of another DCLE molecule
was considered to be “interfacial”. The center of mass of the interfacial DCLE molecules was averaged
each frame and the z-coordinate of this average served as the instantaneous aqueous-organic interface. The
center-of-mass of the Cα of the hPrC GLA domain keel residues (F4, L5, L8) was measured every frame and
the z-coordinate of the center-of-mass measurement was subtracted from the instantaneous aqueous-organic
interface to give the penetration depth. The penetration depth was then averaged over the last 10 ns.
Although insertion simulations were used to determine the efficacy of each solvent as a biphasic mimetic, a
quantitative comparison of each solvent was lacking. Therefore, as a measure of the inherent mobility of each
organic phase, the self-diffusion constant of each molecule was calculated. This was done in a pure solvent
cube, measuring 60×60×60 A˚3 that was constructed as described above in “Construction of the Biphasic
System”, omitting the solvation step, as the aqueous-organic interface could possibly alter the dynamics of
DCLE. The self diffusion constant is usually measured using the Einstein diffusion relation:
D = lim
∆t→∞
〈
|r(t0 + ∆t)− r(t0)|2
〉
2d∆t
(2.1)
where D is the diffusion constant, r(t0) is the position of a molecule at time t0, r(t0 + ∆t) is the position of
the same molecular at a later time t0 + ∆t, d is the dimensionality of the system, and ∆t is the difference
between t and t0. In practice, however, ∆t is limited by the amount of time that can be simulated (as
discussed in Chapter 1). Since only the time difference matters in the diffusion measurement and not the
absolute time, a “sliding window” was used to increase the amount of data used in the analysis. Care was
taken to exclude correlated windows by calculating the autocorrelation function of the position, which gives
the time between the start of subsequent sliding windows. The penultimate 5 ns window was utilized as the
long-time limit of the diffusion curve and the average D over this window was taken to be the self-diffusion
constant of the species.
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Chapter 3
Highly Mobile Membrane Mimetic: A New Take on Membranes
“Somewhere, something incredible is waiting to be known.” –Carl Sagan
As discussed in the previous chapter, peripheral membrane proteins are of significant importance in essential
physiological processes, such as hemostasis, leukocyte recruitment, and membrane sculpting. Yet, very little
is known about the membrane-bound forms of these proteins, mainly due to the difficulties in obtaining
experimental structural information [25, 110, 111]. Difficulties arise due to not only the transient nature of
membrane interaction, but also the small size of membrane anchoring domains, which are generally com-
posed of only a few amino acids. This makes a priori prediction of the membrane binding surface almost
impossible and narrowing the residues to be studied extremely difficult. Several techniques, such as small-
angle X-ray scattering (SAXS) [156], electron paramagnetic resonance (EPR) [114, 157], Fo¨rster resonance
energy transfer (FRET) [114, 158], and mutagenesis [120, 159], can be utilized to infer proximity of certain
residues to the membrane. Further detail is required, however, to fully characterize and understand the
nature of protein-lipid interactions that are crucial to the binding and function of peripheral proteins.
Therefore, molecular dynamics (MD) simulations, which have a high spatiotemporal resolution and ben-
efit from direct observation of the protein-lipid interactions, stand poised to offer novel atomic-level insights
into the membrane-binding dynamics of peripheral proteins. A problem arises, however, when utilizing MD
simulations to study membrane-binding: the slow diffusion of lipids. In order for the protein to be able to
bind, the individual lipids within the membrane need to rearrange and accommodate the inserted protein.
With a lateral diffusion constant on the order of 10−8 cm2s−1 (0.1 A˚2ns−1), however, individual lipids only
diffuse ∼10 A˚, on average, in a typical 100 ns simulation, which is not enough to accommodate the membrane
anchors of most peripheral proteins. Most studies have tried to circumvent this either by brute force, em-
ploying steered molecular dynamics (SMD) techniques to forcibly pull the protein into the membrane on the
timescales reachable by MD [41], or by initially placing the protein in the membrane in a configuration that
This chapter is based, in part, on work previously published, and reprinted with permission, as Y.Z. Ohkubo, T.V.
Pogorelov, M.J. Arcario, G.A. Christensen, and E. Tajkhorshid. 2012. Accelerating membrane insertion of peripheral proteins
with a novel membrane mimetic model. Biophys. J. 102:2130–2139. Copyright 2012 The Biophysical Society. This chapter
is also based on work previously published, and reprinted with permission, as T.V. Pogorelov, J.V. Vermaas, M.J. Arcario,
and E. Tajkhorshid. 2014. Partitioning of amino acids into a model membrane: Capturing the interface. J. Phys. Chem. B
118:1481–1492. Copyright 2014 American Chemical Society.
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is thought to be correct and utilizing restraints [133, 134, 136, 137]. These approaches introduce bias in the
model derived from these studies, however, based on the restraint potential and/or the initial configuration
utilized. Therefore, multiple physics-based models have been described [160, 161] that aim to reduce the
number of atoms in the system, effectively increasing the simulation timescale in order to avoid the biases
introduced in the protocol above.
The coarsest of these physics-based models is the implicit membrane, which is based on Poisson-Boltzmann
continuum electrostatics [37]. In this approach, a slab of low dielectric constant is used to approximate the
hydrophobic core of the membrane and a high dielectric constant to model the aqueous environment [38],
drastically reducing the number of atoms in the system (i.e., the simulation system contains only atoms of
the protein). This approach allows extended timescales, as a fewer number of atoms is considered. Implicit
membranes have been successfully being implemented to observe partitioning [162, 163] and oligimeriza-
tion [164] of peptides. An implicit membrane suffers from an inherent lack of detail, however, modeling the
complex and dynamic membrane interface environment as a simple switch from high to low dielectric as
well as completely ignoring the importance of specific protein-lipid interactions that are essential for proper
peripheral protein function. Moreover, while the biphasic system introduced in Chapter 2 is an all-atom
model, it also suffers from a lack of headgroup description [165], making it difficult to determine how head-
groups affect protein function.
Coarse-grained molecular dynamics (CGMD) represents a compromise between all-atom simulations and
implicit membranes, in that the number of atoms is reduced, but there is explicit representation of the entire
simulation system. The reduction in the number of atoms is achieved by representing groups of atoms, such
as a lipid headgroup or several amino acids, as “coarse-grained beads”, which are then parameterized to
reproduce certain physical properties [39, 40, 166–168]. CGMD has been successfully utilized to simulate
the formation of many lipid structures, such as spontaneous formation of lipid bilayers [39], micelles [40],
disc-like structures [169], and membrane sculpting/remodeling by the BAR domain [130], as well as the
insertion of peripheral proteins [64, 170] and helix oligomerization [171, 172]. While accounting for protein-
lipid interactions that are absent in implicit membranes, CGMD still cannot account for the interaction
between specific lipid headgroup moities and the protein, which are essential for understanding the basis of
peripheral protein binding in general, as well as the role specific lipids play in increasing membrane affinity
for peripheral proteins.
In this chapter, a new membrane mimetic model is introduced that builds on the biphasic model discussed
in Chapter 2 by adding short-tailed lipids to the aqueous-organic interface to approximate the headgroup re-
gion of the membrane. The physical properties and ability of this highly mobile membrane mimetic (HMMM)
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Figure 3.1: The Highly Mobile Membrane Mimetic Model. A molecular image comparing a conventional, full-tailed
DOPS membrane (left) and a PS HMMM model (middle). In the conventional membrane, the “headgroup region” is colored by
atom (carbon, lavender; oxygen, red; nitrogen, blue; phosphorous, gold; hydrogen, white), while the “membrane core region” is
colored yellow. The same general coloring scheme applies to the HMMM model, where DVPS, which represents the headgroup
region, is colored by atom and the DCLE, which represents the membrane core region, is colored yellow. On the right is the
molecular image of an individual DOPS lipid showing the relative length of a DVPS short-tailed lipid (colored by atom).
model to efficiently capture the membrane-binding of the hfVII GLA domain are thoroughly explored and
discussed. In order to determine how well the HMMM model reproduces the chemical, mechanical, and
electrical properties of a true lipid bilayer, several physical properties of the membrane are calculated for
a PC HMMM membrane and compared to a conventional DPPC membrane. These properties, including
atomic density profiles, lateral diffusion constant, order parameters, dipole potential, and area compress-
ibility modulus, demonstrate that the HMMM model is more mechanically deformable than a conventional
membrane, as can be expected from decoupling of the headgroup from the hydrophobic membrane core.
Moreover, the free energy profiles for amino insertion was calculated for 10 amino acids, covering an array of
sidechain moieties, and show excellent agreement with the same calculations in a conventional membrane in
all regions except the DCLE core. Lastly, following the calculation of the physical properties of the HMMM
model, a large set of hfVII GLA domain membrane-binding simulations were performed, which showed that
the HMMM model could not only reproduce the membrane-bound form obtained from full membrane sim-
ulations, but also that multiple simulations could be conducted in a short amount of time leading to a more
robust and accurate model.
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3.1 Adding Short-Tailed Lipids to the Biphasic Model: The HMMM
The composition of lipids in the membrane, especially the headgroup type, drastically effects how efficiently
peripheral proteins bind to the membrane and function at the membrane surface; insertion of peripheral
proteins into full-tailed lipid membranes, however, are prohibitively costly to simulate in most cases. While
the biphasic model introduced in Chapter 2 expedited insertion of the GLA domain, the lack of headgroup
representation was a major drawback to this approach. A headgroup representation is essential to make the
biphasic solvent system a viable tool for studying how peripheral proteins bind the membrane and establish
specific protein-lipid interactions that stabilize their membrane-bound forms. As the majority of slow lipid
diffusion is due to the disordered and entangled tails, lipids that have their tails significantly shortened
should, reasonably, diffuse much faster. Therefore, short-tailed lipids, such as 1,2-divaleryl-sn-glycero-3-
phosphatidylserine (DVPS) or 1,2-divaleryl-sn-glycero-3-phosphatidylcholine (DVPC), were added to the
aqueous-organic interface of the biphasic solvent system model (Fig. 3.1) to represent the headgroup region
of the membrane and create the highly mobile membrane mimetic (HMMM) model. These short-tailed lipids
are made by simply truncating the terminal carbons of a full-tailed lipid, such as DOPS or POPC. In the
cases presented in this and the following Chapter, the headgroup and the first five carbons of each acyl tail
are retained, providing an exact representation of the lipid headgroup that can be used to extensively explore
the establishment and importance of specific protein-lipid contacts. The tail length for these short-tailed
lipids was chosen to balance the need for expedited dynamics and stability of the short-tailed lipid at the
interface. Longer tails would necessarily decrease the lateral mobility of the headgroups, opposing the goal
of the HMMM model, while shorter tails would tend to be readily solvated and a proper bilayer structure
would not be maintained. It should be noted, however, the choice to make the tails five carbons long is not
a unique solution to this delicate balance.
While the dynamics of the lipids in the HMMM are assumed to be expedited, a quantitative analysis
of membrane physicochemical properties is necessary to better understand how the HMMM compares to a
conventional, full-tailed membrane. First, it is essential that the short-tailed lipids are able to reproduce
the atomic density profile of headgroups in full-tailed lipid membranes, as the structure of headgroups is
important in establishing proper protein-lipid contacts. As can be seen in Fig. 3.2a&b, the atomic density
curve for the full-tailed DOPS membrane and the HMMM DVPS membrane show identical distributions in
both position and shape for the headgroup moieties (COO−, NH+3 , and PO
−
4 ). It should be noted that the
atomic density profiles were made in an HMMM model that had an area per lipid of 96 A˚2/L, compared to
67 A˚2/L for the DOPS membrane, and is the reason why the DVPS plot shows a lower density than that of
the DOPS plot. Interestingly, the relative density of the acyl tail carbons (C1-C5) in the DVPS membrane
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Figure 3.2: Physical Properties of the HMMM Model. The atomic density profiles of both the full-tailed (a) and
HMMM (b) lipids are shown up to the fifth carbon of each tail (C1-C5, dashed lines), along with the density of the ester
carbonyl (CO, green trace), phosphate group (PO−4 , black trace), ammonium group (NH
+
3 , blue trace), and carboxylate group
(COO−, red trace). For the HMMM model (b), the density profile for DCLE is also shown (DCLE, maroon trace). (c) Lateral
diffusion coefficient of lipids in both a full-tailed membrane (dashed lines) and an HMMM model (solid lines). The lateral
diffusion coefficient was measured at multiple lipid densities (63 A˚2/L, black; 65 A˚2/L, green; 67 A˚2/L, red) over the entire
length of the simulation. The value of the lateral diffusion coefficient is taken to be the plateau average over the last 10 ns.
(d) Plot of the dipole potential for both the full-tailed (dashed lines) and HMMM (solid lines) lipids. The dipole potential
is presented as the total potential (black) as well as broken into the contributing components, including water (red), lipid
(blue), and DCLE (green). The dipole potential was measured for the last 20 ns of each trajectory. The difference in the
width of the potential is due to the difference in membrane thickness of the full-tailed membrane and HMMM model. The area
compressibility modulus (KA) is presented for both the full-tailed membrane (e) and the HMMM model (f). A line of best
fit was derived from four surface tension measurements at four different lipid densities and is plotted (dashed line); the slope
scaled by the equilibrium area per lipid (67 A˚2/L) gives KA.
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flatten to a much greater extent than those in the full-tailed DOPS membrane. This is due to the larger
degree of freedom that is allowed the short-tails in the HMMM model, resulting in a more diffuse density
profile. The overall shape of the atomic density profile for the HMMM DVPS model, however, matches
that of a full-tailed membrane very well. Also essential to the goal of the HMMM model is increased
lateral mobility of the short-tailed headgroups versus full-tailed headgroups. Therefore, the lateral diffusion
constant of both a DPPC membrane (Fig. 3.2c, dashed lines) and HMMM DVPC model (Fig. 3.2, solid
lines) were measured. It is clear from these plots that at multiple lipid densities, that the HMMM model
has increased lateral lipid dynamics by at least an order of magnitude over full-tailed lipid membranes. The
increased mobility of the headgroups allows for not only expedited insertion of proteins into the membrane,
but also allows for much greater protein-lipid sampling as the lipids can diffuse around the protein more
efficiently as well as bind and unbind on timescales that are routinely accessible to MD simulations. Thus,
the HMMM model is able to properly replicate the structure of the headgroup region while retaining the
increased mobility introduced by the biphasic solvent system.
Lastly, it is important to understand how the structure and construction of the HMMM model affects
the electrical and mechanical properties of the membrane, as these properties are known to influence the
function and dynamics of membrane proteins [173–175]. Therefore, the dipole potential (Fig 3.2d) and area
compressibility modulus (Fig. 3.2e&f) were measured for the HMMM model and compared to a conventional,
full-tailed membrane. The shape of the overall dipole potential for the HMMM model is quite similar to that
of the full-tailed membrane. There is a difference in the potential shape at the center of the membrane where
a slight increase in the dipole potential is observed in the full-tailed membranes, but not in the HMMM
model (Fig. 3.2d). As dipole potential is a function of charge density (see Computational Methods in this
Chapter for a definition of dipole potential), the difference in potential is due to the decreased tail density in
the center of the membrane and can also be observed in the lipid contribution to the dipole potential in the
DPPC simulation (Fig. 3.2d, blue dashed line). Overall, however, the total dipole potential for the DPPC
and DVPC membranes is quite similar. There is quite a large difference in the mechanical properties of the
HMMM model, however, compared to a full-tailed membrane. The area compressibility modulus for the
HMMM DVPC model (111.749 dyn/cm) was about half that of the full-tailed DPPC model (219.76 dyn/cm,
which agrees with previous measurements [98, 176]), signifying that the HMMM model is, in general, much
more compressible and not as stiff as a conventional membrane. This results is to be expected, however, as
the HMMM model was designed to be much more fluid in the lateral dimensions and, therefore, is able to
better accommodate disturbances in the xy-plane.
29
3.2 Comparing Free Energy of Amino Acid Insertion to Full Membranes
In order to quantitatively assess the ability of the HMMM model to accurately describe the interaction
energetics of protein sidechains with the membrane, termed membrane insertion free energy herein, the
potential of mean force (PMF) for inserting amino acid analogues into the HMMM model were calculated
and are presented as free energy profiles in this section. While there are well-documented troubles with
recapturing experimental membrane insertion free energies for certain amino acids, notably arginine [177–
180], the purpose of this study is not to reconcile these differences between experiment and simulation, but to
compare the HMMM model to other computational membrane models. Therefore, the free energy profiles will
be compared directly to previous full-tail [179] and coarse-grained [181] studies that use an identical protocol.
Figure 3.3: Four Regions of the HMMM Model. (a)
Molecular image showing the HMMM model containing two
alanine analogues. This image demonstrates the system con-
figuration utilized in the umbrella sampling calculations. Here,
the blue surface represents water, the green surface represents
DCLE, the multicolored sticks represent the short-trailed lipids,
and the multicolored van der Waals surfaces represent the ala-
nine analogues. (b) Atomic density profile of the HMMM
model system showing the density of DCLE (orange), lipid tails
(green), phosphates (red), cholines (tan), bulk water (blue), and
complete lipid density (black).
The analysis of membrane interaction energies
will be divided into four separate regions with dis-
tinct physical properties: region I, the membrane
core (RI); region II, the tail region (RII); region III,
the headgroup layer (RIII); and region IV, bulk wa-
ter (RIV). Each region has been defined based on
the atomic densities presented in Fig. 3.3. RI, the
membrane core, is defined as the volume centered
on the middle of the membrane which contains only
DCLE density, |z| ≤ 10. RII, the tail region, which
contains the majority of short-tailed lipid density, is
defined as the volume beginning from zero tail den-
sity to the point where tail and phosphate density
are equal; this occupies 10 < |z| ≤ 17.5. RIII, the
headgroup layer, which contains the bulk of head-
group density, is defined as the volume beginning
from where phosphate density becomes larger than
tail density to the point at which water density be-
comes greater than choline density; this corresponds
to 17.5 < |z| ≤ 25. Bulk water is the last region,
RIV, and occupies the remaining volume, |z| > 25.
Because the HMMM model was developed to expedite simulated insertion of peripheral proteins [165, 182],
most of the attention will be focused on regions RII-RIII, which is where most peripheral proteins interact
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with the membrane. Lastly, this collection of simulations calculated the free energy profiles for 10 repre-
sentative amino acids (alanine, isoleucine, phenylalanine, tyrosine, tryptophan, asparagine, serine, cysteine,
aspartate, and arginine), which represents well over 3.5µs of simulation time. Therefore, it would have
proved prohibitively costly to perform these calculations for all twenty amino acids.
Overall, the free energy profiles are able to reproduce the energetics of protein-lipid interaction in RIV,
RIII, and RII, which constitutes the region from bulk aqueous solution to the first five carbon atoms of the
lipid tails. Deviations from previously calculated PMFs start to arise in RI, the membrane core, which is to
be expected as this is the region where DCLE has replaced the lipid tails. It seems that the increased fluidity
and non-zero dipole moment affect interaction with the amino acids. In the study of peripheral proteins,
however, there is very little to no penetrance to the RI region of the membrane during the binding process.
Therefore, deviations from the membrane-bound state observed in a full-tail simulation are expected to be
minimal.
3.2.1 Aliphatic Amino Acid Sidechains
Aliphatic side chains are known to be important for insertion and stabilization of peripheral proteins on the
membrane surface. For example, in the hPrC GLA domain previously discussed, the membrane-inserting
keel is composed of two leucine residues and a phenylalanine residue. The two amino acids chosen to
represent this group were alanine (Ala; methane) and isoleucine (Ile; n-butane), with the name of the amino
acid analogue shown in parenthesis. The PMFs for insertion of these amino acids into the HMMM model
Figure 3.4: Free Energy of Membrane Insertion for Aliphatic Amino Acids. The PMF for alanine (a) and isoleucine
(b) resulting from the umbrella sampling calculations. The free energy traces for HMMM (blue), FULL (black), and MARTINI
(maroon) are shown with error estimates obtained by Monte Carlo bootstrapping provided (error bars). Bulk aqueous solution
was taken to be the zero free energy point. Molecular images of the alanine analogue (methane, a) and isoleucine analogue
(n-butane, b) are shown for clarity. The background image shows the position of the HMMM model in the umbrella sampling
calculations with the demarcation for the predefined regions overlaid as the dashed lines.
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Figure 3.5: Free Energy of Membrane Insertion for Aromatic Amino Acids. The PMF for phenylalanine (a),
tryptophan (b), and tyrosine (c) resulting from the umbrella sampling calculations. The free energy traces for HMMM (blue),
FULL (black), and MARTINI (maroon) are shown with error estimates obtained by Monte Carlo bootstrapping provided
(error bars). Bulk aqueous solution was taken to be the zero free energy point. Molecular images of the phenylalanine analogue
(toluene, a), tryptophan analogue (3-methylindole, b), and tyrosine analogue (p-cresol, c) are shown for clarity. The background
image shows the position of the HMMM model in the umbrella sampling calculations with the demarcation for the predefined
regions overlaid as the dashed lines.
(HMMM) show excellent agreement with previous full-tail (FULL) and coarse-grained (MARTINI) results,
both qualitatively (shape) and quantitatively (numerical values) (Fig. 3.4). There is no coarse-grained PMF
for alanine, as the sidechain analogue would be an uncharged sphere resulting in essentially no interaction
with the environment. Moving from bulk aqueous solution to the headgroup region (RIV→RIII) there is a
small 1 kcal/mol (1.5 kT) energetic barrier to membrane penetrance. Once passed the headgroups, however,
there is a steep decrease in free energy (∼2 kcal/mol for Ala and ∼5 kcal/mol for Ile) across the headgroup
and tails region (RIII→RII), where each amino acid analogue reaches its energetic minimum. The profiles
are flat across RI, reflecting the homogeneous, non-polar environment of the HMMM model. Notably, the
HMMM model is able to reproduce the transfer of both Ala and Ile from bulk aqueous solution to the
membrane core faithfully and somewhat better than coarse-grained models.
3.2.2 Aromatic Amino Acid Sidechains
The PMFs for the three aromatic sidechains, phenylalanine (Phe; toluene), tryptophan (Trp; 3-methylindole),
and tyrosine (Tyr; p-cresol), were calculated and are presented here. These residues, while hydrophobic,
are considerably more complex than the aliphatic residues in the previous section, containing significantly
less torsional freedom, as well as sites for potential hydrogen bonding interactions and net dipole moments.
As can be seen in Fig. 3.5, the PMFs for the aromatic amino acids agrees well with both full and coarse-
grained profiles, except in RI where insertion into the DCLE core is more favorable than a conventional lipid
tail [179].
While Phe has a small (1 kcal/mol) energetic barrier between bulk aqueous solution and penetrance of
the headgroup region (RIV→RIII, Fig. 3.5a), Trp has a favorable movement (Fig. 3.5b) and Tyr has a
relative flat PMF between bulk aqueous solution and the headgroup region (Fig. 3.5c). In these regions
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(RIII & RIV), the HMMM model better replicates both the shape and value of the full-tailed PMF [179]
than the MARTINI coarse-grained model [181]. Moreover, in all three cases, the shape and value in RII of
the PMFs obtained from the HMMM model agree well with the PMFs calculated in conventional, full-tailed
membranes. A discrepancy arises, however, when comparing the PMFs obtained for the HMMM model in
the membrane core (RI), which is where the greatest perturbation is in the HMMM model, with the same
region in full-tailed and coarse-grained systems.
Figure 3.6: Rotational Distribution of Tyrosine in the
HMMM Model. Distribution of the orientation of the tyro-
sine residue ring with respect to the membrane normal in bulk
aqueous solution (RIV, a), the tail region (RII, b), and mem-
brane core (RI, c). All windows within each region (i.e., all
umbrella sampling windows in RII) were collected and analyzed
together. The Tyr vector was taken to be the vector between
the para-carbon and the hydroxyl oxygen. Distribution is nor-
malized so that the total population adds to 1.
As stated above, there is an overstabilization of
the aromatic amino acids in the HMMM model by
∼2 kcal/mol for Phe and ∼4 kcal/mol for Trp and
Tyr compared to full-tailed lipids. The overstabi-
lization is mainly due to two phenomena: increased
rotational and translational freedom in the liquid
DCLE, which is an inherent aspect of the model,
and dipole-dipole interactions, which are a conse-
quence of the choice of DCLE as the membrane core.
It has been previously shown [179], that the disor-
dered and entangled lipid tails significantly hinder
rotational and translational degrees of freedom, de-
creasing entropy and increasing the free energy in
the membrane core for the aromatic amino acids.
In stark contrast to this, in the RI region of the
HMMM model, there is essentially free rotation of
these large, planar aromatic rings (Fig. 3.6), similar
to the free rotation seen in bulk aqueous solution.
Moreover, it is apparent that even in the shortened
lipid tails of the HMMM model, that the rotational
freedom of the Tyr ring is significantly restricted (Fig. 3.6, RII). In addition to the rotational freedom gained,
translational movement in the xy-plane is also increased due to the fluid nature of DCLE. This increase in
rotational and translational freedom could potentially decrease the free energy by up to 5/2 kT (1/2 kT for
each gained degree of freedom), which translates to ∼1.6 kcal/mol overstabilization for each of the aromatic
amino acids. It should be noted that this particular source of overstabilization is inherent in the HMMM
model, the goal of which is to increase the fluidity of the membrane core, and attempting to remove this
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Table 3.1: Solvation Energy of Phe and Tyr in Three Media. Free Energy Perturbation was utilized to calculate the
solvation energy of Phe and Tyr in water, DCLE, and dodecane. The transformation was broken into 25 windows linearly spaced,
with each window being equilibrated for 10 ps and data collection lasting 250 ps. Each residue was solvated and desolvated for
three cycles, resulting in 80 ns of data per residue-solvent pair. Error is estimated using the Bennett acceptance ratio [183].
Residue Water DCLE Dodecane ∆DCLE-Water ∆Dodec.-Water ∆Dodec.-DCLE
Phe 0.29± 0.05 -4.57± 0.05 -4.02± 0.06 4.86 4.31 -0.55
Tyr -4.27± 0.06 -6.31± 0.07 -4.61±0.07 2.04 0.34 -1.70
source of discrepancy is contradictory to the stated goals.
The other cause of the overstabilization, dipole-dipole interactions, are due to the net dipole moment
of DCLE that is absent in the hydrocarbon tails of a conventional, full-tailed membrane. As discussed
previously, DCLE can reorient itself and create polar microenvironments around the incoming charge that
stabilizes it relative to a non-polar analogue of the true lipid membrane core). The reason Phe and Tyr were
chosen is because they only differ by the presence (Tyr) or absence (Phe) of a hydroxyl group, which can be
utilized to discern the role of polar groups in overstabilization. In the same vein, dodecane was chosen as
a comparison because it is non-polar, but there is no overall orientation like that seen in lipid membranes.
Therefore, all rotational and translational degrees of freedom are retained and the role of solvent polarity can
be assessed when comparing solvation in dodecane and DCLE. As can be seen in Table 3.1, there is signifi-
cant stabilization of Tyr in DCLE compared to Phe (-1.74 kcal/mol). When accounting for the stabilization
of Phe in DCLE, the Tyr residue is still overstabilized by 1.15 kcal/mol in DCLE compared to dodecane.
This means the polarity of the DCLE is enhancing the stability of polar or charged groups in the center of
the HMMM model relative to a full-tailed membrane. Moreover, the effect of overstabilization due to the
polarity of DCLE (-0.55 kcal/mol for Phe and -1.70 kcal/mol for Tyr) together with the overstabilization
due to increased entropy (∼1.6 kcal/mol) accounts for the discrepancy observed between the PMFs for the
aromatic amino acids in the HMMM model versus a conventional, full-tailed membrane.
3.2.3 Polar Amino Acid Sidechains
Asparagine (Asn, acetamide), serine (Ser, methanol), and cysteine (Cys, methanethiol) were chosen to
represent the polar group of amino acids and agree well with full-tailed PMFs in RIII and RIV (Fig. 3.7).
Moreover, the shape of the PMFs is quite similar to the full-tailed PMFs, with appropriate energy barriers
in RIII and energy wells in RII replicated. In RII, however, the global minimum for Asn and Ser is shallower
than that for full-tailed lipids; the same phenomenon is observed in the coarse-grained profile for Asn.
Moreover, a shallow minimum is observed in profiles of other residues, such as Trp in Fig. 3.5 and Arg in
Fig. 3.8. This increase in the energy of the system is most likely due to less favorable interactions between
the residue and DCLE molecules that have intercalated between the short-tailed lipids. In contrast, the free
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Figure 3.7: Free Energy of Membrane Insertion for Polar Amino Acids. The PMF for asparagine (a), serine (b),
and cysteine (c), resulting from the umbrella sampling calculations. The free energy traces for HMMM (blue), FULL (black),
and MARTINI (maroon) are shown with error estimates obtained by Monte Carlo bootstrapping provided (error bars). Bulk
aqueous solution was taken to be the zero free energy point. Molecular images of the aspargine analogue (acetamide, a),
serine analogue (methanol, b), and cysteine analogue (methanethiol, c) are shown for clarity. The background image shows the
position of the HMMM model in the umbrella sampling calculations with the demarcation for the predefined regions overlaid
as the dashed lines.
energy profile for membrane insertion of Cys agrees well with a conventional membrane in RII-RIV. In RI,
the membrane core, overstabilization of all three residues is once again observed due to the reasons described
in the previous section.
3.2.4 Charged Amino Acid Sidechains
Aspartate (Asp, acetate) and arginine (Arg, N-propylguanidinium) were chosen to represent the charged
amino acids, ensuring that both positively and negatively charged residues were accounted for. From Fig. 3.8,
it is clear that the HMMM model is able to reproduce the PMFs for membrane insertion of both Asp and
Arg in a conventional, full-tailed membrane [179] in RIV, RII, and RII (i.e., from bulk aqueous solution
to the tail region) and even outperforms the coarse-grained model in these three regions [181]. Moreover,
the free energy profile for Arg agrees well with previous calculations through the membrane core. There is
a somewhat shallow minimum in the tail region (RII), which can, again, be attributed to intercalation of
DCLE in this region that disturbs native contacts. For both profiles, there is a steep increase in free energy
from RII→RI. This is too be expected from burying a naked charge in the center of a non-polar environment
and it is important that the HMMM model was able to reproduce this phenomenon. Notably, at the center
of the membrane, there is considerable difference between the PMF for Asp in a conventional, full-tailed
membrane (FULL) and the HMMM model (∼8 kcal/mol). This is due to the slightly polar nature of DCLE,
which reduces the energy penalty for burying the naked charge as it provides sites for interaction with the
negatively charged carboxylate of Asp. In contrast, the difference seen in the PMFs for Arg is not as large
as that seen in Asp. This is because Arg is much more extended than Asp and even near the center of the
membrane Arg can extend such that the charged guanidinium group is interacting with the ester carbonyl
of the lipids. In fact, this configuration has been noted previously and is thought to be how polycationic
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Figure 3.8: Free Energy of Membrane Insertion for Charged Amino Acids. The PMF for aspartate (a) and arginine
(b) resulting from the umbrella sampling calculations. The free energy traces for HMMM (blue), FULL (black), and MARTINI
(maroon) are shown with error estimates obtained by Monte Carlo bootstrapping provided (error bars). Bulk aqueous solution
was taken to be the zero free energy point. Molecular images of the aspartate analogue (acetate, a) and arginine analogue
(N-propylguanidinium, b) are shown for clarity. The background image shows the position of the HMMM model in the umbrella
sampling calculations with the demarcation for the predefined regions overlaid as the dashed lines.
antimicrobial peptides are able to penetrate the membrane [184].
3.3 Gathering Statistics from Multiple Insertion Events
The main goal in the development of the HMMM model is to have a membrane mimetic model that shows
expedited lipid dynamics capable of accelerated formation of protein-lipid contacts as well as increased ac-
commodation of inserting protein surfaces, both which will allow for the membrane-bound forms of peripheral
proteins to be obtained without the need for biasing potentials. While the physicochemical properties of the
HMMM model have been extensively explored in the previous sections, the ultimate test of this model is
to simulate the membrane-binding of a peripheral protein. In this case, the GLA domain of human factor
VII (hfVII) was utilized as a test case, as the membrane-bound form of the protein had been derived in a
prior study using full-tailed DOPS lipids [41]. Moreover, the structure of hfVII GLA domain is extremely
similar to that of the hPrC GLA domain discussed in the previous chapter, making direct comparison to
the results obtained in Chapter 2 possible. The main drawbacks of the previous study was the artificial
potential and long timescale needed to insert the membrane anchoring domain as well as the ability to sim-
ulate membrane-binding only once. These practicalities directly prevented generation of sufficient statistics
to compare directly to experimental models, somewhat limiting its utility.
Similar to hPrC, the GLA domain of hfVII is known to bind upon exposure of PS lipids to the extracel-
lular environment [109, 185]. Therefore, a PS HMMM model was used to simulate the membrane-binding of
the hfVIII GLA domain. Because the lateral diffusion of lipids is increased by an order of magnitude in the
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Figure 3.9: Binding of hfVII GLA Domain to PS HMMM. (a) Molecular image showing the initial configuration (i.e.,
0 ns) of the hfVII GLA domain and its position within the PS HMMM system. For this and the following molecular images, the
protein backbone is shown in purple, pertinent residues are shown as green sticks, bound Ca2+ ions are shown in magenta, keel
residues as represented by a tan surface, and short-tailed lipids are shown as multicolored sticks. In (a) water is represented as
a blue background and the DCLE as a gray background, with counter-balancing ions (NaCl) shown as red spheres. Snapshots
of the simulation are shown at first contact (b; 1.0 ns), initial insertion of the membrane-anchoring ω-loop (c; 6.0 ns), and at
a fully inserted state (d; 48.0 ns). In (b-d), the gray background represents the whole of the HMMM model (i.e., DCLE and
short-tailed lipids) and water/solvated ions have been omitted for clarity. (e) Average height of the bound Ca2+ ions (red
trace,
〈
Ca2+
〉
) and Cα of the keel residues (blue trace, 〈FLeeL〉) with respect to the center of the membrane. The gray fill
in the plot represents the HMMM model with the average position of the carboxylate (top black trace,
〈
COO−
〉
), phosphate
(middle black trace,
〈
PO−4
〉
), and C5 (bottom black trace, 〈C5〉) groups shown. (f) Plot of the number of lipid moieties that
are interacting with the GLA domain. These values were recorded by counting the number of each lipid moiety (i.e., either
PO−4 or COO
−) within 5.0 A˚ of any GLA domain moiety (i.e., either basic residues or bound Ca2+ ions) for each frame of the
simulation.
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HMMM model (Fig. 3.2c), ten replicate membrane-binding simulations were performed with the HMMM
model. The GLA domain was placed with the ω-loop oriented towards the headgroup region (Fig. 3.9a)
about 8 A˚ above the surface of the membrane. Within the first nanosecond (1.0 ns), the GLA domain begins
to make contact with the PS lipids through R9 and K18 (Fig. 3.9b) and by the first 6.0 ns, contacts between
the protein-bound Ca2+ ions and the phosphate groups of the lipids are established (Fig. 3.9c). This is an
important benchmark as formation of the lipid-Ca2+ contacts has been previously shown to be necessary
for proper binding of the GLA domain [41, 121]. At ∼6.0 ns, the majority of the protein-lipid interactions
have been established, as can be seen in Fig. 3.9f. As the protein continues to settle over the 50 ns trajec-
tory, however, ∼3-4 more protein-lipid contacts are established, fully binding the protein to the membrane.
It should be noted that these contacts are established without further penetration of the membrane itself,
simply due to diffusion and rearrangement of the lipid surrounding the protein. Therefore, at essentially
6.0 ns, the hfVII GLA domain has inserted to a depth almost identical to that which required over 100 ns of
steered molecular dynamics to obtain utilizing a conventional, full-tailed membrane [41].
While the expedited nature of these membrane-binding simulations is exciting, the most important as-
pect of the HMMM model is that it allows for multiple membrane-binding simulations in which a statistical
model of the bound state can be created. A total of ten replicate simulations were performed, each lasting
50 ns. While there are differences in the time required to progress to a fully bound state (Fig. 3.10), as
is expected, each simulation converges to the same penetration depth, the same orientation, and the same
protein-lipid interaction pattern (Fig. 3.11). The contact pattern between the bound Ca2+ ions and phospho-
lipids (Fig. 3.11) emphasizes a novel concept initially discovered with the full-tailed membrane simulations.
Namely, the bound Ca2+ ions have two distinct roles: structural integrity of the protein and adhesion to the
membrane surface. The peripheral Ca2+ ions are exposed to the external environment and preferentially
act as a bridge connected the protein to the membrane. The internal Ca2+ ions, however, remain deeply
concealed by the protein and stabilize the proper folding of the GLA domain ω-loop. Interestingly, a novel
residue was identified to interact with the membrane, that was not observed in the full-tailed simulations.
Residue K32, which has been shown to affect membrane-binding of hfVII [186], can be seen interacting with
both the carboxylate and phosphate groups of the PS lipids (Fig. 3.11). This demonstrates that the HMMM
model can be utilized, with great success, to determine the membrane-bound state of peripheral proteins,
as well as identify residues which are key to the membrane-binding process.
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Figure 3.10: ω-loop Height Above Membrane Center for Ten Replicates in PS HMMM. This plot shows the
relative height of the keel residues above the membrane center (z = 0) for all ten simulated trajectories, each shown as a
differently colored trace. Similarly to Fig. 3.9e, the average height for the carboxylate, phosphate, and C5 carbon are shown as
black traces and the membrane volume is shown as a gray background.
Figure 3.11: Contact Probability of the GLA Domain with PS Lipids. The probability of each Ca2+ ion (top) and
basic residue (bottom) to contact either the carboxylate (COO−) or phosphate (PO−4 ) was measured across all ten simulations.
A carboxylate or phosphate group was considered to be in contact if it was within 5.0 A˚ of the residue of interest. This was
measured across the last 20 ns of each trajectory and averaged across all ten trajectories. The standard deviation is shown in
parenthesis below the average. The color scheme is the same as that used to show the time evolution of contacts in Fig. 3.9f.
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3.4 Computational Methods
3.4.1 Construction of the HMMM Model
The highly mobile membrane mimetic (HMMM) model is generally constructed in a series of steps that
allows for equilibration of the membrane mimetic in small increments. In contrast to the biphasic system, the
HMMM model has short-tailed lipids at the aqueous-organic interface, which approximate the contribution
of lipid headgroups to the membrane-binding of peripheral proteins. Initially, a 90×90×30 A˚3 cube of
DCLE containing 1774 DCLE molecules was created with the Packmol program [152] as in the previous
chapter. This box was allowed to equilibrate for 1.0 ns. Following this, two planes containing 128 1,2-
divaleryl-sn-glycero-3-phosphatidylserine (DVPS) short-tailed lipids (64 per leaflet) were created by placing
the lipids on an 8×8 evenly spaced grid, with small randomized perturbations to the translational and long
axis rotational components. The two plane construct was then added to the +z- and -z-interfaces, such
that the phosphorous atom of each lipid aligned with the edge of the DCLE box. Any overlapping DCLE
molecules were removed from the system. The topology and parameters for the DVPS short-tailed lipids (and
subsequently, DBPS short-tailed lipids) were generated by modification of the existing POPS (1-palmitoyl-
2-oleyl-sn-glycero-3-phosphatidylserine) topology/parameter set available in CHARMM36 [98]. The tails of
POPS were shortened by removing all CH2 groups between C25-C217 and C35-C315 and creating a new
bond between C24-C218 and C34-C316. The structure generated using this process contained an extended
bond and was relaxed in vacuo for 500 ps to allow contraction of the newly generated short-tailed lipid. The
resulting DVPS structure was used in generating all subsequent HMMM models. The Solvate plug-in of
VMD [153] was then utilized to add a 90×90×50 A˚3 box of water to the +z-interface and a 90×90×20 A˚3
box of water to the -z-interface. The system was ionized with 150 mM NaCl and the system was equilibrated
for 2.5 ns. The resulting structure was utilized for the hfVII membrane-binding simulations discussed above.
Membrane used for physical constant calculations were are discussed below.
3.4.2 Membrane Binding Simulations of hfVII
Once again, the hfVII GLA domain was utilized in this study as a test case, as the membrane-binding process
of this membrane-anchoring domain has been studied previously by MD simulation [41]. Ten simulations
in total were performed to test the efficiency and accuracy of the HMMM model. The GLA domain of
hfVII with all bound Ca2+ ions (PDB ID: 1DAN) [125] was equilibrated in a 150 mM NaCl solution for
2.5 ns to allow the crystal structure to relax. The equilibrated structure was then randomly placed in a pre-
equilibrated HMMM model, whose construction is described above, such that the ω-loop was directed towards
40
the membrane and at least 8 A˚ from the DVPS surface. Any overlapping water molecules were removed and
Na+ ions were added to neutralize the system. The system was energy minimized and equilibrated with
weak harmonic constraints on the hfVII GLA domain Cα atoms with the resulting system being utilized for
production runs. Each of the ten systems was then simulated for 50 ns.
3.4.3 Analysis of Physical Constants
In order to quantitatively compare the HMMM model to full membranes, we calculated four physical con-
stants, namely the diffusion coefficient (D), the membrane dipole potential (φ), the surface tension of the
membrane (γ), and the area compressibility modulus (KA), and compared these values to a full membrane.
Because these constants have been measured experimentally for DPPC membranes, we used a DPPC mem-
brane and PC HMMM membrane to do the calculations. Each simulation system contained 72 lipid molecules
(36 per leaflet), ∼2100 water molecules, and was ionized to 150 mM NaCl. Two different conditions were
needed to calculate all four properties. The D, φ, and γ were calculated under an NPnT ensemble, while the
KA was calculated assuming an NPT ensemble, which allows for fluctuation in the area of the membrane.
What follows is the specific protocol to calculate each constant from the simulation data.
The diffusion constant is usually calculated using the mean squared distance definition (i.e., 6Dt =
〈|r(t)− r(0)|2〉). This definition can be adapted to
D = lim
∆t→∞
〈|r(t0 + ∆t)− r(t0)|2〉
2dt
(3.1)
Here, r(t0) represents the position of the molecule’s center of mass at some time, t0, r(t0 +∆t) represents the
molecule’s center of mass at a later time separated by ∆t, t0+∆t, and d represents the dimension of the system
(i.e., 1 for a one-dimensional diffusion coefficient, 2 for a two-dimensional diffusion coefficient, and 3 for a
three-dimensional diffusion coefficient). To correctly calculate D, the translation and periodic boundaries of
the system were accounted for by moving the membrane center of mass to the origin and unwrapping the
periodic image in each frame. Once this was done, the diffusion was calculated by representing the position
of the lipid by its phosphorous atom. Because D is calculated using a time difference, the number of data
points at the ends of the plot are less reliable. Therefore the asymptote was taken as the time average of
the diffusion constant over the last 10 ns of the trajectory, excluding the last 5 ns.
Apart from characterizing the lateral diffusion of lipids, the membrane can be characterized by what is
called the dipole potential, which is a net electrostatic potential along the membrane normal due to ordering
of water at the membrane surface [2]. The dipole potential of the membrane is calculated by integrating
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Poisson’s equation and assuming the potential in solution is zero (i.e. φ(0) = 0) [187]:
φ(z) = − 1
4pi0
∫ ∞
0
dz′
∫ z′
0
ρ(z) dz (3.2)
where ρ(z) is the average charge density along the membrane normal and 0 is the permittivity of free space
(0 = 8.854× 10−12 C/V·m). The average charge density was calculated by splitting the membrane normal
(z-axis) into 0.5 A˚ wide slabs, time-averaging the charge in each slab over the last 10 ns of the simulation,
and dividing by the volume of the slab. Once ρj(z) was calculated, the discrete equivalent to Eq. 3.2 was
used:
φ(z) = − 1
4pi0
n∑
i=0
i∑
j=0
ρj(z) ∆z∆z (3.3)
where n is the number of grid points at which ρ is calculated and ∆z is the distance between gridpoints.
This procedure produces a position-dependent potential profile from which the membrane dipole potential
can be calculated by subtracting the value of the potential at the center of the membrane from the value in
bulk solution.
Bulk elastic properties are also important as they are known to effect membrane protein structure and
function [173–175, 188, 189], especially in the case of mechanosensitive channels. One measure of the
elasticity of the membrane is the area compressibility modulus (KA), which has been measured in previous
simulations for DPPC [98, 176]. The KA is given by:
KA = AL
(
∂γ
∂AL
)
T
(3.4)
where AL is the resting area per lipid and
(
∂γ
∂AL
)
T
is the change in surface tension with respect to the
change in area per lipid of the membrane at a constant temperature. This formulation requires that the
surface tension of DPPC is measured across multiple membrane simulations at multiple lipid densities. The
surface tension is given by:
γ = 〈Lz (Pzz − 1
2
Pxx − 1
2
Pyy)〉 (3.5)
where Lz is the length of the simulation cell and Pxx, Pyy, Pzz are the time-averaged pressure tensors along
x-, y-, and z-axes, respectively. This was accomplished by recording the pressure tensor as well as the length
of the simulation cell z-axis every picosecond and calculating the instantaneous surface tension. The surface
tension presented here is then the time-average of the instantaneous surface tension. With the surface tension
calculated for multiple AL, a line-of-best fit is calculated and the KA is taken as the slope multiplied by the
AL at zero surface tension, which is 50 A˚
2/L [6].
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3.4.4 Free Energy Calculations
To asses the ability of the HMMM to reproduce the energetics of native membranes, we calculated the free
energy profile for inserting single amino acids into an HMMM membrane. Because sampling the entire reac-
tion coordinate using conventional MD simulations is impractical due to the limited timescale accessible, an
enhanced sampling technique called umbrella sampling (US) was utilized to calculate the free energy profiles.
In order to obtain sufficient sampling, the molecule is constrained to one of several “umbrellas” (windows)
along the reaction coordinate via an additional restraint potential term (typically a harmonic potential),
which allows for sampling of high energy areas that would not necessarily be visited during a conventional
MD simulation.
In order to compare the results of these calculations to previous studies on full [179] and coarse-
grained [181, 190] membranes, we calculated the insertion profile for single amino acids into a PC HMMM
membrane containing 64 DVPC molecules with an AL of 63 A˚
2 [191, 192]. The width of the membrane was
constrained to 38 A˚ by placing a light harmonic constraint (k = 0.5 kcal/mol·A˚2) on the carbonyl group of
the lipid ester. The amino acid analogues were constructed be removing the peptide backbone, transforming
the Cα to a hydrogen atom with δq = 0.09, and decreasing the charge on Cβ by 0.09, as has been previously
described [179]. The membrane insertion profile of these analogues was then sampled utilizing 36 windows
evenly distributed along the membrane normal. Each window was separated by 1 A˚ being simulated for
at least 10 ns and the center of mass of the amino acid analogue being harmonically restrained (k = 7.17
kcal/mol·A˚2) to the center of the window. To increase sampling, reduce error, and improve convergence, in
each window a duplicate amino acid analogue was added to the system and occupied a window 36 A˚ along
the membrane normal away from the original. This is a simple way to double the amount of data collected
without increasing the cost of the simulation. The data from the duplicate windows was then combined
and the free energy profile for each amino acid was then constructed using the weighted histogram analysis
method (WHAM) [193, 194] implemented in GROMACS (g wham) [195]. Because WHAM is an iterative
means to find relative free energies, the free energy profiles were deemed converged if the average difference
in subsequent iterations was below the tolerance of 10−5. Error estimates were extracted utilizing the Monte
Carlo bootstrapping method [195, 196] with 1000 target sets generated and compared to the converged
WHAM profile; these are presented as error bars in the plots above.
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Chapter 4
Membrane Binding of Talin F2F3 Requires Subdomain
Rearrangement
“If you want to understand function, study structure.” –Francis Crick
Talin is an abundant and ubiquitous cytoskeletal-associated protein, which was shown to be essential
to cell-extracellular matrix (ECM) adhesion at both hemidesmosomes and focal adhesion complexes nearly
three decades ago [197], although it was unclear in what capactiy. Talin is now known to be the final
common protein in all signaling pathways leading to activation of integrin [51, 52], the protein found in
hemidesmosomes and focal adhesion complexes responsible for adhesion, in addition to playing a prominent
regulatory role in the integrin-mediated cell adhesion process [53]. Integrins are heterodimeric cell-surface
receptors that are crucial to cell adhesion in physiological processes such as cell differentiation, platelet
coagulation, leukocyte recruitment, and tumor metastasis [42, 43, 45, 47, 198]. These adhesion proteins are
composed of one α and one β subunit, with each subunit contributing a short cytoplasmic tail, a single
transmembrane helix, and a large extracellular domain [46, 199]. The mammalian genome encodes for 18
distinct α subunits and 8 distinct β subunits, which can be assembled into 24 distinct integrin heterodimers,
each with a unique function [42]. The majority of integrins are expressed in a default, low ligand-affinity state,
termed the “off state”. The integrin conformational landscape must be altered in order to generate a high
ligand-affinity state (“on state”) that transmits signals across the cell membrane [42–47, 51, 52, 58, 199, 200].
This process is known as “integrin activation” and occurs at the membrane surface in response to intracellular
and extracellular signals, respectively termed “inside-out” and “outside-in” signaling [42]. Talin has recently
been identified as the most potent inside-out activator of integrins [44, 51, 52, 58, 200].
Talin is a high molecular weight (270 kDa) peripheral membrane protein (Fig. 4.1) composed of a large rod
domain, which interacts with cytoskeletal elements, and a head domain, which binds to the membrane and
activates integrin [53, 58, 200]. The talin head domain (THD) is further divided into four subdomains, namely
the F0, F1, F2, and F3 subdomains (Fig. 4.1a) [54, 55, 201]. The F2 and F3 subdomains are essential to the
membrane-binding process as well as to the activation of integrin at the membrane surface [50, 56]. Although
The contents of this chapter are based, in part, on work previously published, and reprinted with permission, as M.J. Arcario
and E. Tajkhorshid. 2014. Membrane–induced structural rearrangement and identification of a novel membrane anchor in talin
F2F3. Biophys. J. 107:2059-2069. Copyright 2014 The Biophysical Society.
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Figure 4.1: Talin F2F3 Subdomain Structure. (a) A schematic displaying the overall arrangement of domains in talin
including the extended talin rod domain and the talin head domain composed of the F0 (orange), F1 (blue), F2 (green), and
F3 (red) subdomains. (b) Crystal structure (PDB ID 3G9W) of talin showing the F2 and F3 subdomains together with the
proposed membrane orientation patch (MOP) residues. The talin backbone is shown in green and MOP residues are shown in
blue and labeled. (c) A surface representation of talin F2F3 together with basic (blue) and acidic (red) residues shown. The
boxed area highlights the proposed MOP and the high number of positive residues that are proposed to directly interact with
the membrane.
the F3 subdomain alone is sufficient for integrin activation [57], interactions between the positively charged
membrane orientation patch (MOP) in the F2 subdomain and anionic lipids, such as phosphatidylserine
(PS) [60] and phosphatidylinositol-3,4-bisphosphate (PIP2) [59, 61], greatly enhance the rate of integrin
binding and activation [202]. Therefore, a proper description of the membrane-bound talin F2F3 subdomain
is necessary to fully understand the mechanism of inside-out integrin activation.
Several structures of talin in solution (i.e., in the absence of any membrane structure such as detergent
micelle or bicelle) have been solved [60, 63, 203]; discrepancies between biochemical data and structural
models remain, however. Both biochemical and structural studies [60, 61, 63, 64] have demonstrated that
basic residues in the talin MOP are essential for membrane binding, with mutagenesis of these residues
producing a talin isoform that is unable to bind the membrane. Several other membrane-binding moieties,
such as the F3 association patch (FAP) or hydrophobic membrane anchor, have been shown to exist [61, 204–
208], yet have not been described by structural models to date. For example, mutation of certain basic
residues in the F3 subdomain have been shown to diminish integrin activation [61, 208]. Those same
residues, however, are not believed to interact with integrin and, as such, it is now suggested that the F3
subdomain together with the F2 subdomain must bind the membrane in order to properly bind both the
membrane-proximal and membrane-distal activation sites on integrin [204, 209]. The relative orientation of
the F2 and F3 subdomains in crystal structures, however, precludes the simultaneous binding of the basic
faces of the F2 and F3 subdomains with the membrane surface (Fig. 4.1b). Because integrin is an integral
membrane protein and the F3 subdomain provides the integrin activation surface, knowing the position of
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the F3 subdomain relative to the membrane surface is crucial to understanding the process of talin-dependent
integrin activation.
In addition to the F3 subdomain, thin film studies [205], antibody labeling [206], as well as construction
and computation of synthetic peptides [207, 210], have been utilized to show that talin inserts into the
membrane core, as opposed to binding more superficially. The hydrophobic binding moiety has yet to be
described in either biochemical or structural studies to date, however. Recently, coarse-grained molecular
dynamics (CGMD) simulations [64] have been utilized to study the membrane-binding of talin. These
simulations were able to successfully verify the role of the MOP residues in membrane association of talin,
but were unable to characterize a hydrophobic membrane anchor or direct interaction of the F3 subdomain
with the membrane surface. Due to the structural constraints imposed in CGMD in order to keep the
proper three-dimensional structure of the protein, the dynamics of talin is greatly restrained, hampering any
dynamics that might lead to conformational changes. In order to understand how talin affects the dynamics
of, and ultimately activates integrin, it is necessary to understand how the membrane might drive structural
changes in talin that lead to proper interaction with integrin.
In this chapter, several questions surrounding the membrane-binding of talin are explored utilizing the
highly mobile membrane mimetic (HMMM) model developed in the Chapter 3 and successfully implemented
in multiple studies outside the scope of this document [211–214]. Multiple independent simulations (n = 5) of
the talin F2F3 subdomain binding to a PS HMMM model demonstrated a conserved binding trajectory and
a converged membrane-bound state. In addition to verifying the role of MOP residues in initial attraction
to the anionic surface, a local conformational change reveals a hidden, Phe-rich membrane anchor that
inserts into the hydrophobic core of the membrane following the initial association. Following this, a large,
interdomain conformational change brings the F3 subdomain into contact with the membrane, in agreement
with previous experimental observations. These results demonstrate the role of the membrane as a dynamic
platform in properly positioning talin for inside-out integrin activation.
4.1 Membrane Binding of Talin: A Three Step Process
In order to understand the membrane bound form of talin and reconcile discrepancies in previous biochem-
ical and structural data, the HMMM model was utilized to explore the initial association and subsequent
penetration of the membrane by the talin F2F3 subdomain (herein also referred to as talin F2F3). Starting
from a random orientation, spontaneous binding and insertion of talin F2F3 into an HMMM PS bilayer
was observed across five independent simulations, producing a well-equilibrated and reproducible model of
membrane bound talin F2F3. In Figure 4.2, the three distinct steps of talin F2F3 subdomain membrane
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Figure 4.2: Distinct Stages in the Membrane Binding of Talin. (a; blue frame) Initial configuration of the talin F2F3
subdomain (green cartoon) in a DBPS HMMM system (DBPS, brown; DCLE, yellow). Residues participating in membrane
association/insertion are shown as sticks (MOP residues, blue; membrane anchor, red; FAP residues, gray). The membrane is
translucent in the snapshots to clearly demonstrate the structural transitions involved in membrane binding. (b-d) The three
distinct stages in talin membrane association and insertion; talin F2F3 is initially attracted to the anionic membrane via the
basic MOP (b; orange frame), followed by exposure and membrane insertion of the Phe-rich hydrophobic anchor (c; green
frame), and a large interdomain conformational change which brings the F3 subdomain also into contact with the membrane
via the FAP (d; red frame). (e) Plot of the height of membrane binding moieties above the phosphate layer (dashed line).
The phosphate layer was taken to be the instantaneous average of the phosphorous atoms’ z-coordinate in the cis-leaflet of the
membrane. The membrane-binding moieties (i.e., MOP, FAP, and membrane anchor) are represented by the center of mass of
their constituent Cα atoms. Solid lines denote the running averages of the transparent curves.
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binding characterized in these simulations, together with specific molecular events associated with each step
are shown for one of the membrane-binding simulations (see Fig. 4.3 for data on all five independent simula-
tions). These steps are: (1) attraction of a highly positive residue patch (termed the membrane orientation
patch, MOP) in the F2 subdomain to the anionic surface of the membrane (Fig. 4.2a,b); (2) release of an
initially buried membrane anchor, which anchors talin F2F3 subdomain to the membrane (Fig. 4.2b,c); and
(3) a large-scale, membrane-induced conformational change between the F2 and F3 subdomains that brings
the F3 subdomain also into contact with the membrane via a triad of residues termed the F3 association
patch (FAP) (Fig. 4.2c,d). As can be seen in Fig. 4.3, all five simulations follow the same trend in relative
penetration depth of the MOP, FAP, and Phe-rich anchor, although the absolute depth is somewhat different
between simulations, as is to be expected due the highly dynamic and fluid nature of the membrane. This
work represents, to the best of our knowledge, the first description of a hydrophobic membrane anchor in
talin F2F3, identifying the residues responsible for the hydrophobic interaction that firmly anchors talin
to the membrane. Moreover, the large-scale conformational changes observed in the simulations reconciles
discrepanices between biochemical studies [61], which suggest simultaneous binding of the basic faces of both
the F2 and F3 subdomains, and structural studies [60, 203], which have only been able to crystallize talin
in states where simultaneous binding of the MOP residues and FAP residues is precluded. Each step of the
membrane-binding process is discussed in greater detail below.
4.2 Electrostatic Steering of Talin to the Membrane Surface
Several mutagenesis studies have demonstrated the critical role of the cationic MOP residues, specificallly
K258, K274, R276, and K280, in the binding of the talin head domain to the membrane [60, 61, 63, 64]. To
this effect, the talin F2F3 subdomain was initially placed ∼15 A˚ above the surface of the membrane with
these residues oriented towards the anionic PS HMMM model (i.e., the cationic face of the F2 subdomain
facing the anionic surface of the membrane) (Fig. 4.2a). Due to the extremely slow dynamics of lipids
on timescales accessible to MD simulations, properly and completely sampling protein-lipid interactions in
conventional, full-tailed membranes is quite difficult and makes the study of peripheral protein membrane
insertion prohibitively costly. In order to overcome this difficulty, the recently developed HMMM model
was utilized [182]. The HMMM model has been shown to have increased lateral mobility of the lipid
headgroups, therefore decreasing the time to membrane insertion of peripheral proteins, while retaining the
atomic detail of a conventional membrane model that are essential to understanding protein-lipid contacts.
In addition to increased lateral mobility, the HMMM model is able to reproduce pertinent properties of the
membrane, including atomic density profiles, area per lipid, and energetics of sidechain-lipid interaction [182,
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Figure 4.3: Expanded Simulation Set for Talin Binding. Plots of the five independent membrane-binding simulations
demonstrating the reproducible membrane-binding and insertion of the talin F2F3 subdomain. The MOP is represented by the
blue trace, the Phe-rich membrane anchor is represented by the red trace, and the FAP represented by the gray trace. Solid
lines represent a five window running averages of the translucent curves. The dashed line represents the average height of the
phosphate layer of the cis-leaflet.
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Table 4.1: Contact Probabilities of MOP and FAP Residues with the PS HMMM. Average (±SD) number of
phospholipids in contact with talin F2F3 in its membrane-bound state. The contacts were counted every 0.05 ns over the last
10 ns of each trajectory and averaged across all five membrane-binding simulations. A contact is defined as either a phosphate
(geometric center of PO−4 ), carboxylate (geometric center of COO
−), or ammonium (geometric center of NH+3 ) group of the
lipid within 4.5 A˚ of any side chain (“Side Chain”) or backbone (“Backbone”) atoms in the protein.
Side Chain Backbone
Residue PO−4 COO
− PO−4 COO
− NH+3
F2/MOP
H255 0.42±0.24 0.08±0.04 0.19±0.24 0.00±0.00 0.09±0.10
K256 0.44±0.10 0.18±0.05 0.05±0.01 0.00±0.00 0.01±0.01
K258 0.73±0.19 0.14±0.06 0.01±0.01 0.00±0.00 0.00±0.00
K274 0.41±0.33 1.09±0.92 0.14±0.08 0.12±0.05 0.20±0.05
R276 1.60±0.04 0.36±0.25 0.69±0.09 0.04±0.03 0.03±0.02
K280 0.67±0.23 0.63±0.54 0.39±0.29 0.04±0.04 0.00±0.00
K287 0.53±0.14 0.53±0.18 0.08±0.07 0.09±0.03 0.11±0.09
F3/FAP
K325 0.37±0.27 0.06±0.02 0.14±0.10 0.01±0.01 0.02±0.01
N326 0.55±0.02 0.06±0.02 0.14±0.10 0.01±0.01 0.03±0.03
K327 0.08±0.01 0.32±0.12 0.02±0.01 0.01±0.01 0.02±0.01
215]. Utilizing the PS HMMM model, the spontaneous membrane-binding of talin (i.e., in the absence of
any external force or biasing potential that artifically induces membrane-binding) was captured across five
independent simulations with randomized initial orientations. As anticipated from previous mutagenesis
studies [60, 61, 63, 64], the basic MOP residues of the talin F2 subdomain described above make initial
contact with the anionic surface of the PS HMMM model very rapidly (<10 ns in all cases). The simulations,
however, were able to elucidate additional basic membrane-binding residues, including H255, K256, K265,
K270, and K287 (Fig. 4.4, Table 4.1). While these residues have not been previously identified, they appear
to interact in a non-specific manner with the charged surface of the PS HMMM model given by the fact that
the residues routinely switch interaction partners between phosphate and carboxylate groups (Table 4.1).
Once talin is completely bound to the membrane, as judged by insertion of the Phe-rich membrane anchor
(see below), it coordinates approximately 12 lipids: 10.1 via the basic residues of the MOP in the F2
subdomain and 1.8 via the FAP residues (see below) in the F3 subdomain.
To better understand the electrostatic forces involved in the membrane-binding of the talin F2F3
subdomain to the PS HMMM model surface, the electrostatic potential map of talin was calculated using
a separate simulation performed in aqueous solution (see Computational Methods for details). The map
(Fig. 4.5) reveals, interestingly, the highly polarized electrostatic nature of the talin F2F3 subdomain. The
membrane-binding face of the talin F2F3 subdomain is a largely positive surface, which is apparent from our
understanding of the role of the MOP residues in membrane-binding. The positive electrostatic potential
strongly contributes to the gravitation of the talin F2F3 subdomain to the largely anionic surface of the PS
HMMM model as observed in the simulations. In stark contrast to the positive underside of the talin F2F3
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Figure 4.4: Membrane-bound Configuration of the Talin F2 and F3 Subdomains. Shapshots showing the talin F2
subdomain bound to the membrane via MOP residues (blue) and the hydrophobic anchor (red) (a) and the talin F3 subdomain
bound to the membrane via the FAP residues K325, N326, K327 (gray) (b). Phosphatidylserine (PS) groups within 3.5 A˚
of labeled residues are shown as multicolored sticks. Talin backbone is shown in green, DCLE molecules as yellow van der
Waals spheres, and non-interacting PS groups are shown in brown. Some lipids are not shown for clarity. (c) Probability of
phospholipid contacts as a function of residue number in membrane-bound talin F2F3 subdomain for the MOP (blue bars) and
FAP (gray bars). Residues outside the range shown in the plot had no contact with lipids and, therefore, are not displayed.
The number of lipids in contact with each residue was calculated every 50 ps for the last 10 ns of each trajectory and then
averaged across all five trajectories. Detailed error estimates are provided in Table 4.1 for both sidechain- and backbone-lipid
contact probabilities.
subdomain, the opposite face of the protein has a large negative electrostatic potential (Fig. 4.5) due to a
grouping of acidic residues (D194, D203, D207, D210, E291, E294). The potential map shows that the talin
F2F3 subdomain is highly polarized, which has not been previously described. The polarization of the talin
F2F3 subdomain seems an effective strategy to minimize unproductive binding attempts as well as ensure
that talin is properly oriented on the membrane surface in order to alter the conformational landscape of
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the integrin heterodimer.
4.3 Identification of a Reversible Membrane Anchor
Figure 4.5: Electrostatic Potential Map of Talin F2F3
Subdomain. The electrostatic potential is calculated using
the last 5 ns of a solution simulation at 50 ps intervals and using
a grid spacing of 1 A˚−3. The electrostatic potential was then
averaged over the entire 5 ns and plotted. A cross-section of
the three-dimensional potential is shown through the middle
of the talin F2F3 subdomain. The outline of the talin F2F3
subdomain is shown using the black line with the MOP, FAP,
and key residues labeled.
The insertion of a hydrophobic membrane anchor
into the hydrophobic core of the membrane provides
a strong stabilizing force for the membrane-bound
forms of peripheral proteins [216–218]. Although
electrostatic interactions do contribute to the overall
binding affinity of peripheral proteins to the mem-
brane, these Coulomb interactions can be displaced
by water and/or ions in physiological solutions and
are not sufficient for complete membrane-binding of
peripheral proteins. Insertion of a hydrophobic an-
chor, therefore, is necessary for stable binding of
peripheral proteins. As opposed to many other pe-
ripheral proteins with clearly exposed hydrophobic
membrane anchors [125, 219] or lipidated domains that insert into the membrane [220], no membrane an-
chor is apparent in the crystallographically determined structure of the talin head domain [60, 63, 203],
although pevious experimental studies have predicted the presence of a hydrophobic anchor in the talin
F2F3 subdomain [205–207, 210]. Description of a membrane anchor, which is essential to understanding
the membrane-bound form of talin, however, has remained elusive to structural [60, 63, 203] and computa-
tional [64] studies.
In the five independent simulations performed, two classes of conformational changes on the surface of the
membrane lead to the identification of a Phe-rich hydrophobic anchor that has not been previously described:
snorkeling of basic residues (Fig. 4.6) and insertion of the Phe-rich membrane anchor into the membrane
core (Fig. 4.4a). These two events are connected, as snorkeling of the basic residues in the MOP allows for
the release and subsequent insertion of the Phe-rich membrane anchor. Following initial association of the
MOP basic sidechains, residues K256, K258, and K270 begin snorkeling within the headgroup region of the
membrane. While this has not been described as a mechanism for membrane-binding in peripheral proteins
previously, snorkeling has been observed in multiple intergral proteins as a means of stabilization [221–223].
The conformational change induced by the membrane causes the sidechains of the basic residues, which are
initially extended from the underside of the talin F2F3 subdomain to the membrane surface (Fig. 4.6b), to
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Figure 4.6: Snorkeling of MOP Residues. (a) Relative height of lysine terminal ammonium nitrogen (Nε) above the Cγ
normalized by the distance between these atoms for K256, K258, K270, K274, K280, and K287. The red shaded areas of these
plots represent the initial association of the talin F2F3 subdomain in which the lysines are still in their extended conformations
and point toward the surface of the membrane, as exemplified in (b) for one of the five simulations. The blue shaded areas in
the plots of K256, K258, and K270 demonstrate the snorkeling of the lysine residues in which the terminal ammonium nitrogen
is incontact with the phosphate while the alkyl chain is embedded deeper in the membrane core. This corresponds with the blue
framed snapshot (c), which displays the snorkeling of K256 and K258. In the molecular images, the talin backbone is shown
in green, the alkyl chain of lysine is shown in orange, the terminal ammonium nitrogen is shown in blue, DBPS molecules are
shown in brown, and DCLE molecules as yellow van der Waals spheres.
spread out from the talin F2 subdomain in the plane of the membrane (Fig. 4.6c), forcing the protein to
sink deeper into the membrane while simultaneously extruding lipids from underneath the talin F2 subdo-
main. The conformational changes allow for the exposure and insertion of the Phe-rich membrane anchor
(Fig. 4.4a), composed of residues F261 and F283. The snorkeling of MOP residues and the extrusion of
lipids caused by snorkeling, supports previous film balance studies [205] in which the are of lipid monolayers
increased upon binding of the talin head domain, suggesting the protein must force out lipids in order to
fully bind the membrane.
While the snorkeling of lysine residues in the MOP of the talin F2 subdomain provides some hydrophobic
stabilization to the membrane-bound talin F2F3 subdomain via inserted alkyl chains, the insertion of the
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Table 4.2: Internal RMSD of Talin F2F3 Subdomain during Membrane-Binding. Average internal RMSD values
(±SD) during the solution and membrane-binding simulations of talin are shown for the F2 subdomain backbone (residues
206-306), the F3 subdomain backbone (residues 312-408), and the MOP/Phe-rich anchor region (residues 250-290). In each
calculation, the reference structure was given by the first frame of the trajectory and the protein backbone was superimposed
on the reference each frame. The RMSD was calculated every 0.05 ns for the last 10 ns of each trajectory and then averaged
across all five membrane-binding trajectories.
Structure Solution Membrane
F2 Subdomain 0.96 ± 0.10 2.18 ± 1.48
F3 Subdomain 1.91 ± 1.38 2.31 ± 1.82
MOP/Anchor:
-Backbone Only 0.82 ± 0.09 1.18 ± 1.09
-All Heavy Atoms 1.03 ± 0.11 10.36 ± 0.77
Phe-rich membrane anchor is expected to contribute the majority of hydrophobic stabilization to membrane-
bound talin. Snorkeling of basic residues drive the talin F2 subdomain further into the membrane, allowing
for release and insertion of the Phe-rich membrane anchor composed of residues F261 and F283 (Fig. 4.4a).
The two phenylalanine residues are initially buried in the interior of the talin F2 subdomain in a hydropho-
bic pocket consisting of four phenylalanine residues: F249, F261, F267, and F283. A local conformational
change, however, together with sidechain rotation of the two phenylalanines allows for insertion of the Phe-
rich membrane anchor. To evaluate the extent of exposure, the solvent accessible surface area (SASA) of the
Phe-rich anchor was measured across the five independent simulations. At a probe radius of 1.5 A˚, which is
the approximate radius of a water molecule, the SASA is 273.04± 5.98 A˚2 when the anchor is buried ver-
sus 524.72± 44.43 A˚2 when the talin F2F3 subdomain is bound. This suggests that binding the membrane
induces exposure of the Phe-rich membrane anchor. Moreover, RMSD measurements (Table 4.2) of the
MOP and Phe-rich membrane acnhor backbone and sidechains show that the backbone is relatively stable
throughout both solution and membrane-binding simulations. There is significant sidechain rearrangement
upon membrane-binding, however, including snorkeling of lysines and flipping down of the phenylalanine
residues in the Phe-rich membrane anchor, which helps the protein fully bind the membrane. Together, the
SASA and RMSD data support the idea that membrane-binding induces a structural change in the talin
F2 subdomain that exposes the Phe-rich membrane anchor (F261/F283) to the membrane core. Once the
Phe-rich membrane anchor is inserted, the talin F2F3 subdomain remains stably bound for the remainder
of the simulation (Fig. 4.3).
4.4 Membrane-Induced Subdomain Rearrangement
The crystal structure of talin F2F3 subdomain depicts the subdomains in the canonical “cloverleaf” ar-
rangement (Fig. 4.1a) in which the F1 and F3 subdomains sit higher than the F2 subdomain (resembling
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a three-leaf clover) [53, 60]. This conformation prevents simultaneous interaction of the basic faces of the
F2 and F3 subdomains with the anionic membrane surface. Mutagenesis studies [61, 208], however, have
shown that the F3 subdomain must interact with the surface to activate integrin. Moreover, the electrostatic
calculations (Fig. 4.5) predict a string interaction between the basic face of the talin F3 subdomain (called
the F3 association patch, FAP) and the anionic surface of the membrane. Because the F3 subdomain is the
point of interaction between talin and integrin [57], a complete description of its behavior in the presence of
the membrane is key to understanding how talin modulates integrin activity.
Following insertion of the F2 subdomain, there is attraction of the F3 subdomain to the membrane
surface that leads to a large, interdomain conformational change (Fig. 4.2d and Fig. 4.3) manifested by
spontaneous binding of the F3 subdomain to the membrane via residues K325, N326, and K327 (Fig. 4.4).
This observation agrees with mutagenesis studies [61, 208] demonstrating weaker binding of talin upon neu-
tralization of these charged residues. The internal backbone RMSD of the F3 subdomain is relatively small
and changes very little between solution and membrane-binding simulations (Table 4.2) signifying that there
is very little local structural rearrangement. The F3 subdomain, however, does undergo a large structural
rearrangement with respect to the F2 subdomain (Fig. 4.7), representing the largest membrane-induced
effect observed in the simulations. A control simulation of talin in aqueous solution clearly demonstrates
that this phenomenon is membrane-induced and not an effect of crystal structure relaxation. While some
structural fluctuation is observed in the control simulation (Fig. 4.7), indicating the inherent flexibility be-
tween the F2 and F3 subdomains, the structural fluctuations are much smaller than those observed in the
membrane-binding simulations. Moreover, the angle between the talin F2 and F3 subdomains (Fig 4.7)
demonstrates the distinct rotation of the F3 subdomain relative to the F2 subdomain induced by the mem-
brane. The angle is much smaller (11.2± 5.0◦) when talin binds the membrane than when talin remains in
solution (35.5± 5.5◦). Therefore, in order to properly and completely bind the membrane, the talin F2 and
F3 subdomains undergo internal structural rearrangements that are induced by the membrane.
The talin F3 subdomain is thought to disrupt a highly conserved, intermolecular salt bridge between the
integrin heterodimer, leading to integrin activation [43, 44, 47, 51, 53, 58]. NMR studies [60] have demon-
strated that residues K325 and K327 in the talin F3 subdomain intimately interact with the conserved salt
bridge. The role of the talin F3 subdomain in integrin activation cannot be ascertained from the crystal
structures, however, which preclude simultaneous binding of the F2 and F3 subdomains. These simulations
demonstrate that simultaneous binding of the F2 and F3 subdomains is possible via a large, interdomain
conformational change. Residues K325 and K327 remain bound superficially to the membrane (Fig. 4.2d,
Fig. 4.3, Table 4.1), sitting approximately 1.5 A˚ above the phosphate layer of the membrane, which would
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Figure 4.7: Membrane-induced Conformational Change in F3 Subdomain. Representative snapshots of the talin
F2F3 subdomain during solution (a; blue cartoon) and membrane-binding (b; green cartoon) simulations. The snapshots are
from t = 30 ns, which corresponds to a fully bound state in (b). (c) RMSD of the talin F3 subdomain (residues 312-408) relative
to the talin F2 subdomain (residues 192-311) for solution (blue trace) and membrane-binding (green traces) simulations. For
both simulations, the backbone of the talin F2 subdomain was superimposed on the initial structure (i.e., t = 0 ns) and the
backbone RMSD of the F3 subdomain was measured at 50 ps intervals. The solid line represents the running average of the
translucent curve. (d) Plot of the angle between the the talin F2 and F3 subdomains. The backbone of the F2 subdomain
was superimposed on the initial structure and the angle between the reference vector (solid lines in a and b) and measurement
vector (dashed lines in a and b) was recorded every 50 ps. The reference was taken to be the xy-plane, while the measurement
vector was taken to be the vector between the center-of-mass of the backbone atoms of the MOP residues and the FAP residues.
The solid line represents the running average of the translucent line.
optimally position talin to interact with the two integrin acitvation sites, leading to separation of the integrin
heterodimer (Fig. 4.8).
4.5 Membrane-bound Structure of Talin F2F3 in a DOPS Membrane
While the HMMMM model allows for expedited binding of peripheral proteins as well as enhanced protein-
lipid sampling, the model was not designed to, and indeed does not in some cases, completely and faithfully
reproduce the mechanical and electrical properties of a coventional, full-tailed membrane. Therefore, to
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Figure 4.8: Schematic Model of Membrane-Mediated Activation of Integrin by Talin. Cytosolic talin F2F3
subdomain (a) is initially attracted to the anionic surface of the membrane (red layer) by the basic residues of the MOP (blue
layer in the talin F2 subdomain). Once the F2 subdomain associates with the the membrane surface (b), basic MOP residues
in the talin F2 subdomain begin snorkeling, which leads to local conformational changes (c) allowing insertion of the Phe-rich
membrane anchor and stabilization of talin in the membrane. Following insertion of the Phe-rich membrane anchor, the positive
residues in the FAP (blue layer in the talin F3 subdomain) are attracted to the anionic surface of the membrane, leading to
an interdomain conformational change that brings the F3 subdomain into contact with the membrane (d). Once the talin F3
subdomain associates with the membrane, it is optimally positioned to interact with the integrin activation sites (two notches
in integrin β-tail), promoting spearation of the native integrin heterodimer.
answer the question of whether the membrane-bound form of talin F2F3 subdomain garnered utilizing the
HMMM model is stable and accurate, a 1,2-dioleyl-sn-glycero-3-phosphatidylserine (DOPS) membrane was
slowly grown around the membrane-bound form of talin (see Computational Methods for more details on
this process). Through successively decreasing levels of restraint, the DOPS membrane slowly adapted to
the membrane-bound conformation of talin F2F3. Important protein-lipid contacts were kept intact and the
talin F2F3 subdomain backbone was harmoincally restrained. Once equilibrated, the system was simulated
for 100 ns to explore the stability of the membrane-bound configuration in a conventional membrane. The
internal structure of talin remains stable throughout the 100 ns trajectory, with the average backbone RMSD
for the whole protein (including the flexible linker) being less than 3 A˚ (Table 4.3). Moreover, the talin F2
subdomain has an RMSD of 1.63 A˚, with the MOP/Anchor residues having an RMSD of only 1.00 A˚. While
there is slight descrease in the depth of penetration (less than 5 A˚ altogether), talin remains stably bound
Table 4.3: RMSD of Membrane-Bound Talin F2F3 in a DOPS Membrane. Average internal RMSD values (±SD)
during the DOPS (full) membrane simulation of talin F2F3 are shown for the whole protein (residues 206-408), F2 subdomain
backbone (residues 206-306), the F3 subdomain backbone (residues 312-408), and the MOP/Membrane Anchor moiety (residues
250 to 290). In each calculation, the reference structure was given by the first frame of the trajectory and the protein backbone
was superimposed on the reference each frame. The data presented are average RMSD ± standard deviation. The average is
calculated every 0.1 ns for the last 90 ns of the trajectory.
Structure RMSD (A˚)
Whole Protein 2.99 ± 0.41
F2 Subdomain 1.63 ± 0.21
F3 Subdomain 2.54 ± 0.39
MOP/Anchor 1.00 ± 0.24
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to the DOPS membrane for the duration of the simulation (Fig. 4.9). The Phe-rich membrane anchor
remains inserted into the membrane core and the MOP and FAP residues remain stably in contact with
the anionic phospholipids. Therefore, the membrane-bound model of the talin F2F3 subdomain observed
across five independent simulations using the PS HMMM model is a stable conformation of talin, suggesting
that the results garnered from the HMMM model studies represent physiologically relevant states crucial to
understanding the membrane-bound form of talin and how this conformation affects the integrin activation
landscape.
4.6 Computational Methods
4.6.1 Modeling the Talin F2F3 Subdomain
The initial structure of the talin F2F3 subdomain, consisting of residues 192-408 of the talin2 isoform, was
taken from the crystal structure of a talin F2F3/integrin β1D complex (PDB ID 3G9W) [60]. Hydrogen
atoms, a C-terminal carboxylate capping group, and an N-terminal ammonium capping group were added
using Psfgen plug-in of VMD [153]. Structural water molecules were retained, while crystallization media
molecules (i.e., glycerol and di(hydroxyethyl)ether) were removed prior to simulation. Talin F2F3 was then
solvated in 22,518 water molecules and ionized to 150 mM NaCl (61 Na+ and 67 Cl− ions), giving the system
final dimensions of 88×93×93 A˚3 and containing ∼71,500 atoms. The system was energy minimized over
5,000 steps and equilibrated under an NPT ensemble (P = 1.0 atm, T = 310 K) for 2 ns without constraints.
The structure resulting from this equilibration period was used as the initial structure in all subsequent
solution and membrane-binding simulations. The solution simulation, starting from this structure, was
extended to 40 ns under the same conditions to describe the behavior of talin in solution as well as provide
a control simulation to compare against the membrane-binding simulations.
4.6.2 Membrane Simulations of Talin F2F3 Subdomain
A biphasic system consisting of 1,1-dichloroethane (DCLE) and water was constructed as previously re-
ported [165], with the organic layer measuring 80×80 A˚2 in the xy-plane in order to provide sufficient surface
to accommodate insertion of talin F2F3. The number of DCLE molecules needed to fill the organic layer is
based on the density of the solvent (1.2 g/mL) and the volume of solvent slab to be used in the simulation,
which measures 80×80×40 A˚3 in this case. As talin has been shown to preferentially bind to anionic mem-
brane surfaces [54, 55, 59], 200 DBPS molecules (100 per leaflet) were placed with the phosphate group at
the interface of the aqueous and organic interface. This number was chosen to replicate the experimentally
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Figure 4.9: Stability of the Talin F2F3 Subdomain in a DOPS Membrane. (a; green frame) Snapshot of the
membrane-bound form of talin F2F3 obtained obtained from the PS HMMM simulations. Here, talin is shown as the green
backbone, with MOP (blue), Phe-rich membrane anchor (red), and FAP (gray) residues highlighted. DBPS molecules are shown
in brown and DCLE molecules are shown in yellow. (b, purple frame) Snapshot from t = 98 ns in the DOPS full membrane
simulation. The coloring scheme is retained from (a). (c) Plot of height of the MOP (blue trace), Phe-rich membrane anchor
(red trace), and FAP (gray trace) above the phosphate layer (y = 0) over the entire 100 ns full membrane simulation. This data
is from the production run following the conversion from the HMMM model and equilibration (see Computational Methods for
details).
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measured area per lipid (AL) of 64 A˚
2/L for DOPS [224]. The membrane patch was then solvated and ionized
to 150 mM NaCl, giving the system final dimensions of 80×80×240 A˚3. This system was energy minimized
over 8,000 steps and equilibrated under an NPnAT (constant temperature, pressure, and area) ensemble
(Pn = 1.0 atm, T = 310 K) for 5 ns. The equilibrated talin F2F3 subdomain was placed into the equilibrated
DBPS HMMM model approximately 10 A˚ above the membrane surface, with each independent simulation’s
initial orientation randomized. Overlapping solvent molecules were removed and an additional 6 Cl− ions
were added to neutralize the system, giving the system a final atom count of ∼150,000 atoms. Following
energy minimization, each system was simulated for 40 ns under an NPnAT ensemble.
4.6.3 Conversion of the HMMM Model to a Conventional Membrane
To ensure that the model of talin generated using the HMMM model is stable in full membranes, the HMMM
model was converted to a conventional DOPS membrane using a snapshot of membrane-bound talin F2F3
(Fig. 4.2d). In making this conversion, it was important to minimize the perturbation to the protein-
lipid contacts established in the HMMM model simulations. In order to accomplish this goal, conversion
of the HMMM model to a conventional membrane was undertaken in several successive steps followed
by several simulations with diminshing restraints on the lipids. First, all DCLE molecules were removed
from the system. For each short-tailed lipid in the membrane, the headgroup (i.e., the phosphate and
serine moieties) from a DOPS lipid was superimposed onto the headgroup of an existing DBPS molecule,
therefore ensuring that the protein-headgroup contacts were not disturbed. With headgroup orientation
preserved, the tails from the DOPS lipids were modeled onto the short tails of the DBPS molecules, essentially
elongating the DBPS short-tailed lipid to create full length DOPS lipid. Following conversion to a full DOPS
membrane, the lipid tails were melted for 2 ns, with the headgroups and protein harmonically restrained
(k = 5.0 kcal/mol·A˚2). During simulation, the HMMM model membrane width expanded slightly, leaving it
∼42 A˚ wide versus the 38.5 A˚ experimentally measured for a DOPS membrane [224]. Therefore, the trans-
leaflet was relaxed for 2 ns with the restraints still enforced on the cis-leaflet and the protein, allowing the
membrane to relax to the correct width. Lastly, the restraints on the cis-leaflet were lifted to allow the lipid
membrane to relax around the restrained protein for 2 ns. Following this, the production run was begun
and all restraints were lifted and the system simulated for 100 ns under and NPT ensemble (P = 1.0 atm,
T = 310 K).
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4.6.4 Electrostatic Potential Calculations
The electrostatic potential map was calculated using the Pmepot plugin [225] of VMD in order to study
the general electrostatic features of talin F2F3 and how it might affect membrane-binding. Because elec-
trostatic calculations utilizing the particle mesh Ewald sums (PME) method [32] rely on the periodicity of
the simulation system, rotation and translation of the protein can complicate proper averaging of the po-
tential around the protein. Moreover, the edges of the bounding box of the simulation system are prone to
error. Therefore, to obtain accurate potentials at the surface of talin, a separate solution simulation system
was generated, similar to the one utilized above. In this case, however, talin was harmonically restrained
(k = 7.5 kcal/mol·A˚2) at four Cα atoms, two from the F2 subdomain (P211/C238) and two from the F3
subdomain (P330/T357), in order to prevent rotation and translation while still allowing for local rearrang-
ments of sidechains and backbone atoms. The system was simulated for 5 ns. The backbone of talin in each
frame was superimposed onto the initial structure to minmize noise generated by random fluctuations in the
trajectory and the potential was calculated every 0.05 ns with a grid resolution of 1 A˚−3.
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Chapter 5
Developing in silico Anesthetic Models for Use in Biological
Simulations
“What I cannot create, I do not understand.” –Richard Feynman
Despite well over 150 years of clinical use, a detailed molecular mechanism of anesthetic action remains
unresolved. The once prevailing hypothesis suggested that anesthetics worked through a non-specific, mem-
brane disruption mechanism [66], known as the Meyer-Overton hypothesis (or Meyer-Overton correlation).
Recent studies [69–71] have shown that most, if not all, anesthetics target a specific family of ion channels
in the nervous system, including the Cys-loop family of pentameric ligand-gated ion channels (pLGIC), the
HCN family of channels, the two-pore K+ leak channels, and voltage-gated cation channels [226, 227]. The
most well-studied family of channels, however, is the Cys–loop receptors. These receptors act in response to
the release of neurotransmitters from the pre-synaptic terminal, initiating the action potential on the post-
synaptic neuron, and are the targets for multiple pharmacological agents, including alcohol, barbituates,
and benzodiazepines, in addition to anesthetics [69–71]. The structural changes associated with channel
modulation, however, are still poorly understood due to the challenge of resolving high-resolution structures
of these receptors. Recently, crystal structures of GLIC (G. violaceus ligand-gated ion channel) [78–82, 228]
and ELIC (E. chrysanthemi ligand–gated ion channel) [84, 85], which are bacterial homologues of nervous
system pLGICs, have been solved both in the presence and absence of anesthetics, and provide a tremendous
opportunity to resolve the molecular mechanism behind pLGIC function and modulation.
Several hurdles remain to understanding anesthetic action, however, including determining the energet-
ics and kinetics of anesthetic binding to pLGICs, elucidating how anesthetic binding disturbs the normal
dynamics of these channels, and uncovering the anesthetic binding site (or sites) in ligand-gated ion chan-
nels. Multiple methods have been used to try to elucidate the latter, including crystallography [80, 228],
mutagenesis [92, 229], photolabeling [230, 231], and molecular dynamics (MD) [94, 95]; however, multiple
binding sites have been reported and there is no consensus as to which site modulates ion channel function.
This chapter is based, in part, on work previously published, and reprinted with permission, as M.J. Arcario, C.G. Mayne,
and E. Tajkhorshid. 2014. Atomistic models of general anesthetics for use in in silico biological simulations. J. Phys. Chem.
B. 118:12075-12086. Copyright 2014 American Chemical Society.
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While static structures provide insight into possible binding sites of anesthetics, the modulation of channel
function is an inherently dynamic process which requires a dynamic description of the anesthetic/pLGIC
complex. MD simulation is a technique that can probe the effects of bound anesthetics on ion channel
dynamics [93–96, 232–234] with a high degree of spatial and temporal resolutions that is unavailable in other
techniques. Moreover, the solution of atomic-resolution (2.9-3.1 A˚) GLIC structures with bound anesthetics
place MD simulations in a psoition to be an integral tool in understanding how anesthetics affect ion channel
dynamics in atomic detail.
Crucial to these simulations are well-parametrized models of anesthetics. Modern anesthetics can be
placed into two main classes based on their delivery method: inhaled (volatile) anesthetics and intravenous
anesthetics. Most inhaled anesthetics are heavily halogenated (e.g., halothane and desflurane) and can
be difficult to model due to the unique chemical properties of large halogens. Intravenous anesthetics are
generally larger than volatile anesthetics (e.g., propofol and lidocaine) and/or contain complex multi–ring
structures (e.g. ketamine and etomidate) which require extensive computational resources to model ac-
curately, making parametrization difficult and time consuming. Due to the availability of parameters for
myriad chemical groups in standard force fields [148, 149], one common solution is to transfer parameters
Figure 5.1: Classes of General Anesthetics Chemical structures of modern anesthetics grouped by chemical scaffold as
well as widely used anesthetics which do not build upon a specific scaffold. Inhalational anesthetics generally belong to the
halogenated ether class, which consist of a ethyl methyl ether which is heavily halogenated, usually with fluorine as it is difficult
to metabolize,. Intravenous anesthetics have a greater variation in structure. They can generally be broken into barbiturates
and benzodiazepines. Three modern anesthetics, namely propofol, ketamine, etomidate, however, do not belong to any specific
class as they do not reflect a specific chemical scaffolding group.
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from similar molecules in order to create an amalgamated parameter set for each individual molecule. While
this is generally acceptable for bonds and angles, however, atomic charges and torsions are more complex and
not as portable. Moreover, standardized parameters for halogenated ethers are non-existent, and therefore,
make volatile anesthetics unamenable to this technique. Models of halothane [235–237] have been published
previously, but were not designed for compatibility with biomolecular force fields, such as CHARMM. Ad-
ditionally, other models of modern anesthetics have been published [95, 238, 239], but most models lack
extensive and rigorous testing against experimentally determined physicochemical properties. In order to
study the effect of anesthetics on ion channels, a set of standardized parameters compatible with biomolec-
ular force fields that are validated against experimentally verifiable physicochemical properties is necessary.
In this study, a novel set of parameters was generated for the ubiquitous modern anesthetics desflurane,
isoflurane, sevoflurane, and propofol (Fig. 5.1), which is compatible with the widely-used CHARMM force
field for biomolecules [98, 99, 148, 240, 241]. The parameters generated for each anesthetic were compared
against five different experimentally measured properties, namely dipole moment, density, heat of vapor-
ization, free energy of solvation in water, and free energy of solvation in oil, to assess the accuracy of the
parameter set developed. In all four cases, the atomic models reproduce experimental physicochemical prop-
erties, signifying the robustness of the model and reflecting their ability to reproduce the molecular behavior
of anesthetics in multiple environments. Moreover, the free energy of partitioning of each anesthetic into a
1-palmitoyl-2-oleyl-sn-glycero-3-phosphatidylcholine (POPC) bilayer was calculated to investigate how these
molecules interact with the membrane. In all cases, the anesthetics preferred the glycerol backbone region of
the membrane over either the membrane core or aqueous solution by 4–5 kcal/mol. These results suggest that
anesthetics partition into the membrane prior to binding pLGICs and gives context for the Meyer-Overton
correlation. Since determination of a detailed free energy profile of anesthetic insertion is not feasible exper-
imentally, the free energy was transformed into a membrane:water partition coefficient, a readily measurable
quantity, and is shown to agree with experiment. Lastly, “flooding” simulations were utilized to better
understand how anesthetics affect membrane structure. After partitioning into the POPC membrane, it was
found that anesthetics do not affect the atomic density distribution, lipid order parameters, area per lipid,
dipole potential, or lateral stress profile. Therefore, it seems general anesthetics most likely do not exert
their effects via non-specific membrane disruption mechanisms.
5.1 Validation of the Parameterized Anesthetic Models
The solution of multiple atomic resolution crystal structures of the bacterial Cys–loop receptors GLIC and
ELIC [78–82, 84, 85, 87, 228, 242] has enabled the detailed, atomic-level study of anesthetic-induced changes
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Table 5.1: Bulk Properties of Parameterized Anesthetics.
Dipole(D) Density (g/mL) ∆Hvap (kcal/mol)
Calca Expt Calcb Expt Calc Expt
Desflurane 3.39 2.87 1.48±0.01 1.46 8.02±0.03 7.60
Isoflurane 2.91 2.47 1.48±0.02 1.49 8.03±0.01 7.61
Sevoflurane 2.72 2.33 1.46±0.01 1.52 7.87±0.03 7.89
Propofol 1.92 1.60 0.95±0.01 1.03 16.27±0.05 12.27-20.58c
a. Because dipole is calculated using only the equilibrium geometry, there is no uncertainty
attached to this measurement. b. Calculated values are presented as mean±standard deviation,
where standard deviation was calculated across five replicates. c. Due to the high boiling point
of propofol (529 K), the ∆Hvap varies widely. However, the value calculated is well within the
experimental range.
in pLGICs by MD simulations. Absolutely crucial to these simulations, however, are well-parameterized
models of anesthetics compatible with popular bimolecular forcefields, such as CHARMM, AMBER, and
GROMACS, that have been extensively tested against experimentally measured physicochemical properties.
A rigorously tested set of force field parameters is lacking for most modern anesthetics, however. Modern
anesthetics (Figure 5.1) can be divided into two main classes based on method of delivery: inhalational and
intravenous anesthetics. Inhalational anesthetics (e.g., desflurane, isoflurane, sevoflurane) are comprised
almost exclusively of halogenated ethers and, due to the poor description of polarizability in classical force-
fields, are difficult to model, especially for molecules containing larger halogens. Intravenous anesthetics
are generally complex and/or conjugated multi-ring structures (e.g., propofol, etomidate, midazolam) which
require extensive computational resources to model accurately. Due to the availability of parameters for
myriad chemical groups [148, 149], one common solution is to transfer parameters from similar chemical
moieties to create an amalgamated parameter set, a process called “parameterization by analogy”. In gen-
eral, however, parameters are not portable and this technique becomes obsolete when attempting to model
novel chemical groups, such as the halogenated ethers or conjugated, fused–ring systems found in modern
anesthetics. Molecular models of anesthetics have been parameterized for MD simulations, but have either
been incompatible with biomolecular forcefields [235–237] or have not been rigorously tested against exper-
imental data to ensure the accuracy and validity of the parameters [95, 238, 239, 243]. The work herein
presents a rigorous development of de novo force field parameters that are compatible with the widely-
used CHARMM force field for four ubiquitous anesthetics: desflurane, isoflurane, sevoflurane, and propofol.
While desflurane and sevoflurane have not been previously parameterized, models for isoflurane [239] and
propofol [95] have recently been developed, but have not been tested against experimental physicochemical
data.
The Lennard-Jones (LJ) terms for all atoms were taken, by analogy, from the CHARMM force field
and, in all cases except isoflurane, were left unmodified in the models presented here. The equilibrium ge-
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ometry was calculated first using ab initio calculations (B3LYP/6-311+G(2d,p) for halogenated ethers and
MP2/6-31G(d) for propofol). Once the geometry was optimized, the minimum energy distance between a
water molecule and every chemically-unique, accessible atom in the molecule was calculated and used to
assign partial charge to each atom in the molecule.
In order to judge whether the equilibrium geometry and charge distribution reflect a chemically relevant
state, the magnitude of the dipole moment was calculated for each molecule according to Eq. 5.1. The exper-
imental dipole moment is generally determined in the gaseous phase, whereas the condesed phase is relevant
to the biological simulations in which these models will be used. Therefore, to reproduce the condensed
phase properties of the anesthetics, the parameterized models should overestimate the experimental dipole
by 15-20% [148]. The results in Table 5.1 show that the dipole moment overestimates the experimental
dipole anywhere from 16.7% in the case of sevoflurane to 20.0% in the case of propofol. For each anesthetic,
the geometry optimization and charge distribution was successful on the first iteration and did not require
successive iterations in order to establish an acceptable dipole moment.
Following validation of the equilibrium geometry and charge distribution against the experimental dipole
moment, the parameters for bonds and angles (equilibrium values and force constants) were assigned bassed
on transformation of the ab initio Hessian matrix [244]. Once the bonds and angles were assigned, a set of
QM torsion scans were performed at 3◦ increments radiating 180◦ in each direction from the equilibrium
value. These scans created a potential energy surface, which was fit by the dihedral parameters in the
molecule. Therefore, apart from the LJ terms, this parameter set represents a de novo parameterization of
all four anesthetics. With a full set of parameters generated, the density and ∆Hvap were calculated for each
anesthetic from bulk phase MD simulations and compared to experimental values (Table 5.1). The param-
eters were deemed acceptable, and the free energies of solvation calculated, if the density was within 5% of
the experimental value and ∆Hvap was within 1 kT (0.59 kcal/mol at the simulation temperature of 298K)
of experimental value, standards set forth in parameterization by the CHARMM General Force Field [148].
The density stayed below 5% in all cases. Desflurane and isoflurane had the least accurate ∆Hvap; however,
the values deviated from experiment by only 0.42 kcal/mol, less than the 1 kT threshold.
All anesthetics, except isoflurane, were able to be parameterized in one iteration. The first iteration
of the isoflurane parameters, however, produced a density of 1.52 g/mL (1.7% error) and the ∆Hvap was
8.79 kcal/mol, which differs from the experimentally measured value by 1.18 kcal/mol, greater than the 1 kT
threshold. Because larger halogens, such as the chlorine in isoflurane, are quite polarizable (an effect not
accounted for in most classical force fields), the electronic distribution of these atoms is more senesitive to
the chemical environment and the parameters for these atoms are even less transferable than C, N, and O
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Table 5.2: Calculated Free Energies of Parameterized Anesthetics.
∆GH2Osolv (kcal/mol) ∆G
Oil
solv (kcal/mol) logK
Calca Expt Calc Exptb Calcc Expt
Desflurane 0.24±0.20 0.92 -2.45±0.42 -1.74 2.48±0.88 –
Isoflurane 1.03±0.25 0.31 -2.77±0.36 -2.72 3.24±0.81 2.22
Sevoflurane 1.47±0.28 0.27 -3.12±0.32 -2.28 2.64±0.96 3.00
Propofol -3.93±0.30 -4.39d -7.28±0.38 -6.32 2.14±1.01 3.63
a. Calculated values are presented as mean±standard error. Standard error in free energies calculated
using BAR. [183] Standard error in logK values calculated using Monte Carlo bootstrap error analysis. b.
Experimental values are determined for anesthetics in olive oil. Calculations were performed using dodecane
as an approximation of olive oil. c. Calculated values are presented as mean±standard error. Standard
error in logK values calculated using Monte Carlo bootstrap error analysis. d. Although no data for free
energy of solvation in an aqueous solution exist for propofol, using the aqueous solubility of 160 mg/L [245]
and a vapor pressure of 0.01 mmHg, the free energy of solvation could be predicted. [246]
parameters. The ∆Hvap for isoflurane was too high in the first round of parameterization, but the dipole
moment was accurate, suggesting that the van der Waals interaction was too large. Therefore, the LJ
well term, ε, for the isoflurane chlorine atom was reduced (ε = −0.343 → −0.225) in order to reduce the
strength of the van der Waals interaction. Beginning with the modified LJ term, a complete second round
of parameterization was performed (including equilibrium geometry, charge distribution, bonds, angles, and
dihedrals), yielding an isoflurane model that reproduced both density and ∆Hvap measures to within the
acceptance criteria discussed above (Table 5.1).
5.2 Robust Anesthetic Models Reproduce Free Energies of Solvation
While being able to reproduce bulk properties, such as density and ∆Hvap, is essential to an accurate pa-
rameter set, the bulk phase is not representative of the biological or physiological environment. In biological
environments, anesthetics are likely to be found in aqueous solution, partitioning into the membrane, or
interacting with protein lumens. Therefore, to quantify how well the anesthetic models generated behave in
these varied environments, the solvation energies in both polar and non-polar environments were calculated
and compared to experimental values (Table 5.2).
The free energy of solvation was calculated for each anesthetic in water (∆GH2Osolv ) and in dodecane
(∆GOilsolv), which acts as a mimic for the non-polar environment provided by olive oil. These free energies
were calculated utilizing alchemical free energy perturbation (FEP) [95, 239, 247], an expedient, albeit non-
physical, method to calculate the free energy between two chemical distinct states. In this method, the
anesthetic is placed at the center of a solvent box (containing either water or dodecane) where it is slowly
and incrementally decoupled from its environment by gradually scaling the electrostatic and van der Waals
interactions between the anesthetic and the environment to zero. With each increment, or window, the free
energy to make the transformation can be accurately tabulated and added together over all windows. Due
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Figure 5.2: Free Energies of Solvation for Parameterized Anesthetics. Computed free energy change as a function of
the coupling parameter, λ, in both water (blue trace) and dodecane (orange trace), the latter mimicking an olive oil environment,
for desflurane (top left), isoflurane (top right), sevoflurane (bottom left), and propofol (bottom right). The curve shown for
each anesthetic represents the average of ten decouple/recouple cycles, with the average and error calculated using the Bennett
acceptance ratio (BAR) [183]. Shown in the inset of each plot is a molecular image of the anesthetic, with carbon in cyan,
hydrogen in white, oxygen in red, fluorine in magenta, and chlorine in green.
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to the immense computational cost of calculating free energies of solvation (a total of 2µs of simulation for
all FEP data presented here), validation of the parameter set against experimentally measured ∆GH2Osolv and
∆GOilsolv was deemed to be the final step in determining accuracy of the anesthetic model. The parameter
sets were accepted if the absolute difference in free energy was less than 1.5 kcal/mol and the sign of the
calculated and experimental free energy were the same.
The solvation free energy for each anesthetic in both aqueous and non-polar environments is presented
in Table 5.2. In each case, the in silico model parameters that were judged acceptable using bulk proper-
ties produced accurate solvation energies in two very different chemical environments, some even within a
kT of experimental values. The inhaled anesthetics (desflurane, isoflurane, sevoflurane) generally prefer a
non-polar environment with ∆GH2Osolv > 0 and ∆G
Oil
solv < 0. In contrast, the free energy data suggests that
propofol is quite amphipathic and that solvation in either environment is a low energy state (∆GH2Osolv < 0
and ∆GOilsolv < 0); propofol is more soluble in a non-polar environment, however. In the case of propofol, an
experimental ∆GH2Osolv is not currently available for comparison. The free energy of solvation, however, can
be estimated if the aqueous solubility and vapor pressure are known [246]. Given that the aqueous solu-
bility of propofol is 160 mg/L [245] and the vapor pressure at 298K is 0.01 mmHg, the predicted ∆GH2Osolv is
-4.39 kcal/mol, which is less than a kT away from the calculated value of -3.93± 0.30 kcal/mol for the propo-
fol model proposed here. Reproducibility of both ∆GH2Osolv and ∆G
Oil
solv demonstrates that the parameter sets
generated in this work are quite robust and of high enough quality to be utilized in a variety of simulations,
such as protein-anesthetic interaction, free energy calculations, and binding constant determination.
5.3 Interaction of Anesthetics with the Membrane
Although there is now a general consensus that anesthetics exert their effects through interaction with
pLGICs, there is currently debate as to where the anesthetics bind and how they affect the dynamics of
these protein channels [80, 87, 92, 94, 95, 248]. Moreover, the trend observed in the Meyer-Overton hy-
pothesis [66, 249] suggests that the membrane has a role in the binding and/or biological action of general
anesthetics. In order to better understand how general anesthetics affect and interact with biological mem-
branes, the partitioning of anesthetics into a POPC membrane was simulated and the effects on membrane
physical properties was measured. Partitioning of anesthetics was accomplished by both umbrella sampling
(US) simulations and “flooding” simulations in which a high copy number of the drug is added to the
system in order to overcome sampling deficiencies. While the partitioning of anesthetics between phases
has been studied computationally for several simplified systems, such as water:hexane [238, 250] and wa-
ter:vacuum [239], their behavior in physiologically relevant systems, such as that presented here, has not
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Figure 5.3: Free Energy of Anesthetic:Membrane Partitioning. (a) Snapshot of the POPC membrane used in the
simulations. Water and ions are omitted for clarity. The color of the atom groups in this molecular image correspond with the
colors of the traces found in the atomic density profile found in (b). (b) Atomic density profile of the simulated systems used to
demarcate the regions of the membrane for analysis of anesthetic-membrane interactions. The total POPC density is shown as
the black dashed line and water density is shown as the light blue trace. POPC density was further subdivided into tail (gray),
glycerol (red), phosphate (gold), and choline (blue) density. The solid black horizontal lines demarcate the different regions of
the membrane outlined in Chapter 3. The choline density (blue trace) decays to zero at z = 25 A˚, which corresponds to the
membrane width, w0 in Eq. 5.5. (c) PMF for inserting desflurane (blue), isoflurane (green), sevoflurane (orange), and propofol
(red) into a POPC membrane. The zero-energy point was taken to be bulk aqueous solution (i.e., z = 35). (d) Representative
snapshot of (starting left and moving right) desflurane, isoflurane, sevoflurane, and propofol in the US simulations showing the
location of the global minimum at the amphipathic boundary of the membrane.
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been previously explored computationally.
Utilizing US calculations, the free energy of partitioning was calculated for each anesthetic in a POPC
membrane (Fig. 5.3). The calculations demonstrate a significant energetic minimum of ∼4-5 kcal/mol rel-
ative to bulk aqueous solution where the fatty acyl tails meet the glycerol backbone (Fig. 5.3b,c). At this
level of the membrane, the hydrocarbons composing the fatty acyl tails provide a hydrophobic environment,
while the ester moieties and phosphate groups provide opportunities to interact with the polar moieties
on the anesthetics. This large energetic well suggests that anesthetics partition to the membrane prior to
interacting with pLGICs. In contrast to the large preference for the interfacial region of the membrane, the
PMFs show the anesthetics have no distinct preference for the membrane core or bulk aqueous solution,
with the free energy difference being less than 1 kcal/mol between these two regions in all cases. Because
detailed free energy profiles are not experimentally measurable, the PMFs were transformed to POPC:water
partition coefficients, in the form of logK, and compared with experimentally measured octanol:water par-
tition coefficients. As can be seen in Table 5.2, the in silico models are able to capture partitioning into a
non-polar phase fairly well. There are some discrepancies between the calculated and experimental parition
coefficients, which can be likely contributed to the direct comparison between partitioning into octanol and
a POPC membrane. These two media, although similar, are not identical and could cause discrepancy in
the measured values.
While it is known that general anesthetics affect the conduction of pLGICs, it is still unclear if anes-
thetics have drastic effects on membrane structure and whether these effects might indirectly lead to ion
channel modulation. To better understand how anesthetics interact with the membrane, we simulated a high
concentration (initial aqueous concentration of ∼100 mM or anesthetic:lipid ratio of 1:5) of each anesthetic
for 100 ns in a POPC membrane system. As the anesthetics partition into the membrane rather rapidly,
with 60-90% of anesthetics partitioned within 50 ns (Fig. S1), the length of the simulations was sufficient to
observe partitioning of a majority of anesthetic and explore the effect of these drugs on a POPC membrane.
To measure the effect of such a high concentration of the anesthetic on membrane structure, several physical
properties of the POPC membrane (atomic density profiles, area per lipid, order parameters, dipole poten-
tial, and lateral stress profiles) were measured after the anesthetics had partitioned into the membrane. As
can be seen from Fig. 5.4, the anesthetic has no measurable effect on distribution of atomic groups in the
membrane, as all atomic groups have no shift in peak density nor any difference in distribution width upon
partitioning of anesthetics. Moreover, the high concentration of anesthetic does not seem to affect the local
structure of the headgroups, nor the palmitoyl/oleyl tails, with no changes in the order parameters detected
for any anesthetic simulated (Fig. 5.4b,c). The area per lipid (AL) was measured for the membrane both
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in the absence and presence of anesthetics. There was no detectable change, as the AL for the pure POPC
membrane was 65.05±3.15 A˚2 versus an average of 65.27± 0.42 A˚2 across all four anesthetic simulations
(desflurane, 65.47±3.19 A˚2; isoflurane, 65.30±3.18 A˚2; sevoflurane, 64.67±3.13 A˚2; propofol, 65.62±3.19 A˚2).
With those three measures of membrane structure showing no change, we made two additional measure-
ments to see if the effect of anesthetics on the membrane is more subtle. Because anesthetics partition to
the membrane-water interface (Fig. 5.5a-d)), it is possible that anesthetics might perturb the organization
of water molecules at this layer, thereby disturbing membrane electrostatics and structure. Therefore, to
account for this, we measured the dipole potential of the POPC membrane, a net positive potential at the
center of the membrane due to the ordering of water molecules at the membrane interface, across all five
simulations (Fig. 5.5). These plots show that, to within error, there is no significant change in the dipole
potential of the membrane, suggesting that there is no gross disturbance of water structure at the membrane
surface. It is important to note that dipole calculations from MD simulations are known to overestimate
the dipole potential [98], due to the lack of polarizability in classical force fields. Comparison between the
profiles calculated, however, remain valid, as each simulation suffers from this deficiency. Moreover, since
these small molecules are partitioning into the membrane, it is conceivable that partitioned anesthetics affect
the inter-lipid dynamics in the membrane, the effects of which can be measured in lateral stress profiles.
As can be seen in Fig. 5.5, there is no statistically significant difference in the lateral stress profile between
POPC only and POPC/anesthetic membranes for all cases. While these measures do not constitute an ex-
haustive study of membrane behavior, they do provide significant evidence that anesthetics do not perturb
membrane structure, agreeing with previous experiments that have shown no effect of anesthetics on mem-
brane structure at clinically-relevant concentrations [251]. Noble gas molecules, such as xenon which has
been used as an anesthetic, have been shown to disturb membrane structure in previous simulations. [252]
These species, however, are vastly different from the general anesthetics studied here in that xenon is a
hydrophobic atom, and much smaller in size compared to the anesthetic molecules studied here, that readily
partitions to the membrane center, not the amphipathic membrane interface. Therefore, it should be noted
that the anesthetics studied here did not show any disturbance of membrane structure, but anesthetics with
completely distinct chemical structures might have an effect on gross membrane structure. [253]
5.4 Computational Methods
The recent development of the Force Field Toolkit (ffTK) [244] enables the rapid and robust parameteriza-
tion with application to biomolecular simulations employing CHARMM-compatible force fields. In addition
to semi-automated parameter optimization, ffTK provides multiple graphical tools for assessing parameter
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Figure 5.4: Structural Effects of General Anesthetics on the Membrane. (a) Atomic density profiles for membrane
components in the (starting left and moving right) POPC, desflurane, isoflurane, sevoflurane, and propofol systems. The atomic
density of the tails (black trace), glycerol (red trace), phosphate (gold trace), and choline (blue trace) moieties are shown as an
average over the last 50 ns of the trajectory (accounting for insertion of over 90% of anesthetics). The atomic density of water
is also shown (cyan trace) and measures 1.0 g/mL, which is the experimentally determined density of water at 298K. Order
parameters for both the headgroup (b) and lipid tails (c) are shown for POPC (black), desflurane (blue), isoflurane (green),
sevoflurane (orange), and propofol (red). Additionally, the order parameters for palmitoyl (dashed line) and oleyl (solid line)
tails is shown separately.
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Figure 5.5: Effects of General Anesthetics on Mechanical and Electrical Properties of the Membrane. Plotted
is the atomic density for desflurane (a), isoflurane (b), sevoflurane (c), and propofol (d) as a function of position along the
membrane normal. The density of the whole molecule is shown in black with the density of various chemical moieties within
each molecule also shown. Plot of the dipole potential (e) and the lateral stress profile (f) of a POPC membrane (black) and
a POPC membrane with either desflurane (blue), isoflurane (green), sevoflurane (orange), or propofol (red) partitioned. The
average of the two halves of the profile is shown together with the standard deviation between the two halves of the profile.
The measurments for all plots was made in the final 50 ns of each trajectory.
qualtiy throughout the entire parameterization process. These tools, as well as simulation-based physico-
chemical calculations, were utilized extensively to develop optimal sets of parameters for four anesthetics:
desflurane, isoflurane, sevoflurane, and propofol (Fig. 5.1). These four anesthetics were chosen as these four
species represent the most ubiquitous modern anesthetics in current use and as the focus of later stud-
ies was the effect of general anesthetics of ion channels no local anesthetic species were included in the
parameterization.
5.4.1 Parameterization
Two levels of theory were utilized to properly model the different characteristics of the heavily halogenated
voltaile anesthetics and the large intravenous anesthetics. The Gaussian09 program was used for all ab initio
calculations [254]. Ab initio calculations on desflurane, isoflurane, and sevoflurane (volatile anesthetics)
utilized the hybrid B3LYP density-functional theory [255, 256] with the 6-311+G(2d,p) basis set (B3LYP/6-
311+G(2d,p)) for geometry optimization and calculation of bonded, electrostatic, and torsional interactions.
B3LYP is known to calculate accurate geometries and hydrogen-bonded complexes for small molecules
containing first row elements [257, 258] and has been previously used with great effect to parameterize
halogenated molecules [237, 239, 259]. For propofol, second-order Møller-Plesset theory (MP2) and the 6-
31G(d) basis set (MP2/6-31G(d)) were utilized for geometry optimization as well as to calculate bonded,
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electrostatic, and torsional terms.
Parameterization of the anesthetics follows the ffTK workflow [244], which is based on the principles used
in CHARMM parameterization [148] in order to be consistent with the CHARMM force field utilized in all
biological simulations contained in this work. Currently, ffTK is not capable of abscribing Lennard-Jones
(LJ) parameters to atoms ab initio. Therefore, all LJ parameters used in the parameterization process
are taken from chemically similar atoms in the established CHARMM forcefield (i.e., the LJ parameters
for the fluorine atoms of the trifluoromethyl group in desflurane are taken from the 1,1,1-trifluoroethane
parameters in CHARMM). Following geometry optimization, partial charge assignments were made based
on minimum interaction energies and distances between water and all accessible atoms (e.g., an sp3 carbon
would not be accessible to water) derived from quantum mechanical (QM) calculations at the appropriate
theory level discussed above. The QM dipole moment was used as an additional constraint in optimizing
charge distribution, with equal weighting applied to QM dipole moment and QM water interaction distance.
Because these calculations happen in the gas phase, the calculated dipole moment needs to overestimate
the QM dipole moment by ∼20% in order to reproduce condensed phase properties in molecular dynamics
(MD) simulations [148]. Therefore, an overestimation of 15-20% of the QM dipole moment was used as the
acceptance criterion for the charge distribution. If the dipole moment was outside of this specified range,
another iteration of charge optimization was performed and the dipole moment measured again. This process
continued until a charge distribution satisying the criterion was found. The dipole moment was calculated
according to:
D =
∣∣∣∣∣
N∑
i=1
qiri
∣∣∣∣∣ (5.1)
where the bars denote the vector length, N denotes the number of atoms in the molecule, qi denotes the
charge of the ith atom, and ri denotes the position vector of the i
th atom. The bond and angle terms were
calculated from the Hessian [244]. Scans of each torsion were made at 3◦ steps and the dihedral parameters
were fit to the resulting potential energy surface. In order to validate the quality of parameters generated
using this workflow, MD simulations were performed to calculate the bulk physicochemical properties of
each anesthetic (described in further detail below), which were then compared to experimental data.
5.4.2 Calculating Bulk Physicochemical Properties
Following the optimization of bond, angle, and dihedral terms against the QM data, the bulk properties
of density and enthalpy of vaporization (∆Hvap) were calculated for each anesthetic and compared against
experimentally determined values as an initial assessment of parameter accuracy. In the case that the
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parameters did not fall within the acceptance criteria outlined below, another round of bonded and torsional
term optimization was performed. A temperature of 298K was utilized throughout the simulations presented
herein as the anesthetics are liquid at this temperature and the experimental data was measured in standard
conditions (i.e., T = 298K). The simulated system was comprised of 216 copies of the anesthetic positioned
on an equally spaced 6×6×6 cubic grid. Each copy was randomly oriented around its center-of-mass with
the initial grid spacing based on experimentally measured density. The system was minimized for 10,000
steps, then equilibrated for 100 ps, and finally simulated in an NPT ensemble for 2.5 ns. Each simulation
was repeated five times to ensure proper sampling and averaging.
Conventionally, the heat of vaporization is calculated using:
∆Hvap = −〈Uliq〉+ P 〈Vliq〉
Nmol
+ 〈Ugas〉+RT (5.2)
where 〈Uliq〉 is the potential energy of the system in the liquid state, P is the pressure of the system, 〈Vliq〉 is
the volume of the liquid system, Nmol is the number of molecules in the system, and 〈Ugas〉 is the potential
energy of the molecule in the gaseous phase. The brackets, 〈...〉, denote a time average over the length
of the simulation. In order to calculate ∆Hvap, however, the number of gas phase trajectories must equal
the number of molecules in the liquid phase simulation, making this calculation computationally expensive.
Therefore, a method to calculate the ∆Hvapusing a single condensed phase MD simulation was utilized
instead [260]. Knowing that P 〈Vliq〉 is negligible [148], this formula can be reduced to:
∆Hvap = −〈Uliq〉
Nmol
+ 〈Ugas〉+RT
∆Hvap = −
〈U interliq 〉
Nmol
+RT (5.3)
While Eq. 5.3 assumes that the intramolecular energy is the same in the gas and condensed phases (i.e.,
〈U intragas 〉 = 〈U intraliq 〉), which in most cases is a justified assumption [148], it allows us to calculate the heat of
vaporization using a single trajectory instead of hundreds. Therefore, ∆Hvap was measured by calculating
the intermolecular energy of the liquid and applying Eq. 5.3. The intermolecular energy of the liquid system
was calculated according to:
〈U interliq 〉 = 〈Uliq〉sys −
Nmol∑
i=1
〈U intraliq 〉i (5.4)
The density was calculated by taking the average volume of the system over the 2.5 ns and dividing this
volume by 216. The parameters were deemed acceptable if the density was within 5% and the ∆Hvapwas
within a kT (0.59 kcal/mol) of experimentally determined values. These acceptance criteria were taken from
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recent CHARMM parameterization workflows [148]. If the parameters were within the error bounds for
density and ∆Hvap, the ∆G
H2O
solv and ∆G
Oil
solvwere calculated for each anesthetic as a final verification of the
accuracy of the parameters.
Taking advantage of the readily available experimental data on free energy of solvation in water (∆GH2Osolv )
and in oil (∆GOilsolv), these physicochemical properties were utilized as the last verification of the accuracy
of the molecular model generated. As the composition of olive oil is generally heterogenous and variable,
dodecane was used as a substitute for the oily environment [239]. For each environment, the anesthetic was
placed at the center of a pre-equilibrated box measuring 30 A˚ per side, using the Solvate plug-in from VMD
to construct the water box or the Packmol software [152] to construct the dodecane box. Alchemical free
energy perturbation (FEP), which has been successfully used to calculate the solvation energy of anesthetics
previously [95, 239], was used to calculate the free energy of salvation by slowly decoupling the anesthetic
from its surrounding environment followed by recoupling to the environment. Each transformation proceeded
over 25 windows run both forward (solvation) and backward (desolvation), a total of 50 windows, to minimize
hysteresis. Each window was equilibrated for 1 ps and simulated for 0.5 ns of data collection, requiring 25 ns
for each solvation/desolvation cycle. To avoid the “end-point catastrophe” [247], the Zacharias soft–core
potential [261] was used in addition to shifting the Lennard-Jones potentials by 5.5 A˚ and slowly decoupling
the electrostatics and van der Waals interactions of the anesthetic from solution. The transformation was
repeated ten times for each molecule in each environment and the free energy change was calculated using
the Bennett acceptance ratio (BAR) [183].
5.4.3 Free Energy of Membrane Partitioning
In order to understand and quantify how anesthetics interact with and partition into the membrane, we
calculated the free energy profile for inserting each anesthetic into a full-tailed POPC membrane. Because
MD simulations can only reach the sub-µs range, the entire reaction coordinate (distance from the mem-
brane center in this case) often cannot be sampled sufficiently to give convergent results. Therefore, we have
employed umbrella sampling (US), where the reaction coordinate is divided into multiple overlapping um-
brellas, each with an additional restraint potential that allows for sampling of the entire reaction coordinate,
in order to properly sample the energetics of anesthetic-membrane interaction. Based on previous protocols
used for small molecules [179, 181, 190], the reaction coordinate was broken into 38 windows separated by
1 A˚ with a harmonic potential (k=7.17 kcal/mol·A˚2) restraining the anesthetic to its initial center-of-mass in
each window. Each umbrella was simulated for 10 ns, which was judged to give good convergence in all cases,
recording the position of the center-of-mass of the molecule every 0.2 ps. The free energy profile, or potential
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of mean force (PMF), was reconstructed with the weighted histogram analysis method (WHAM) [193, 194],
using a convergence criterion of 10−5 and the last 9.5 ns of each trajectory for the analysis. In order to
increase computational efficiency and gain better statistics for each anesthetic, the simulation system con-
tained two copies of each anesthetic offset by 38 A˚, in order to prevent any unwanted interactions. Once
the PMF was calculated, the profile was utilized to calculate the POPC:water partition coefficient using the
following equation
K =
1
w0
∫ w0
0
e−
∆G(z)
RT dz (5.5)
where w0 is the width of the membrane taken to be the point along the membrane normal where the choline
density decays to zero (z = 25 A˚).
5.4.4 Anesthetic-Flooded Membrane Simulations
In order to better understand how anesthetics affect membranes and membrane structure, the interaction
between a high concentration of anesthetic and a POPC membrane was simulated. This was done by
“flooding” the system with anesthetic molecules, which entails placing a large number of these molecules
in a pre-equilibrated membrane system and performing an equilibrium MD simulation. The POPC mem-
brane used measured 96×96 A˚2 in the xy-plane and was constructed using the Membrane Builder plu-
gin of VMD. This membrane was solvated and ionized to 150 mM NaCl giving the system dimensions of
96×96×120 A˚3 with 216 lipids (108 lipids per leaflet). The resulting membrane system was energy minimized
and equilibrated in an NPT ensemble (P = 1.0 atm, T = 298K) for 3 ns, giving the system final dimensions
95×86×95 A˚3. This system was used as the starting structure for the membrane only simulation and was
simulated for 50 ns. Using the equilibrated system, anesthetics were randomly placed in the aqueous phase
of the system to give a 1:5 anesthetic:lipid ratio. Each anesthetic system was simulated for 100 ns in an
NPT ensemble.
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Chapter 6
Identifying General Anesthetic Binding Sites in an Ion Channel
“What seems to physicists to be a hopelessly complicated process may have been what nature found simplest,
because nature could only build on what was already there.” –Francis Crick
The discovery that small molecules, such as diethyl ether or chloroform, could cause reversible immo-
bilization and loss of consciousness helped usher in a modern era in medicine and surgical therapy. As
described in the previous Chapter, despite well over a century of investigation, an atomic-detail model of
the mechanism of general anesthesia is still vague and incomplete. It was once generally accepted that
anesthetics exerted their effects through a non-specific membrane disruption disruption mechanism, based
on the observation that, for early anesthetics, the more potent drugs were more soluble in olive oil; this is the
Meyer-Overton hypothesis [66]. More recently, however, this theory has fallen out of favor as many studies
support the theory that anesthetics specifically target a family of ion channels in the nervous sytem known
as the Cys-loop family of pentameric ligand-gated ion channels (pLGICs) [69–71], although other targets of
anesthetics have been found, such as the two-pore K+ channels and voltage-gated ion channels [226, 227].
Proteins in this family, such as the nicotinic acetylcholine receptor and the GABA receptor, act in response
to neurotransmitters released from the pre-synaptic terminal and are the target for multiple pharmaceutical
agents, including alcohols, barbituates, benzodiazepines, and general anesthetics [70, 226, 227, 262–264].
General anesthetics are known to inhibit the excitatory, cation-permeable channels of this family, such as
the serotonin and nicotinic acetylcholine receptors, while they potentiate the inhibitory, anion-permeable
channels, such as the glycine and GABA receptors [70, 226, 262–264]. The mechanism of channel modulation
remains poorly characterized, however, due to the difficulty in resolving high-resolution structures of these
eukaryotic receptors [72–75]. Recently, bacterial homologues to this family have been discovered [77] that are
sensitive to clinical, and in some cases sub-clinical, concentrations of anesthetics [86, 87]. Multiple crystal
structures of these bacterial homologues, such as GLIC (Gloeobacter violaceus ligand-gated ion channel) [78–
83, 228, 265] and ELIC (Erwinia chrisanthemi ligand-gated ion channel) [84, 85], have been solved, both in
The contents of this chapter are based, in part, on work that is currently under preparation to be submitted as M.J. Arcario
and E. Tajkhorshid. 2015. General anesthetic binding to GLIC proceeds through a membrane-embedded pathway.
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native and anesthetic-bound states, providing a tremendous oppotunity to study the molecular mechanism
behind anesthetic modulation of pLGIC function.
Of the bacterial pLGIC homologues studied to date, the most well-characterized channel is GLIC, with
multiple crystal structures solved [78–83, 228, 265] and a clear understanding of the effects of general anes-
thetics on ion conduction [86]. GLIC is a pH-activated (pH50 ∼ 4.5 − 5.0), cation-permeable homologue
of the Cys-loop receptor superfamily [77, 266]. The bacterial channel is a homopentamer with a five-fold
symmetry axis located coaxial with the ion conduction pore (Fig. 6.1). Each monomer is composed of an
extracellular domain and a transmembrane domain (TMD), lacking the intracellular domain found in eu-
karyotic pLGICs. The TMD of each monomer is composed a four-helix bundle (labeled M1-M4) with each
monomer contributing its M2 helix to create the ion conduction pore (Fig. 6.1). The 9’ and 16’ residues on
the M2 helix (I233 and I240, respectively) are thought to form the hydrophobic gate of the channel, which,
when closed, dehydrates the pore and prevents conudction of ions [267–269]. Moreover, a ring of glutamate
residues at the -2’ position (E222) resides at the intracellular mouth of the channel and is thought to aid in
ion translocation as well as act the selectivity filter for the channel [265, 270].
Although multiple techniques have been utilized in search of a general anesthetic binding site, there is
little consensus as to the site of anesthetic action in GLIC. Currently, debate centers around two distinct
binding sites located in the TMD, named the intrasubunit (binding site located completely within one sub-
unit) [80] and intersubunit (binding site located between two adjacent monomers) [92] sites, with evidence
supporting each site. Moreover, a pore-blocking mechanism has been proposed outside of these two TMD
binding sites [95]. Convoluting analysis of the anesthetic binding site is the fact that the open and closed
states of this channel are poorly defined at best and there is significant debate over whether the crystal
structures reflect physiologically open and closed states [78, 84, 242]. Crystal structures of the proposed
open state of GLIC and proposed closed state of ELIC have been solved. Addition of anesthetics to the
open state of GLIC, however, does not affect the structure of the open state [80], while mutations that
constituitively activate ELIC show no structural changes to the closed state [85].
The solution of atomic resolution (2.9-3.1 A˚) GLIC structures with bound anesthetics, together with
the rigorously developed parameter set introduced in the previous Chapter, presents an unprecedented op-
portunity to study how anesthetics bind to and affect ion channel dynamics via molecular dynamics (MD)
simulations. Presented here is a series of computational studies aimed at identifying the binding mechanism
of inhaled general anesthetics and characterizing conformational changes associated with binding. Starting
from the anesthetic-bound state, a membrane-embedded tunnel was identified that allowed for binding and
unbinding of the anesthetic. Within the timescale of the simulation two anesthetics unbound from their
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Figure 6.1: Structure of the Prokaryotic Ion Channel, GLIC. (a) Molecular image of the equilibrated MD system
showing the GLIC channel embedded in a POPC membrane. GLIC is shown in a multicolor representation, with each monomer
displayed in a different color. Bound desflurane molecules crystallized with the protein [80] are shown as magenta van der Waals
surfaces and POPC lipids are shown as mutlicolored sticks. (b) Cartoon representation of a single subunit of the homopentamer
is shown in blue with the position of the bound desflurane represented by the magenta van der Waals spheres. The residues that
comprise the extracellular domain and the transmembrane domain (TMD) are delineated. This snapshot shows the outer surface
of the protein (i.e., facing the lipid environment) in the foreground, with the ion conduction pore shown in the background. (c)
Top-down view of the TMD of GLIC with each monomer colored according to its position in (a). Each monomer of the TMD
is comprised of four helices, labeled M1-M4. The M2 helices, one contributed from each monomer, forms the ion conduction
pore. (d) Side view of the TMD with two monomers removed to make the ion conduction pore more apparent. Each GLIC
monomer is colored accoring to its color in (a) and the positions of bound desflurane molecules is shown by the magenta van
der Waals spheres. The hydrophobic gate residues (I233 (9’), I240 (16’)) are shown as cyan sticks and the ring of glutamates
(E222 (-2’)) is shown as multicolored sticks.
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binding sites leading to an asymmetric binding pattern. This asymmetry induces a conformational change
that dehydrates the pore and prevents ion conduction as shown by free energy calculations. In separate
flooding simulations, desflurane molecules spontaneously associated with the same site, called the TM1 site,
found in the crystal structure, supporting the idea that this is a true binding site. Moreover, a novel binding
site, called the TM2 site, established by residues Y254 and N308, was identified that aids in stabilization of
bound anesthetics. Simulation of the Y254A showed diminished ability to bind anesthetics in both the TM1
and TM2 sites.
6.1 Membrane-Embedded Tunnel Allows Anesthetic Binding and Unbinding
While the effects of anesthetics on membrane structure and properties were explored in the previous Chapter,
most current evidence suggests that anesthetics exert their effects via interaction with pLGICs [70, 226, 227,
264]. Therefore, to probe how anesthetics interact with pLGICs, two distinct simulation techniques were
utilized; a bound state simulation in which the the position of the aneshetic was derived from its binding site
in the crystal structure (i.e., the binding site was assumed to be known a priori, a site called TM1 herein)
and a flooding simulation in which the anesthetics were allowed to freely diffuse throughout the system to
find areas of low energy.
From the bound state simulation, it is readily apparent that the desflurane molecules are loosely bound
to the binding region identified in the crystal structure (Fig. 6.2), exploring, on average, over 116 A˚3 of space
within the lumen formed by helices M1-M4. By the end of the 100 ns simulation, two of the desflurane
molecules have spontaneously dissociated from their binding region (Fig. 6.2a,b). This suggests that the
interaction between the protein and the anesthetic is not a traditional “binding pocket” with complimentary
positioning of amino acids that tightly binds the ligand, but rather an amphipathic “binding region” that
is relatively low in energy compared to the environment. This loose binding might help to explain why
anesthetics need to be given in such high doses (frequently in the µM range [86, 87] compared to nM for
most current drugs) in order to exert their effects; an overwhelming concentration is needed to fully bind these
sites. The contact probabilities computed from the simulation (Table 6.1, Fig. 6.2c) show that desflurane
fairly evenly samples the entire lumen surrounding the TM1 site provided by the TMD helices, supporting
the idea that there is not a high affinity anesthetic binding site, but rather a low affinity binding region.
The TM1 site, identified with the crystal structure [80], is positioned at the level of the energetic minimum
for the anesthetic in a simple POPC membrane (Fig. 5.3, Fig. 6.2b), meaning transfer between the site and
the membrane should be rapid. A group of bulky aromatic residues, including Y119, F121, Y197, F238,
and Y254, blocks the exit of the anesthetic, however (Fig. 6.2d,e). Interestingly, recent studies have shown
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Figure 6.2: Elucidation of a Membrane-Embedded Binding Tunnel. (a) Plot of the position of each anesthetic in the
bound state simulation as a function of time projected onto the xy-plane. In the plots of the red and blue subunits, the desflurane
molecule spontaneously dissociates from its binding site during the simulation. Cartoon representations of the TMD of each
monomer are shown in order to establish the position of the protein. The black star within each monomer denotes the original
position of the anesthetic. (b) Plot of the z-coordinate of the center-of-mass of each anesthetic as a function of time over the
entire trajectory. The solid line is a running average of the translucent trace. The color blocks in the plot represent the height
of the same colored residues in (d), while the horizontal dashed line represents the z-coordinate of the membrane-embedded
tunnel. (c) For each monomer, the desflurane contact probability was measured across the entire simulation, normalized against
the highest level of contact probability (I202, 80.0%), and is plotted onto the backbone of the TMD. The first two subunits
on the left are those from which desflurane spontaneously unbinds. In this scheme, blue represents low probability, while red
denotes high probability of contact. Contact probability was measured by counting the number of frames desflurane was within
3.5 A˚ of the residue and dividing by the number of frames in the trajectory. (d) Molecular image of the binding site of desflurane
including bulky residues that sterically hinder the exit of the protein (green and red) as well as smaller residues that allow for
exit of the molecule (orange). The color of the residues corresponds to the same color blocks from (b). (e) Molecular image of
the same bulky residues in (d) from the top down.
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Table 6.1: Desflurane Contact Probabilities. The desflurane contact probabilities were calculated for the bound state
simulation by recording whether for each residue in the binding region there was any anesthetic atom within 4.5 A˚ of any
protein atom, including backbone and sidechains. This was done every 1 ns for the entire duration of the simulation or until
the anesthetic was judged to unbound (i.e. more than 5 A˚ from protein). The data was then averaged over all 5 subunits to
give the values presented here.
Residue Desf. Contact Prob. (%)
Y119 41.6
P120 55.6
F121 46.0
Y197 44.6
I201 50.6
I202 80.0
M205 47.4
L206 33.2
F238 79.6
V242 47.2
Y254 51.0
T255 61.0
I258 71.8
N307 25.4
that mutation of F238 to alanine (F238A or F14’A) generates a channel that is potentiated by general
anesthetics [91, 96, 271], instead of being inhibited, suggesting the importance of these bulky residues in
trapping anesthetics and allowing them to exert their effects. Even with the bulky residues, two molecules
of desflurane spontaneously dissociate from the TM1 site and the protein lumen altogether, at 45 and 72 ns
in the trajectory (Fig. 6.2a,b). In order to exit the transmembrane lumen, the desflurane molecules first
sink ∼8 A˚ within the protein lumen (i.e., move ∼8 A˚ closer to the membrane center) to where there is small
opening afforded by smaller residues L206 (M1 helix) and N307 (M4 helix) (Fig. 6.2d). The anesthetic can
exit through this tunnel and partition into the membrane. Once in the membrane, the anesthetics partition
to the glycerol region (Fig. 6.2b), as this is the lowest energy state for desflurane (Fig. 5.3). A membrane-
embedded tunnel to anesthetic binding and unbinding helps to explain why the Meyer-Overton hypothesis
is useful in predicting anesthetic potency. Anesthetics must partition to the membrane in order to bind the
inhibitory TM1 site; therefore, anesthetics that partition into the membrane better will necessarily have a
better chance of being able to diffuse to the TM1 binding site.
6.2 Anesthetic Dissociation Leads to Non-Conductive Channel
Dissociation of two desflurane molecules from the bound state simulation leads to an asymmetric bind-
ing configuration in GLIC. In this asymmetric binding configuration, the upper portion of the M2 helices
(residues 233-244) tilts in a clockwise direction by approximtely 10◦ (Fig. 6.3), causing an iris-like contrac-
tion of the pore radius and dehydration of the channel, which is known to prevent ion conduction [267–269].
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Figure 6.3: Asymmetric Binding Leads to Pore Collapse and Dehydration. (a) Plots of the angle of the top (blue)
and bottom (red) halves of the M2 helix with respect to the ion conduction axis (the angle is 0◦ at t = 0). This was calculated
and plotted separately for each subunit. The vertical dashed lines represent the timepoints at which each desflurane exited
the protein lumen (45 and 72 ns). The solid line is the running average of the translucent trace. (b) Molecular image showing
the starting conformation of the M2 helix (green) and the non-conductive conformation following spontaneous dissociation of
the desflurane molecules (gray). The red and blue portions of the M2 helix denote the residues used to measure the tilt angle
in (a). (c) Plot of the radius of the ion conduction pore in an apparently open state (“Symmetrically Bound”; blue), the
non-conductive state generated from simulation (“Asymmetrically Bound”; red), the same non-conductive state garnered from
flooding simulations (“Flooding”; green), and a recent “locally-closed” conformation (black) [81]. The pore radius was generated
using the Hole program [272]. The position of the -2’. 9’, and 16’ residues is shown on the plot as well as the area covered
by the hydrophobic gate (gray transparent box). (d) Number of waters in the hydrophobic gate as a function of time for the
whole simulation. The time points of desflurane unbinding are marked by the magenta arrows and the hydration/dehydration
cutoff is represented by the black sahed line (crystal structures [265] show the Na+ ion coordinating five waters and this was
used as the cutoff). Molecular images showing both the fully hydrated (e) and dehydrated (f) channel are shown. The color
box corresponds to the same colored vertical line in (d) and shows the timepoint in the simulation the molecular image was
taken from (41 ns for the hydrated structure and 88 ns for the dehydrated structure). One monomer has been removed in order
for the water column to be clearly visible. In (f), the 9’ and 16’ positions are demarcated to show the hydrophobic gate.
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Table 6.2: RMSD of Non-Conductive State and Crystal Structures. Measured RMSD between the proposed closed
state crystal structure [81] and the structures observed in the simulations reported here. The Bound State RMSD is measured
over the last 20 ns of the simulation using the closed state crystal structure as a reference. The Flooding RMSD is measured
over the last 50 ns of the trajectory with the closed state crystal structure as a reference. Data is presented as mean± S.D.
Structure Bound State RMSD (A˚) Flooding RMSD (A˚)
Whole Prot. 2.97± 0.05 2.87± 0.22
ECD (14-192) 3.08±0.16 3.21± 0.29
TMD (195-315) 1.49± 0.06 1.42± 0.05
Pore (221-244) 1.20± 0.04 1.31± 0.05
Although the exact stoichiometry is not known, experimental evidence has pointed to the activation of
Cys-loop receptors being dependent on an asymmetric binding pattern [273, 274], with recent simulations
showing that symmetric binding of anesthetics prevents closure of GLIC [275]. The conformational changes
described here, however, have not been previously linked with anesthetic action. As can be seen in Fig. 6.3c,
the tilting of the upper portion of the M2 helices causes a definite contraction of the ion conduction pore
radius by 1 A˚ at the 9’ (I233) position and by 2 A˚ at the 16’ (I240) position, the two residues believed to be
the hydrophobic gate necessary to dehydrate the pore [68, 71, 265, 269]. By the end of the simulation, the
pore radius is smaller at the 9’ residue (extracellular end of hydrophobic gate) by 0.3 A˚. The constriction
created by these residues as a result of the conformational shift in the M2 helices leads to a dewetting of
the channel (Fig. 6.3d) that leaves the volume between the 9’ and 16’ residues completely devoid of water
molecules. As opposed to the upper portion of the M2 helices, the lower half of the M2 helices (residues
221-230) undergoes relatively little to no conformational change due to the asymmetric binding pattern
(Fig. 6.3a,c), although there is a ∼0.5 A˚ contraction of the pore radius centered at the -2’ ring of glutamates
compared to the starting structure. The dehydrated structure generated from these bound state simulations
shows remarkable similarity to the “locally closed” structure crystallized recently (Table 6.2, Fig. 6.4). The
RMSD of the protein compared to the crystal structure is less than 1.5 A˚ over the last 20 ns of the trajectory
and the superimposition of the structures shows the backbone shape is almost identical to the crystal. In
fact, in Fig. 6.4, the unraveling of the first turn of the M2 helix is observed in both the crystal structure and
simulation.
In order to explore how the conformational change affects the free energy landscape and to unequivocally
show that the structural change induces a non-conductive state, the free energy profile for Na+ translocation
was calculated for both the open and non-conductive state (Fig. 6.5) utilizing umbrella sampling (US) sim-
ulations. Because the M2 helices appear to be the most important structure in terms of the conformational
change exerted by desflurane, in the US simulations, the backbone atoms of the M2 helices were harmonically
restrained (k = 5.0 kcal/mol·A˚2) to their starting points, while allowing the rest of the protein to fluctuate
normally. In the open state, which represents an equilibrated version of the open state crystal structure [80],
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the free energy profile is essentially flat (Fig. 6.5a). There is a small ∼1 kcal/mol barrier near the 16’
Figure 6.4: Structural Comparison between Non-
Conductive and Closed Crystal Structure. Molecular im-
age of the superimposed transmembrane domains of the locally
closed crystal structure (gray) [81], the non-conductive state
observed in the bound state simulation (red), and the non-
conductive state observed in the flooding simulation (green).
The locally closed transmembrane domain (residues 195 to 315)
were used as the reference structure for superimposition.
residue and a 2-3 kcal/mol energy well in the region
of the ring of glutamates. The channel, however,
would be able to conduct ions in this state. In stark
contrast, following the conformational change in the
M2 helices in which the hydrophobic gate collapses
and the channel dewets, there is a significant in-
crease in the energy barrier to Na+ translocation.
Whereas in the open state the hydrophobic gate
offers essentially no barrier, in the non-conductive
state there is a 10 kcal/mol barrier from z = 18 to
z = 27, followed by a 13.5 kcal/mol barrier in the
vicinty of the 16’ residue (Fig. 6.5). This is over
a ten-fold increase in the barrier to ion transloca-
tion and in this state, the channel would certainly
be non-conductive. As can be seen in Fig. 6.5b,
the conformational change in the M2 helices corre-
sponds with the isoleucine residues of the hydropho-
bic gate infiltrating the ion conduction pore, which
agrees with the pore radius profiles in Fig. 6.3c. The
movement of the isoleucines into the ion conduction pore is most likely the cause for the dewetting and in-
creased barrier to ion conduction. Interestingly, as stated above, there is a contraction of the ring of
glutamates during the simulation that brings these residues closer together. This difference is captured in
the free energy profile in which there is a significant increase in the energy well around the ring of glutamates
(∼3 kcal/mol). Therefore, in the conductive state, the ring of glutamates would act as an ion sink, attracting
Na+ ions and aiding in conduction through the channel.
6.3 Flooding Simulations Identify Novel Binding Site
While the bound state simulations relied on information on anesthetic binding prvoided by previous crystal
structures, it is clear that the binding site identified is not highly stable and it is possible that more stable
general anesthetic binding sites exist in GLIC. To probe for additional binding sites, a 300 ns “flooding”
simulation was performed. As described in the previous chapter, flooding is a technique in which a large
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Figure 6.5: Free Energy of Na+ Translocation in Open and Closed States. (a) Free energy profile of Na+ translocation
across the transmembrane domain of open (red) and non-conductive (blue) GLIC. The position of the hydrophobic gate and
ring of glutamates is indicated by the gray boxes. Error bars are estimates generated by Monte Carlo bootstrap error analysis.
(b) Molecular image showing a superimposition of the transmembrane domain of the open crystal structure (red) and the non-
conductive conformation observed in the simulations (blue). Only the M2 helices are shown as there is little rearrangement in
the TMD outside of the M2 helices and omitting the M1, M3, and M4 helices enhances the clarity. Shown in this superimposition
of structures is the conformational change in the M2 helices as well as the starting (red) and final (blue) positions of the 9’ and
16’ isoleucines, also known as the hydrophobic gate.
copy number of the ligand being studied are randomly placed into the aqueous solution (Fig. 6.6) and an
equilibrium MD simulation is performed, allowing the ligand to freely explore the system and find areas
of low energy [94, 276–278]. The large copy number decreases the time needed to see interaction between
the ligand and protein. The ligand can interact with sites that are not binding sites, however, so caution
is needed in assessing results of these simulations. In this simulation, the initial aqueous concentration of
desflurane was 130 mM, corresponding to a 1:2 desflurane:POPC ratio, much higher than the EC50 for GLIC,
0.56 mM [86]. The anesthetics immediately partition to the membrane (Fig. 6.6 with the number of aqueous
desflurane molecules fluctuating between 0-1 by 220 ns. Noteworthy, partitioning of anesthetics to the
membrane prior to binding GLIC was predicted based on the results from free energy calculations (Fig. 5.3)
and the elucidation of a membrane-embedded binding tunnel (Fig. 6.2). Throughout the simulation, several
desflurane molecules can be seen binding and unbinding from the extracellular domain of GLIC. Interestingly,
no desflurane molecules were observed to diffuse into the pore of the channel and block hydration as has
been proposed recently [95]. Multiple regions of low energy were identified (Fig. 6.6e,f), defined as occupying
a space within the protein for greater than 140 ns (or half) of the trajectory. Most of the sites observed,
however, were observed in only one subunit, which suggests that these sites are more likely kinetic traps than
true binding sites. Therefore, the remainder of this section will be focused on two binding sites, namely the
crystal structure binding site (called TM1 herein) and a novel binding site, termed the TM2 site (Fig. 6.6f).
By the end of the simulation, three desflurane molecules are bound to TM1, while five are bound to the
TM2 site, one per subunit (Fig. 6.6f, Fig. 6.7). Although three anesthetics remain bound in the bound state
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Figure 6.6: GLIC System Flooded with the General Anesthetic, Desflurane. Plots of the aqueous concentration of
desflurane (a) as well as fraction of desflurane in water (blue), membrane (green), and protein (red) (b). The number bound to
the protein was counted as any desflurane molecules that was within 4.5 A˚ of the protein. In the same fashion, the fraction in
water was counted as desflurane molecules within 3.5 A˚ of water, but not within 4.5 A˚ of either protein or membrane. Molecular
images showing the flooding system at t = 0 ns (c) and t = 275 ns (d) are shown to illustrate the flooding technique in addition
to showing the distribution of desflurane molecules at the start and end of the simulation. The color of desflurane molecule
in (c and d) corresponds to the color in (b). The POPC lipids are shown as multicolored sticks and the protein is shown as a
gray cartoon representation, with one subunit shown in orange for clarity. A snapshot of the final frame of the trajectory is
shown in (e) with the opposite face of the protein shown in (f). In this image, every subunit is colored differently. Desflurane
molecules that were bound for more than 140 ns (i.e., greater than half of the trajectory) are shown as van der Waals spheres.
The cyan desflurane molecules were those that were observed in only one subunit. The desflurane molecules in magenta and
gray were observed across multiple subunits, with magenta corresponding to the TM1 site and gray corresponding to the TM2
site. Also shown are the time each anesthetic was bound to the protein throughout the trajectory.
89
Figure 6.7: The Second Transmembrane Binding Site in GLIC. (a Molecular image of the transmembrane domain of
GLIC at t = 0 ns (white cartoon) and at t = 275 ns (multicolored cartoon) with anesthetics bound to the TM1 (magenta) and
TM2 (gray) sites. Plots of the distance from the TM1 (b) and TM2 (c) sites for the bound desflurane molecules. The color
in these plots correspond with the color of the subunit in (a). (d) Plot of the angle of the M2 helix with respect to the ion
conduction axis, with 0◦ being coaxial with the ion conduction axis. This was measured in the same manner as Fig. 6.3. The
color in these plots corresponds with the color of the subunit in (a).
simulation described above, it is unclear whether this is a coincidence or whether this is the optimal binding
pattern for inducing channel closure. In any case, the anesthetics that bind to both the TM1 and TM2 sites
diffuse to these sites from within the membrane. This lends further evidence to the idea that anesthetics
must partition to the membrane prior to binding to their molecular targets, helping to explain why the
Meyer-Overton hypothesis is useful in quasi-predicting the efficacy of general anesthetics. Interestingly,
occupation of the TM2 site appears to stabilize occupation of the TM1 site. As can be seen in Fig 6.7, the
red subunit has a desflurane molecule stably bound for ∼150 ns while the TM2 site is occupied, which is
much longer than it takes desflurane to spontaneously dissociate (45 ns was the fastest dissociation in the
bound state simulation (Fig. 6.2)). The stabilization appears to be due to the nature of residues composing
the TM2 site. Residues Y254 and N307 appear to provide most of the stabilization afforded by the TM2 site.
The Y254 hydrogen bonds with the ether oxygen of desflurane, which is a very stable interaction (Fig. 6.8),
whereas N307 interacts with either the trifluoromethyl (CF3) group of desflurane or difluoromethyl (CHF2)
group via a dipole-dipole interaction. The latter interaction appears to be less stable with frequent breaking
and reforming of this interaction throughout the simulation (Fig. 6.8b). Residue N307, forms part of the
binding tunnel that was elucidated in the bound state simulation. This suggests that the desflurane bound
to the TM2 site acts as a steric barrier to the exit of the TM1 site by blocking the tunnel between the TM1
site and the membrane.
To test whether abolition of the TM2 site affects TM1 binding, a flooding simulation of the Y254A
mutant was performed for 250 ns. The Y254A mutant was chosen due to the fact that distance measurements
(Fig. 6.8) suggests that the Y254-desflurane interaction is stronger than the N307-desflurane interaction. As
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Figure 6.8: Stabilization of the TM2 Site by Y254 and N307. (a) Plot of the Y254-ether O-O distance as a function
of time over the length of the trajectory. The color of the trace corresponds with the subunit color in (Fig. 6.7) and the colored
vertical dashed lines represent the timepoint at which the desflurane molecule binds to the TM2 site in the same colored
subunit. The horizontal dashed black line represents the average Y254-ether O-O distance across all five subunits. (b Plot of
the N307-CF3 distance as a function of time over the length of the trajectory. This was measured as the distance between
the center-of-mass between the amide group on N307 and the center-of-mass of the three fluorine atoms in the CF3 group.
The horizontal black dashed lines represent the average minimum and maximum distance between the center-of-masses, as
the interaction between N307 and the CF3 group is frquently broken and reformed. (c) Molecular image showing the relative
position of the TM1 and TM2 sites from the side, clearly demonstrating that the TM2 site blocks the exit of the TM1 site.
Here, only one GLIC subunit is shown for clarity. Desflurane bound to the TM1 site is shown in magenta and desflurane bound
to the TM2 site is shown as a multicolored van der Waals surface. Residues Y254 and N307 are shown are multicolored sticks.
(d) Plot of the number of waters in the hydrophobic gate as a function of time. The dashed horizontal black line signifies the
threshold between hydrated and dehydrated [265]. The magenta vertical lines signify the timepoints at which desflurane binds
to the TM1 sites.
can be seen in Fig 6.9, mutation of Y254 to alanine almost completely abolishes binding to the TM2 site,
as in the wild-type channel, the TM2 site is bound with 4.01± 1.21 desflurane over the last 50 ns of the
trajectory compared to 0.06± 0.24 desflurane molecules in the Y254A mutant. Moreover, mutation of Y254
causes a significant reduction in the number of anesthetics bound to the TM1 site (WT: 1.75± 1.01; Y254A:
0.71±0.48. Thus, abolition of the TM2 site by mutation shows a reduced ability to bind desflurane in the
TM1 site. There also is significantly more fluctuation in the number of bound desflurane molecules in the
TM1 site (Fig. 6.9a), also demonstrating that the TM2 site stabilizes desflurane bound to the TM1 site.
As in the bound state simulation, there is a conformational change observed in the M2 helices (Fig. 6.7d)
that leads to an iris-like contraction and dehydration of the channel pore. The pore radius measured in the
simulation is identical to that described described in the bound state simulation (Fig. 6.3, green trace) and the
same dehydration of the channel between the 9’ and 16’ residues is observed in this simulation as well. While
there is some concern regarding the stability of the GLIC crystal structure [95], we believe the dehydration
is due to anesthetic binding to the TM1 site. In a plot of the hydration level of the ion conduction pore
(Fig. 6.8e), there two incidents of transient dewetting of the channel; however, hydration is re-established
until desflurane begins to bind to the TM1 sites. Following this, there is a permanent dewetting of the
channel, making GLIC non-conductive as shown by the free energy profile of ion translocation (Fig. 6.5).
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Figure 6.9: Y254A Reduces Binding Affinity to TM1 and TM2 Sites. Plots of the number of desflurane molecules
bound to the TM1 (a) and TM2 (b) sites as a function of time for both the wild-type (black traces) and Y254A mutant (red
traces) flooding simulations. The dashed lines and numbers show the average number of bound desflurane to the TM1 site (a)
and TM2 site (b) for the wild-type (black dashed line) and Y254A mutant (red dashed line). Molecular images of the wild-type
(c) and Y254A mutant (d) with bound desflurane are shown. Each subunit in GLIC is colored differently. Desflurane bound
to the TM1 site are shown as magenta van der Waals surfaces and desflurane bound to the TM2 site are shown as gray van
der Waals surfaces. The initial conformation of the transmembrane helices in each simulation are shown in a white cartoon
representation.
6.4 Computational Methods
6.4.1 Preparation of the GLIC System
Several of the simulations described in this Chapter utilize the membrane-embedded GLIC channel. This sec-
tion describes construction of this system as well as the equilibration process, which prepared the membrane-
embedded channel for further simulation. Utilizing a crystal structure of GLIC with bound general anesthetic
desflurane (PDB ID 3P4W) [80], the coordinates for all five bound anesthetics were removed and the ion
channel placed in a POPC membrane measuring 115×115 A˚2 in the xy-plane using the Membrane Builder
plugin of VMD [153]. Following this, the system was solvated and ionized to 150 mM NaCl, giving the system
initial dimensions of 115×115×132 A˚3, containing ∼180,000 atoms. The coordinates for the entire system
were then loaded into the Propka 3.1 plugin for VMD [279] and the pKa shifts for each amino acid were cal-
culated, accounting for its total environment (i.e., protein, lipids, water, ions). Because GLIC is pH-gated,
with a maximal activation at pH of 4.5 [266], any sidechain with a pKa larger than 4.5 was assumed to
be protonated in the active state and was thus protonated in these simulations. In particular, the residues
that were protonated were all histidines in the system along with E26, E25, E67, E75, E82, D86, D88, and
E177. Once the system was completely constructed and protonated, the lipid bilayer was relaxed in two
steps in an NPT ensemble (P = 1.0 atm, T = 298K) while harmonically restraining all heavy atoms in the
protein (k = 5.0 kcal/mol·A˚2) and allowing unrestricted dynamics of water and ions. First, the lipid tails
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were “melted” over 2 ns by harmonically restraining the headgroups (i.e., choline, phosphate, and glycerol)
while allowing the tails to interact. following this, the headgroup restraints were released, and the membrane
was allowed to optimally pack against membrane-embedded GLIC for 2 ns. Once the POPC membrane was
equilibrated, the restraints on GLIC were released and the protein was allowed to dynamically interact with
the membrane for 5 ns in an NPT ensemble. The resulting system gave dimensions of 116×115×130 A˚3 and
was used as the initial structure for all following simulations.
6.4.2 Bound Anesthetic Simulation
Using the pre-equilibrated structure, described in detail above, as a reference, the backbone of the crystallized
GLIC [80] transmembrane domain (residues 195-315) was superimposed onto the backbone of the equilibrated
structure; once fit, the positions of the five bound desflurane molecules were copied into the equilibrated
system. Each anesthetic was harmonically restrained (k = 5.0 kcal/mol·A˚2) to its center-of-mass while
the surrounding protein was allowed to accommodate around the drugs for 2 ns under an NPT ensemble
(P = 1.0 atm, T = 298K). Following this, the restraint on the anesthetic center-of-mass was reduced to
0.5 kcal/mol·A˚2 to allow the anesthetics greater freedom to explore conformational space for 2 ns. For the
production simulation, all restraints were released and the system was simulated for 100 ns under an NPT
ensemble. The parameters for desflurane used were those developed in Chapter 5 [280].
6.4.3 Anesthetic Flooding System
FLooding simulations were employed to probe for binding sites outside of those that were crystallized with
the protein. The flooding technique consists of randomly placing a large copy number of the drugs into
the surrounding solution in order to staurate the protein and prevent the situation in which no binding
is observed due to the short timescales available to MD simulations. The large copy number of drugs is
allowed to randomly diffuse throughout the system in order to find areas of low energy [94, 276–278]. Using
the equilibrated system, desflurane molecules were randomly placed in aqueous solution at a ratio of 1:2
desflurane:POPC while simultaneously ensuring that no anesthetic was within 10 A˚ of the protein or 5 A˚ of
the membrane. This ratio gives an initial aqueous concentration of 150 mM, much larger than the EC50 of
0.56 mM. Once placed in solution, overlapping water molecules were removed and the system simulated for
300 ns. The parameters for desflurane used were those developed in Chapter 5 [280].
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6.4.4 Generation of Y254A Mutant
A flooding simulation of the Y254A mutant was performed in order to establish the residues responsible for
binding to the TM2 binding site. In each of the five subunits, the Y254A mutant was generated with the
Mutate Residue plugin of VMD [153]. Following generation of the mutant, all heavy atoms in the protein
were harmonically restrained (k = 5.0 kcal/mol·A˚2) while the mutated residue was allowed to accommodate
to the protein lumen over a 2 ns simulation under an NPT ensemble (P = 1.0 atm, T = 298K). Then, the
restraints were removed from the sidechains, but reatined on the protein backbone, allowing the protein to
accommodate to the mutated residue over 2 ns in an NPT ensemble. All harmonic restraints were then
removed and the protein allowed to equilibrated with the environment over 5 ns in an NPT ensemble.Using
this equilibrated structure, the system was flooded with desflurane as described above to a ratio of 1:2
desflurane:POPC. The system was then simulated under an NPT ensemble for 250 ns. The parameters for
desflurane used were those developed in Chapter 5 [280].
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